Fibromyalgia

A common nonarticular rheumatic syndrome characterized by myalgia and multiple points of focal muscle tenderness to palpation (trigger points). Muscle pain is typically aggravated by inactivity or exposure to cold. This condition is often associated with general symptoms, such as sleep disturbances, fatigue, stiffness, HEADACHES, and occasionally DEPRESSION. There is significant overlap between fibromyalgia and the chronic fatigue syndrome (FATIGUE SYNDROME, CHRONIC). Fibromyalgia may arise as a primary or secondary disease process. It is most frequent in females aged 20 to 50 years. (From Adams et al., Principles of Neurology, 6th ed, p1494-95)

Synonyms(1)

Synonym
Fibromyalgia

Research Excerpts

Overview

Excerpt	Reference
"Fibrositis (fibromyalgia) is best treated by attaining patient acceptance of and compliance with a comprehensive treatment program."	( Gatter, RA, 1986)
"Primary fibromyalgia is a common but often unrecognized rheumatic condition."	( Calabro, JJ; Masi, AT; Shah, IK; Yunus, M, 1982)
"Fibromyalgia is rarely included in the differential diagnosis of dyspnea, and timely diagnosis and treatment may be delayed."	( Albert, RK; Kreck, T; Weiss, DJ, 1998)
"Fibromyalgia is a common rheumatologic disorder that is often difficult to treat effectively."	( Gums, JG; Schmidt, SO; Smith, JD; Terpening, CM, 2001)
"Fibromyalgia is a chronic condition that is diagnosed primarily by the presence of generalized pain along with tenderness on palpation of certain body regions."	( Cohen, HM; Freedenfeld, RN; Fuchs, PN; Jewell, C; Kiser, RS, 2001)
"Fibromyalgia is a form of non-articular rheumatism characterised by long term (>3 months) and widespread musculoskeletal aching, stiffness and pressure hyperalgesia at characteristic soft tissue sites, called soft tissue tender points."	( Maes, M; van West, D, 2001)
"Fibromyalgia is a syndrome characterized by chronic musculoskeletal pain and fatigue without biological detectable disturbances."	( Goichot, B; Grunenberger, F; Perrin, AE; Schlienger, JL, 2001)
"Fibromyalgia is a stress-related disorder characterized by chronic pain, memory impairment, and neuroendocrine aberrations."	( Ho, I; Hoover, K; Lynch, G; McGuffin, S; Salmon, P; Sephton, SE; Studts, JL; Weissbecker, I, 2003)
"Fibromyalgia is a common and disabling chronic pain syndrome."	( Calandre, EP; Dominguez, I; García-Leiva, JM; Hidalgo, J; Rico-Villademoros, F, 2005)
"Fibromyalgia is a common disorder characterized by chronic widespread pain that affects an estimated 2% of the general population."	( Wood, PB, 2006)
"Fibromyalgia is a prevalent syndrome characterized by chronic pain, fatigue, and insomnia."	( Alonso, C; Coe, CL; Loevinger, BL; Muller, D, 2007)
"Fibromyalgia is a significant clinical problem associated with generalized pain and significant interference with daily activities."	( Freedenfeld, RN; Fuchs, PN; Kiser, RS; Murray, M, 2006)
"The pain of fibromyalgia is described in terms suggestive of the pain in muscles following extreme exertion and anaerobic metabolism."	( Ali, A; Faridi, Z; Greene, L; Katz, DL, 2007)
"Fibromyalgia is a common disorder that is characterized by chronic widespread pain, tenderness to light palpation, fatigue and sleep disturbances."	( Holman, AJ; Jones, KD; Wood, PB, 2007)
"Fibromyalgia is characterized by chronic widespread pain and bodily tenderness and is often accompanied by affective disturbances."	( Bushnell, MC; Chizh, BA; Dagher, A; Hakyemez, H; Jaeger, E; Rabiner, EA; Schweinhardt, P; Wood, PB, 2007)
"Fibromyalgia is a chronic pain syndrome, common in primary care."	( Allaz, AF; Cedraschi, C; Girard, E; Luthy, C; Rentsch, D, 2007)
"Fibromyalgia is a common and disabling syndrome."	( Clauw, DJ, 2008)
"Fibromyalgia is a disorder characterized by chronic widespread pain."	( Harth, F; Kaiber, F; Machado, F; Malucelli, T; Schafranski, MD; Schmidt, C; Takeshi, H, 2009)
"The etiology of fibromyalgia is not clearly understood."	( Akkuş, S; Eriş, S; Naziroğlu, M; Yalman, K; Yener, M; Yilmaz, N, 2009)
"Fibromyalgia is a prevalent and disabling disorder characterized by widespread pain and other symptoms such as insomnia, fatigue or depression."	( Alda, M; Andrés, E; del Hoyo, YL; García-Campayo, J; Luciano, JV; Magallón, R; Rodero, B; Serrano-Blanco, A, 2009)
"Fibromyalgia is a prevalent and disabling disorder characterized by widespread pain and other symptoms such as insomnia, fatigue or depression."	( Alda, M; Andrés, E; del Hoyo, YL; García-Campayo, J; Luciano, JV; Magallón, R; Rodero, B; Serrano-Blanco, A, 2009)
"Fibromyalgia is associated with reductions in gray matter density within brain regions ostensibly involved in phenomena related to the disorder, including enhanced pain perception, cognitive dysfunction, and abnormal stress reactivity."	( Glabus, MF; Patterson, JC; Simpson, R; Wood, PB, 2009)
"Patients with fibromyalgia are at increased risk to experience increased and prolonged postoperative pain."	( Englbrecht, JS; Pogatzki-Zahn, EM; Schug, SA, 2009)
"Fibromyalgia is a prevalent and burdensome disorder characterized by chronic widespread pain and complex comorbid symptoms."	( Aoki, T; Matsuoka, N; Nagakura, Y; Oe, T, 2009)
"(1) Fibromyalgia is characterised by a range of symptoms that include muscle pain, fatigue and sleep disorders."	( , 2009)
"Fibromyalgia is an ill-defined condition that causes pain and disability but still lacks effective treatment."	( Amital, D; Amital, H; Leader, A; Rubinow, A, 2009)
"Fibromyalgia is a significant health problem for women of working age."	( Kukkurainen, ML; Mikkelsson, M; Peltokallio, L; Sallinen, M, 2010)
"Fibromyalgia is a chronic pain disorder characterized by widespread pain, stiffness, insomnia, fatigue and distress."	( Staud, R, 2010)
"Fibromyalgia is a disorder characterized by chronic widespread musculoskeletal pain and stiffness."	( Briley, M, 2010)
"Fibromyalgia is a chronic pain syndrome with unknown etiology."	( Bonal, P; Bullon, P; Campa, F; Carmona López, IM; Cordero, MD; Cotán, D; De Miguel, M; Garrido Maraver, J; Gómez Izquierdo, L; Moreno Fernández, AM; Navas, P; Sánchez Alcázar, JA, 2010)
"Fibromyalgia is a chronic condition associated with widespread pain, sleep disturbance and disability."	( Bowrin, K; Choy, E; Lloyd, A; Richards, S; Sadosky, A; Watson, P; Zlateva, G, 2010)
"Fibromyalgia is a condition characterized by long term body-wide pain and tender points in joints, muscles and soft tissues."	( Ramachandran, VS; Seckel, EL, 2010)
"Fibromyalgia is a chronic disorder of uncertain aetiology, more common in women than in man, characterized by widespread pain, muscle tenderness and decreased pain threshold to pressure and other stimuli."	( Grembiale, RD; Pipicelli, G; Ursini, F, 2010)
"Fibromyalgia is a difficult-to-treat chronic pain syndrome that affects 2% of the US population."	( Cushman, T; Gardner, H; McDonagh, M; Siler, AC; Yanit, K, 2011)
"Fibromyalgia is a debilitating, chronic pain disorder typically present with allodynia and hyperalgesia."	( Arora, V; Chopra, K; Kuhad, A, 2011)
"Fibromyalgia is characterised by chronic musculoskeletal pain and multiple symptoms including fatigue, multidimensional function impairment, sleep disturbance and tenderness."	( Bennett, RM; Benson, BA; Choy, EH; Lai, C; Spaeth, M; Wang, YG, 2012)
"Fibromyalgia is a chronic widespread pain disorder commonly associated with comorbid symptoms, including fatigue and nonrestorative sleep."	( Arnold, LM; Clauw, DJ; Dunegan, LJ; Turk, DC, 2012)
"Fibromyalgia is a chronic disorder characterized by widespread pain and tenderness."	( Nishioka, K; Ohkura, M; Ohta, H; Oka, H; Suzuki, M; Usui, C, 2012)
"Fibromyalgia is a prevalent chronic rheumatic disease of great clinical importance."	( Andrés, E; Arcega, R; Garcia-Campayo, J; López-del-Hoyo, Y; Magallon, R; Masluk, B; Olivan-Blázquez, B; Pérez-Yus, MC; Puebla, M; Roca, M, 2013)
"Fibromyalgia is characterized by chronic widespread pain and sleep disturbances."	( de Oliveira, AR; Góes, SM; Homann, D; Leite, N; Lopes, AL; Louzada, FM; Roizenblatt, S, 2013)
"Fibromyalgia is a syndrome characterized by the presence of chronic widespread pain, representing sensitization of the central nervous system."	( Ablin, JN; Buskila, D, 2013)
"Fibromyalgia is a common chronic pain disorder with unclear etiology."	( Kim, SC; Landon, JE; Solomon, DH, 2013)
"Fibromyalgia is a pain disorder associated with frequent comorbid mood, anxiety, and sleep disorders."	( Agabio, R; Carboni, M; Carta, MG; Mameli, S; Marchi, A; Melis, MR; Minerba, L; Pili, A; Pisanu, GM; Sardo, S; Trincas, G, 2014)
"Fibromyalgia is a painful disease affecting 1-2% of the United States population."	( Smith, SM; Trinkley, KE; VanderWeide, LA, 2015)
"Fibromyalgia is a chronic pain syndrome characterized by widespread pain, fatigue, and memory and mood disturbances."	( Clauw, DJ; Hampson, JP; Harris, RE; Harte, S; Ichesco, E; Kairys, A; Peltier, S; Schmidt-Wilcke, T, 2014)
"Treatment of fibromyalgia is an unmet medical need."	( Mukae, T; Uchida, H; Ueda, H, 2015)
"Fibromyalgia is diagnosed using an updated set of clinical criteria that no longer depend on tender point examination; laboratory testing may rule out other disorders that commonly present with fatigue, such as anemia and thyroid disease."	( Kodner, C, 2015)
"Fibromyalgia is a diffuse chronic pain condition that occurs predominantly in women and may be under-reported in men."	( Robinson, TD; White, HD, 2015)
"Fibromyalgia is a clinically well-defined chronic condition with a biopsychosocial aetiology."	( Cantrell, SE; Häuser, W; Nishishinya, MB; Urrútia, G; Walitt, B, 2015)
"Fibromyalgia is characterized by widespread pain and is often accompanied by accessory symptoms."	( Alev, L; Mizuno, H; Murakami, M; Nishioka, K; Ochiai, T; Osada, K, 2015)
"Fibromyalgia is characterized by chronic generalized pain accompanied by a wide range of clinical manifestations."	( Calandre, EP; Rico-Villademoros, F; Slim, M, 2015)
"Fibromyalgia is a disorder that is part of a spectrum of syndromes that lack precise classification."	( Borchers, AT; Gershwin, ME, 2015)
"Fibromyalgia is a syndrome of chronic widespread pain typically accompanied by fatigue, nonrestorative sleep, cognitive dysfunction, and mood disorders."	( McCarthy, J, 2016)
"Fibromyalgia is a syndrome characterized by chronic widespread pain and associated with sleep disturbance, depression, fatigue, and cognitive dysfunction."	( Chaparro, LE; DuMerton-Shore, D; Gilron, I; Holden, RR; Milev, R; Towheed, T; Tu, D; Walker, S, 2016)
"Fibromyalgia is a clinically well-defined chronic condition of unknown aetiology characterised by chronic widespread pain that often co-exists with sleep problems and fatigue."	( Häuser, W; Klose, P; Phillips, T; Üçeyler, N; Walitt, B, 2016)
"Fibromyalgia is a clinically well-defined chronic condition of unknown aetiology characterised by chronic widespread pain that often co-exists with sleep problems and fatigue affecting approximately 2% of the general population."	( Fitzcharles, MA; Häuser, W; Klose, P; Phillips, T; Walitt, B, 2016)
"Fibromyalgia is more common in women."	( Cooper, TE; Derry, S; Moore, RA; Wiffen, PJ, 2017)
"Fibromyalgia is a prevalent disorder characterized by chronic widespread pain and complex symptoms."	( Abd El Fattah, MA; Kenawy, SA; Radwan, RR; Shabaan, EA; Shibrya, EE, 2017)
"ConclusionFibromyalgia is a chronic pain disorder characterized by diffuse musculoskeletal pain, fatigue, sleep disturbance and cognitive impairment."	( Arkfeld, DG; Chen, CL; Metyas, S; Solyman, J; Yeter, K, 2018)
"Fibromyalgia is a chronic syndrome characterized by widespread musculoskeletal pain and an extensive array of other symptoms including disordered sleep, fatigue, depression and anxiety."	( Bonomini, F; Favero, G; Lavazza, A; Rezzani, R; Rodella, LF; Stacchiotti, A; Trapletti, V, 2017)
"Fibromyalgia is a refractory disease characterized by chronic intractable pain and psychological suffering, the cause of which has not yet been elucidated due to its complex pathology."	( Hashimoto, R; Hayakawa, K; Hayaki, C; Hosoi, M; Inoue, K; Iwaki, R; Kanba, S; Kato, TA; Ohgidani, M; Sagata, N; Sudo, N; Tsuda, M, 2017)
"Fibromyalgia is a chronic widespread pain condition affecting millions of people worldwide."	( Gilron, I; Moore, RA; Shum, B; Thorpe, J; Wiffen, PJ, 2018)
"Fibromyalgia is a clinically defined chronic condition of unknown etiology characterized by chronic widespread pain that often co-exists with sleep disturbances, cognitive dysfunction and fatigue."	( Häuser, W; Klose, P; Üçeyler, N; Walitt, B; Welsch, P, 2018)
"Fibromyalgia is a poorly understood, chronically disabling pain syndrome."	( Arout, CA; Bastian, LA; Rosenheck, RA; Sofuoglu, M, 2018)
"Fibromyalgia is a clinically defined chronic condition of unknown etiology characterised by chronic widespread pain, sleep disturbance, cognitive dysfunction, and fatigue."	( Bernardy, K; Derry, S; Häuser, W; Moore, RA; Welsch, P, 2018)
"Fibromyalgia is characterized by widespread and chronic pain, and its prevalence is increasing worldwide."	( Cardot, JM; Delage, N; Dualé, C; Giron, F; Macian, N; Marcaillou, F; Pereira, B; Picard, P; Pickering, G; Sickout-Arondo, S, 2018)
"Many people with fibromyalgia are significantly disabled, and experience moderate to severe pain for many years, for which conventional analgesics are usually not effective."	( Costa, J; Ferreira-Dos-Santos, G; Sousa, DC; Vaz-Carneiro, A, 2018)
"Fibromyalgia is a multifaceted chronic pain condition of unknown etiology."	( Jarrahi, B; Mackey, S; Martucci, KT; Nilakantan, AS, 2018)
"Fibromyalgia is a chronic disorder with a very complex symptomatology."	( Cirrito, C; Lleshi, A; Pavanello, M; Piasentin, C; Taibi, R; Tirelli, U, 2019)
"Fibromyalgia is characterized by myalgia and a combination of different symptoms including pain, fatigue, insomnia, morning rigidity, depression and a reduction in every-day functioning."	( Ferreira, I; Moore, P; Ortigoza, Á, 2019)
"Fibromyalgia is a disease characterised as generalised chronic primary pain that causes functional disability and a reduction in patients' quality of life, without specific pathophysiology or appropriate treatment."	( Brusco, I; Cunha, TM; Ferreira, J; Fischer, S; Justino, AB; Machado-de-Ávila, RA; Oliveira, SM; Scussel, R; Silva, CR, 2019)
"The pathogenesis of fibromyalgia is still unknown."	( Alfosea-Cuadrado, G; Blasco-Serra, A; Cervera-Ferri, A; González-Soler, EM; Lloret, A; Martínez-Ricós, J; Teruel-Martí, V; Valverde-Navarro, AA, 2020)
"Fibromyalgia is a heterogeneous condition that appears to be associated with physiological and biochemical disturbances of pain modulation, and that consequently affects numerous other facets of life."	( Civile, V; da Rocha, AP; da Silva Vieira, AG; Mizzaci, CC; Nunes Pinto, ACP; Trevisani, VFM, 2020)
"Fibromyalgia is a refractory syndrome characterized by chronic wayward pain and complex co-morbid psychological trepidation."	( Bhatti, R; Garg, S; Kaur, A; Singh, AP; Singh, L, 2020)
"Fibromyalgia is a common and challenging chronic pain disorder with few, if any, highly effective and well-tolerated treatments."	( Gilron, I; Gray, C; Holden, R; Milev, R; Robb, S; Towheed, T; Tu, D; Wang, L; Ziegler, D, 2021)
"Fibromyalgia is commonly considered a stress-related chronic pain disorder, and daily stressors are known triggers."	( Chen, CC; Chen, CH; Hsu, CY; Hung, CH; Lai, CL; Lee, CH; Lin, HF; Tsai, MH, 2020)
"Fibromyalgia is a complex disease process that is as prevalent as it is poorly understood."	( Berger, AA; Eskander, JP; Gilbert, E; Kaye, AD; Keefe, J; Urits, I; Viswanath, O; Winnick, A; Yazdi, C, 2020)
"Fibromyalgia is characterized by the amplification of central nervous system pain with concomitant fatigue, sleep, mood disorders, depression, and anxiety."	( Antunes, FTT; Campos, MM; Correa, ÁP; de Oliveira, IB; de Souza, AH; do Nascimento Cordeiro, M; Gomez, MV; Klein, CP; Pedron, C; Rebelo, IN, 2021)
"Fibromyalgia is a potentially disabling chronic disease, characterized by widespread pain and a range of comorbidities such as hypertension."	( Brusco, I; Justino, AB; Machado-de-Ávila, RA; Oliveira, SM; Scussel, R; Silva, CR, 2021)
"Fibromyalgia is a common, chronic, and generalized pain syndrome that is often associated with comorbid depression."	( Bhatti, R; Kaur, A; Singh, AP; Singh, L, 2021)
"Fibromyalgia is a common chronic pain condition of unknown aetiology, although mitochondrial dysfunction, oxidative stress, and inflammation have been implicated in the pathophysiology of this disorder."	( Hargreaves, IP; Mantle, D, 2021)
"Fibromyalgia is a disorder of pain processing with characteristic symptoms."	( Bendinger, T; Perfitt, JS, 2021)
"Fibromyalgia is a centralized multidimensional chronic pain syndrome, but its pathophysiology is not fully understood."	( Andronesi, OC; Berry, MP; Edwards, RR; Ellingsen, DM; Grahl, A; Isaro, L; Lazaridou, A; Lee, J; Loggia, ML; Napadow, V; Paschali, M; Ratai, EM; Torrado-Carvajal, A; Wasan, AD; Weerasekera, A, 2021)
"Fibromyalgia is a chronic multidimensional pain disease with no curative treatment currently available."	( Dangoisse, M; Fils, JF; Gillain, A; Javorcikova, Z; Lechat, JP; Nikis, S; Van der Linden, P, 2021)
"Fibromyalgia is a chronic syndrome characterized by widespread muscular pain and tenderness with no evidence of soft tissue inflammation."	( Bou Khalil, R; Zarzour, M, 2022)
"Fibromyalgia is characterized by diffuse musculoskeletal pain and fatigue."	( Dirawi, N; Habib, G, 2022)
"Fibromyalgia is a clinical condition that affects 1% to 5% of the population."	( Cordaro, M; Cuzzocrea, S; D'Amico, R; Di Paola, D; Di Paola, R; Franco, G; Fusco, R; Genovese, T; Impellizzeri, D; Marino, Y; Siracusa, R, 2022)
"Fibromyalgia is a prevalent disorder manifesting with widespread musculoskeletal pain and central sensitization, as well as fatigue, sleep issues, psychologic distress, and poor quality of life."	( Barman, RA; D'Souza, RS; Hagedorn, JM; Schappell, JB, 2023)
"Fibromyalgia is a complex pain-focused syndrome."	( Hayun, Y; Hershkovich, O; Lotan, R; Oscar, N; Shtein, A, 2023)
"Fibromyalgia is a heterogenous primary pain syndrome whose severity has been associated with descending pain modulatory system (DPMS) function and functional connectivity (FC) between pain processing areas."	( Alves, RL; Bruck, SM; Caumo, W; da Silveira Alves, CF; de Oliveira Franco, Á; de Oliveira Venturini, G; Fregni, F; Ramalho, L; Tomedi, R; Torres, ILS; Vicuña, P, 2022)
"Fibromyalgia is a chronic, centralized pain syndrome characterized by disordered processing of painful stimuli."	( Dang, L; Vandal, C; Winslow, BT, 2023)
"Drug therapy for fibromyalgia is limited by incomplete efficacy and dose-limiting adverse effects (AEs)."	( Gilron, I; Holden, RR; Milev, R; Robb, S; Towheed, T; Tu, D, 2023)
"Fibromyalgia is a chronic pain syndrome with unsatisfactory response to current treatments."	( Ablin, JN; Aloush, V; Catalogna, M; Doenyas-Barak, K; Efrati, S; Finci, S; Fishlev, G; Hadanny, A; Korin, C; Lang, E; Meir Genuth, O; Polak, N; Tzidky, RY, 2023)
"Fibromyalgia is a widespread chronic pain syndrome associated with several comorbid conditions that affect the quality of patients' life."	( Abd Elmaaboud, MA; Awad, MM; El-Shaer, RAA; Kabel, AM, 2023)
"Fibromyalgia is not generally recognized as a modifiable risk factor prior to THA."	( Kagan, R; Mildren, ME; Morrell, AT; Smith, S; Yoo, J, 2023)
"Fibromyalgia is a chronic pain syndrome with a multifactorial pathophysiology affecting 2-8 % of the population."	( Abdelghany, AK; Desouky, MK; Ibrahim, MFG; Mokhemer, SA, 2023)
"Fibromyalgia is a prototypical central pain disorder, which is often used as a model to study chronic pain disorders."	( Gulur, P; Nelli, A; Wright, MC, 2023)
"Fibromyalgia is a chronic pain syndrome that is considered a pain processing disorder; its pathophysiology is not completely understood."	( Flynn, D, 2023)

Context

Excerpt	Reference
"Patients with fibromyalgia have an impaired ability to activate the hypothalamic-pituitary portion of the hypothalamic-pituitary-adrenal axis as well as the sympathoadrenal system, leading to reduced ACTH and epinephrine responses to hypoglycemia."	( Adler, GK; Goldenberg, DL; Hurwitz, S; Kinsley, BT; Mossey, CJ, 1999)
"Fibromyalgia has been called a "stress-related disorder" due to the onset and exacerbation of symptoms in the context of stressful events."	( Wood, PB, 2004)
"Fibromyalgia has been characterized as a basic disorder of endocrine stress responses in which psychological stress has been linked both with etiology and symptom severity."	( Banis, PL; Dedert, EA; Salmon, PG; Sephton, SE; Studts, JL; Weissbecker, I, 2004)
"Fibromyalgia has gender, age and probably hormonal associations."	( Eichling, PS; Sahni, J, 2005)
"Both depression and fibromyalgia have many overlapping symptoms, and antidepressants of several classes are among recommended treatment options for patients with fibromyalgia syndrome."	( Branco, JC; Cruz, MR; Filipe, A; Tomé, AM, 2011)
"Fibromyalgia has been associated with dysregulation of the stress systems, but results are inconsistent."	( Lundberg, U; Mork, PJ; Okkenhaug Johansen, T; Riva, R; Westgaard, RH, 2012)
"Patients with fibromyalgia have difficulty with activities of daily living, they exhibit reduced muscle strength and high incidence of reported falls."	( Góes, SM; Homann, D; Leite, N; Rodacki, AL; Shay, BL; Stefanello, JM, 2012)
"Fibromyalgia has a distinct pathophysiology involving central amplification of peripheral sensory signals."	( Kodner, C, 2015)
"Fibromyalgia has been reported as having some clinical overlap with both depression and emotionally-unstable disorders, although both types of disorders present different cortisol suppression response to dexamethasone."	( Carrasco, JL; De la Vega, I; Díaz-Marsá, M; González-Vives, S; López-Villatoro, JM; Palomares, N; Palomo, T; Vázquez, S, 2020)
"Patients with fibromyalgia have diffuse chronic pain, poor sleep, fatigue, cognitive dysfunction, and mood disturbances."	( Dang, L; Vandal, C; Winslow, BT, 2023)

Actions

Excerpt	Reference
"Fibromyalgia Impact Questionnaire outcomes were used for the individuals' treatment and combined across patients for sample-based analyses."	( Feuer, JM; Fischer, PA; Goldenberg, DL; Kieval, RI; Mogavero, N; Rapoport, RJ; Ruthazer, R; Schmid, CH; Selker, HP; Stotsky, SA; Winston, E; Zucker, DR, 2006)
"Fibromyalgia Impact Questionnaire (FIQ), Pittsburgh Sleep Quality Index (PSQI), a Clinical Global Impression improvement scale (CGIi), and a scale evaluating the severity of fibromyalgia symptoms were administered at 4 week intervals for 12 weeks."	( Calandre, EP; Hidalgo, J; Rico-Villademoros, F, 2007)
"Fibromyalgia impact questionnaire was used for functional assessment."	( Sendur, OF; Tastaban, E; Turan, Y; Ulman, C, 2008)
"Fibromyalgia Impact Questionnaire (FIQ), Health Assessment Questionnaire, and a visual analog scale (VAS) for pain were applied before the first lidocaine infusion, immediately after the fifth infusion and 30 days after the fifth infusion."	( Harth, F; Kaiber, F; Machado, F; Malucelli, T; Schafranski, MD; Schmidt, C; Takeshi, H, 2009)
"The Fibromyalgia Impact Questionnaire (FIQ) is a disease-specific composite instrument that measures the effect of problems experienced by patients with fibromyalgia (FM)."	( Bennett, RM; Bushmakin, AG; Cappelleri, JC; Sadosky, AB; Zlateva, G, 2009)
"The fibromyalgia impact questionnaire (FIQ) and clinical examination were done before tegaserod treatment and 1 month after."	( Kalichman, L; Malnick, S; Novochatko, G; Polishchuck, I; Reitblat, T; Zamir, D, 2009)
"The fibromyalgia impact questionnaire (FIQ) tiredness item score (0 to 10 scale) was used to define tiredness subgroups."	( Bennett, R; Bradley, LA; Chappell, AS; D'Souza, DN; Moldofsky, H; Russell, IJ; Wang, F; Wohlreich, MM, 2010)
"Fibromyalgia affects an estimated 2% of the general U."	( Thiessen, CN; Traynor, AP; Traynor, LM, 2011)
"Pain intensity, fibromyalgia impact on quality of life, physical activity level and fall prevalence were assessed."	( Góes, SM; Homann, D; Leite, N; Rodacki, AL; Shay, BL; Stefanello, JM, 2012)
"Fibromyalgia Impact Questionnaire (FIQ) was the main outcome measure, and was administered at baseline and at weeks 4, 8, and 12."	( Calandre, EP; Hidalgo-Tallón, J; Menéndez-Cepero, S; Rodríguez-López, CM; Vilchez, JS, 2013)
"The Fibromyalgia Impact Questionnaire (FIQ) is a patient-reported outcome that evaluates the impact of fibromyalgia (FM) on daily life."	( Bushmakin, AG; Cappelleri, JC; Chandran, AB; Zlateva, G, 2013)
"Fibromyalgia Impact Questionnaire-Revised, Quality of Life Scale, Arthritis Self-efficacy Scale, and COPE Scales for CSs were administered to both the groups."	( Agarwal, GG; Alok, R; Das, SK; Salwahan, L; Srivastava, R; Tiwari, SC, 2014)
"Components of Fibromyalgia Impact Questionnaire-Revised, namely, pain, function, and symptoms, were found to be significantly and negatively associated with problem-focused coping (P < 0."	( Agarwal, GG; Alok, R; Das, SK; Salwahan, L; Srivastava, R; Tiwari, SC, 2014)
"Fibromyalgia impact and pain were analyzed by Fibromyalgia Impact Questionnaire (FIQ), tender points (TPs), visual analog scale (VAS)."	( García-Pinillos, F; Latorre Román, PÁ; Santos E Campos, MA, 2015)
"Fibromyalgia Impact Questionnaire scores were 42."	( Chaparro, LE; DuMerton-Shore, D; Gilron, I; Holden, RR; Milev, R; Towheed, T; Tu, D; Walker, S, 2016)
"They answered the Fibromyalgia Impact Questionnaire (FIQ), Perceived Stress Questionnaire (PSQ) and McGill Pain Questionnaire (MPQ-Br), and collected saliva to evaluate CC before and after the end of each month."	( Borghi, F; da Silva, LGRV; de Oliveira Crege, DRX; de Oliveira, FR; Gomes, AE; Grassi-Kassisse, DM; Luiz de Souza, A; Trevisan, G; Visnardi Gonçalves, LC, 2018)
"They filled out the Fibromyalgia Impact Questionnaire (FIQ) and the Short Form-36 Health Status Questionnaire (SF-36) at baseline and 6 to 12 months after the FTP."	( Hwang, JM; Kim, CH; Lee, BJ; Oh, TH; Park, D, 2019)
"The Fibromyalgia Impact Questionnaire (FIQ) was used for the assessment of FM severity."	( Genç, H; Mansız Kaplan, B; Mülkoğlu, C; Selvi, AB; Taşkın, S; Vural, S, 2020)
"The Fibromyalgia Impact Questionnaire (FIQ) was applied at pre- and postintervention moments and in five visits over eight weeks."	( Bittencourt, PCT; Chaves, C; Pelegrini, A, 2020)
"The data from the fibromyalgia impact questionnaire (FIQ) and the physical and mental subscales short form 36 (SF36) were extracted at last follow-up."	( Colarossi, G; Eschweiler, J; Knobe, M; Maffulli, N; Migliorini, F; Tingart, M, 2022)
"The Revised Fibromyalgia Impact Questionnaire (FIQR), Short-Form Health Survey (SF-12), pain visualized analog scale (pain VAS), Beck Depression Inventory-II (BDI-II), polysymptomatic distress scale (PSD) and serum BDNF were measured and compared at baseline and 4 weeks after treatment in FM group."	( Bidari, A; Gharibpoor, F; Ghavidel-Parsa, B, 2022)
"The fibromyalgia impact questionnaire (FIQ), Pittsburgh sleep quality index (PSQI), and 12-item short-form health survey (SF-12) were used for evaluation pre- and post-intervention."	( Soydaş, N; Sucuoğlu, H, 2023)
"The Fibromyalgia Impact Questionnaire (FIQ1, FIQ2) was applied and compared before and after IV iron treatment."	( Aydemir, AE; Gürcü, S; Hamarat, H; Kıvanç, BK, 2023)

Treatment

Excerpt	Reference
"In conclusion, 28 days treatment of fibromyalgia patients with 5 mg tropisetron resulted in significant pain reduction, which was most pronounced after 10 days with a further reduction up to day 28."	( Haus, U; Müller, W; Späth, M; Stratz, T; Varga, B, 2000)
"Unfortunately, the pharmacological treatment of fibromyalgia remains problematic."	( Cohen, HM; Freedenfeld, RN; Fuchs, PN; Jewell, C; Kiser, RS, 2001)
"Short-term treatment of fibromyalgia patients with 5 mg tropisetron for 10 days proved to be efficacious and well tolerated."	( Brückle, W; Färber, L; Kötter, I; Lautenschläger, J; Müller, W; Neeck, G; Peter, HH; Pongratz, D; Späth, M; Stratz, TH; Welzel, D; Zöller, B, 2001)
"Individuals who were seeking treatment for fibromyalgia had a higher production rate of responses indicating fear and phobic concerns (FEAR) than individuals in the other 2 groups."	( Panek, PE; Skowronski, JJ; Wagner, EE, 2002)
"Duloxetine treatment improved fibromyalgia symptoms and pain severity regardless of baseline status of major depressive disorder."	( Arnold, LM; Crofford, LJ; Detke, MJ; Goldstein, DJ; Iyengar, S; Lu, Y; Wohlreich, M, 2004)
"An interdisciplinary guideline for the treatment of fibromyalgia syndrome (FMS) and chronic widespread pain (CWP) was developed in cooperation with ten German medical and psychological associations and two patients' self-help organizations."	( Berliner, M; Brückle, W; Ehlers, S; Häuser, W; Mönkemöller, K; Moradi, B; Nutzinger, DO; Petzke, F; Sommer, C; Uçeyler, N; Winter, E; Wörz, R, 2008)
"Increasing use of these agents to treat fibromyalgia (FM) raises concern for this unexpected toxicity in a new group of patients."	( Holman, AJ, 2009)
"However response to treatment of fibromyalgia symptoms with paroxetine CR was not associated with a history of depressive and/or anxiety disorders."	( Krulewicz, S; Mannelli, P; Marks, DM; Masand, PS; Pae, CU; Patkar, AA; Peindl, K, 2009)
"Composite responder rates for the treatment of fibromyalgia and fibromyalgia pain (co-primary efficacy variables) were generally higher with milnacipran 100 or 200 mg/day (in two divided doses) than with placebo after 12 weeks of fixed-dose treatment."	( Chwieduk, CM; McCormack, PL, 2010)
"A broad range of drugs has been used to treat fibromyalgia."	( Thiessen, CN; Traynor, AP; Traynor, LM, 2011)
"There is a changing pattern of drug treatment in fibromyalgia, consisting mostly of decreased NSAID and amitriptyline use and an increase in NCAD."	( Häuser, W; Katz, RS; Lee, YC; Michaud, KD; Walitt, BT; Wolfe, F, 2013)
"Canabinoid agonists hold promise in the treatment of fibromyalgia although current evidence is incomplete."	( Ablin, JN; Buskila, D, 2013)
"However, its possible use in the treatment of fibromyalgia (FM) was never demonstrated."	( Albuquerque-Júnior, RL; Araújo, AA; Bonjardim, LR; Camargo, EA; DeSantana, JM; Lucca-Júnior, W; Menezes, PP; Nascimento, SS; Quintans-Júnior, LJ, 2014)
"The pharmacological treatment of fibromyalgia is limited to a few drugs that have been demonstrated to be moderately effective in some but not all dimensions of the disease."	( Calandre, EP; Rico-Villademoros, F; Slim, M, 2014)
"To develop novel therapies for the treatment of fibromyalgia, we explored pain therapeutic actions of existing pharmaceuticals, which inhibit the somatic symptoms frequently observed in fibromyalgia patients."	( Mukae, T; Uchida, H; Ueda, H, 2015)
"Minalcipran has been approved for the treatment of fibromyalgia in several countries including Australia."	( Abtroun, L; Bunouf, P; Gendreau, RM; Vitton, O, 2016)
"It is not licensed for the treatment of fibromyalgia, but is commonly used because fibromyalgia can respond to the same medicines as neuropathic pain."	( Cooper, TE; Derry, S; Moore, RA; Wiffen, PJ, 2017)
"Two studies tested gabapentin to treat fibromyalgia pain."	( Cooper, TE; Derry, S; Moore, RA; Wiffen, PJ, 2017)
"Pregabalin is a drug licensed for the treatment of fibromyalgia in the United States of America, with a mechanism of action similar to gabapentin."	( Costa, J; Ferreira-Dos-Santos, G; Sousa, DC; Vaz-Carneiro, A, 2018)
"MC is an effective treatment for fibromyalgia, with nearly zero % withdrawal from this treatment."	( Habib, G; Levinger, U, 2020)
"In this analysis of a pharmacological treatment for fibromyalgia, most pain summary measures indicated similar effects; improvements in Maximum Pain and Pain Variability contributed to understanding PGIC over Average Pain."	( Broderick, JE; Junghaenel, DU; Ono, M; Schneider, S; Stone, AA, 2021)
"The efficacy of treatments for fibromyalgia is limited and many factors have been identified to trigger the current complaints."	( Aydemir, AE; Gürcü, S; Hamarat, H; Kıvanç, BK, 2023)

Research

Studies (1,804)

Timeframe	Studies, This Condition (%)	All Conditions %
pre-1990	217 (12.03)	23.3326
1990's	217 (12.03)	12.5806
2000's	502 (27.83)	18.1394
2010's	637 (35.31)	28.8240
2020's	231 (12.80)	9.53

Drug	Relationship Strength	Studies	Trials
acetylcarnitine	medium	3	1
2,3-diphosphoglycerate	low	1	0
gamma-aminobutyric acid	medium	131	30
5-hydroxytryptophan	medium	8	1
adenine	low	1	0
ammonium hydroxide	low	1	0
butyric acid	low	1	0
carbamates	low	1	0
carbon monoxide	low	1	0
carnitine	low	2	0
catechol	low	1	0
choline	medium	4	1
citric acid, anhydrous	medium	1	1
chlorine	low	1	0
hydrochloric acid	low	1	0
salicylic acid	low	1	0
guaiacol	low	1	0
n(g),n(g')-dimethyl-l-arginine	low	1	0
malic acid	medium	3	1
creatine	medium	9	3
lactic acid	medium	9	2
formaldehyde	low	2	0
glycine	low	3	0
glycerol	low	1	0
histamine	low	1	0
hydrogen	low	1	0
dihydroxyphenylalanine	medium	4	1
kynurenine	low	4	0
thioctic acid	medium	2	2
racemethionine	low	1	0
inositol	low	1	0
nickel	medium	1	1
niacin	low	3	0
nitrates	low	5	0
nitrites	medium	2	1
4-aminobenzoic acid	low	1	0
phosphorylcholine	low	2	0
phosphorylethanolamine	low	1	0
pyridoxal phosphate	low	1	0
pyridoxine	low	1	0
pyruvic acid	medium	4	1
selenious acid	medium	1	1
thiamine	low	5	0
uric acid	medium	5	2
urea	low	1	0
xanthine	low	1	0
pk 11195	low	2	0
1-anilino-8-naphthalenesulfonate	medium	4	3
homovanillic acid	low	1	0
phenytoin	low	1	0
hydroxyindoleacetic acid	low	6	0
acetaminophen	medium	19	8
alprazolam	medium	2	1
ambroxol	low	1	0
dan 2163	low	2	0
amobarbital	low	1	0
anastrozole	low	1	0
aspirin	medium	10	4
baclofen	low	1	0
bendroflumethiazide	low	1	0
bupivacaine	low	1	0
buspirone	low	1	0
caffeine	medium	2	2
carbamazepine	low	2	0
carisoprodol	medium	4	1
celecoxib	low	1	0
chloral hydrate	low	1	0
chlormezanone	medium	2	1
chloroquine	low	2	0
chlorphenesin carbamate	low	1	0
chlorpromazine	low	4	0
chlorpyrifos	low	2	0
chlorzoxazone	low	2	0
ciprofloxacin	medium	2	1
citalopram	medium	6	4
clonazepam	low	3	0
clonidine	low	2	0
cyproheptadine	low	1	0
debrisoquin	medium	1	1
diazepam	medium	13	1
diclofenac	low	2	0
valproic acid	low	1	0
donepezil	low	1	0
doxazosin	low	1	0
doxepin	low	2	0
erythrosine	low	1	0
ethosuximide	low	1	0
fentanyl	medium	5	1
flufenamic acid	medium	3	3
fluphenazine	low	1	0
flumazenil	low	1	0
guanethidine	low	1	0
hydroxychloroquine	low	2	0
ibuprofen	medium	10	7
phenelzine	medium	1	1
imipramine	low	4	0
indapamide	low	1	0
indomethacin	medium	8	2
isoproterenol	low	2	0
isradipine	low	1	0
ketamine	medium	17	7
ketanserin	medium	1	1
ketoprofen	medium	1	1
lamotrigine	low	1	0
loperamide	low	1	0
maprotiline	low	1	0
meperidine	low	1	0
mephenesin	low	3	0
meprobamate	low	2	0
metformin	low	2	0
methadone	low	1	0
metyrapone	medium	1	1
mianserin	medium	5	3
moclobemide	medium	3	1
modafinil	low	3	0
apnea	low	1	0
neostigmine	low	2	0
nitroglycerin	low	1	0
nortriptyline	medium	1	1
ondansetron	medium	2	1
orphenadrine	low	1	0
oxyphenbutazone	low	4	0
palmidrol	medium	4	1
pargyline	medium	1	1
pentoxifylline	low	1	0
phenobarbital	low	2	0
phenylbutazone	medium	10	3
pindolol	medium	1	1
pioglitazone	low	1	0
piracetam	low	3	0
pirenzepine	low	1	0
prilocaine	medium	1	1
procaine	low	5	0
procyclidine	low	1	0
proglumetacin	medium	1	1
propofol	low	1	0
ramifenazone	low	1	0
ritanserin	medium	1	1
rofecoxib	low	1	0
sibutramine	low	1	0
succinylcholine	medium	2	1
sulpiride	low	2	0
sumatriptan	medium	1	1
tiaprofenic acid	medium	1	1
tolmetin	medium	1	1
tolperisone	low	3	0
trazodone	medium	3	3
triazolam	medium	1	1
triclosan	low	1	0
trimipramine	low	1	0
zolpidem	medium	2	1
zopiclone	medium	2	2
corticosterone	low	1	0
prednisolone	low	7	0
reserpine	low	35	0
phentolamine	low	2	0
thymidine	medium	1	1
hydroxyproline	low	3	0
thyroxine	low	6	0
dextroamphetamine	low	3	0
spironolactone	medium	1	1
aldosterone	low	1	0
penicillamine	low	1	0
prednisone	medium	7	1
dehydroepiandrosterone	medium	4	1
pilocarpine	low	1	0
triiodothyronine	low	3	0
serine	low	1	0
aspartic acid	medium	8	3
glutamine	medium	11	3
lysine	low	1	0
sucrose	low	1	0
tubocurarine	low	1	0
aminopyrine	low	2	0
levodopa	low	1	0
edetic acid	low	1	0
phenylethyl alcohol	low	1	0
methylene blue	low	1	0
zoxazolamine	low	2	0
leucine	low	1	0
methionine	low	4	0
phenylalanine	low	1	0
colchicine	low	2	0
norethindrone	low	1	0
thurfyl nicotinate	low	1	0
asparagine	low	1	0
valine	medium	3	1
tryptophan	medium	24	2
isoleucine	low	2	0
arginine	low	5	0
ethyl chloride	low	2	0
acetonitrile	low	1	0
linalool	low	2	0
isoprene	low	1	0
pantothenic acid	medium	2	1
dehydrocholic acid	low	2	0
methylprednisolone	low	7	0
pyrrolidonecarboxylic acid	low	1	0
pyridostigmine bromide	medium	4	2
chlorphenesin	low	1	0
cyclohexanol	medium	6	2
pyrroles	medium	2	1
thiophenes	medium	74	15
phenformin	low	1	0
1-naphthylamine	medium	1	1
2-naphthol	low	1	0
yohimbine	medium	1	1
thiamine pyrophosphate	medium	1	1
quinazolines	low	1	0
oxazoles	low	1	0
thiazoles	medium	5	2
calcium gluconate	medium	2	1
ephedrine	low	2	0
opipramol	low	1	0
galantamine	low	1	0
betamethasone	low	4	0
hydantoins	low	2	0
imperatorin	low	1	0
alpha-aminopyridine	low	2	0
oleanolic acid	medium	1	1
myrtenol	low	1	0
malondialdehyde	low	8	0
lithium carbonate	low	3	0
glycerylphosphorylcholine	low	1	0
3-hydroxyflavone	medium	2	1
dehydroepiandrosterone sulfate	low	3	0
ethylestrenol	low	1	0
d-alpha tocopherol	medium	7	1
tocopherols	low	1	0
pseudouridine	medium	1	1
selenomethionine	medium	1	1
s,n,n'-tripropylthiocarbamate	low	11	0
dronabinol	medium	12	4
fluorescein	low	1	0
alpha-terpineol	low	1	0
sulfur hexafluoride	low	1	0
floxacillin	low	1	0
n-methylaspartate	low	6	0
manganese	low	1	0
mercury	medium	2	1
osmium	low	1	0
technetium	low	2	0
cadmium	medium	1	1
gadolinium	low	2	0
gold	low	1	0
aluminum chloride	low	1	0
ozone	medium	8	3
radon	low	1	0
trolamine salicylate	medium	139	2
tetrazepam	low	1	0
stanozolol	low	1	0
stearoylethanolamide	low	2	0
tetradecanoylphorbol acetate	low	2	0
lisuride	medium	1	1
phenyl acetate	low	1	0
cetylpyridinium chloride anhydrous	medium	4	2
triamcinolone	low	2	0
4-methoxyamphetamine	low	1	0
glutamic acid	medium	33	7
amoxicillin	low	1	0
tramadol	medium	22	3
s-adenosylmethionine	low	1	0
zidovudine	low	1	0
substance p	medium	41	3
meptazinol	medium	1	1
enkephalin, methionine	medium	2	1
propiconazole	low	3	0
captopril	low	1	0
atracurium	medium	1	1
colforsin	low	1	0
fomesafen	medium	12	3
metsulfuron methyl	low	1	0
flupirtine	low	2	0
idazoxan	low	1	0
atomoxetine hydrochloride	low	1	0
raloxifene hydrochloride	medium	1	1
ziprasidone	medium	2	1
adenosine	low	4	0
carfentanil	low	1	0
trazodone hydrochloride	medium	2	2
glucose, (beta-d)-isomer	low	2	0
n-acetylaspartic acid	medium	7	3
6-sulfatoxymelatonin	medium	3	1
peroxynitric acid	low	2	0
milnacipran	medium	69	28
xenon radioisotopes	low	1	0
triazoles	medium	2	1
fluorodeoxyglucose f18	medium	6	1
sertraline	medium	5	3
ibuproxam	low	1	0
pirlindole	low	3	0
s20098	medium	4	2
3,4-dihydroxyphenylethanol	low	1	0
coenzyme a	low	1	0
nicotine	low	1	0
fibrinogen	medium	5	1
homocysteine	low	1	0
alpha-hydroxyisocaproic acid	low	1	0
vitamin b 6	medium	1	1
pyridinoline	low	3	0
deoxypyridinoline	low	3	0
1,1'-ethylidene bis(tryptophan)	low	1	0
perindopril	low	1	0
2'-5'-oligoadenylate trimer	low	1	0
pentosidine	low	1	0
5-fluorodopamine	low	1	0
peroxynitrous acid	low	1	0
mk 0663	medium	1	1
enkephalin-met, arg(6)-phe(7)-	medium	2	1
n,n-dimethylarginine	low	1	0
glycerophosphoethanolamine	low	1	0
methotrexate	low	2	0
dexpanthenol	low	1	0
2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman	low	1	0
aspartame	medium	2	1
proline	low	1	0
3-(3,5-dichlorophenyl)-1-methyl-2,5-pyrrolidinedione	low	1	0
naproxen	medium	3	2
angiotensin ii	low	1	0
atropine	low	1	0
ropivacaine	low	1	0
esketamine	medium	1	1
isospaglumic acid	medium	1	1
ezlopitant	low	1	0
cholic acid	low	1	0
cortisone	low	3	0
mezlocillin	low	1	0
benzofurans	low	1	0
glycogen	low	3	0
bradykinin	low	1	0
glucosamine	low	2	0
oxytocin	medium	9	2
inositol 3-phosphate	low	1	0
cortodoxone	medium	1	1
pentazocine	low	1	0
rocuronium	low	1	0
lignans	medium	1	1
dironyl	medium	1	1
betadex	low	4	0
retinol	low	1	0
palmitoleic acid	medium	1	1
oleic acid	medium	1	1
cocaine	low	1	0
keratan sulfate	low	2	0
zithromax	low	1	0
enkephalin, leucine	low	2	0
riboflavin	low	1	0
dipyrone	low	1	0
arginine vasopressin	low	1	0
pyrophosphate	low	1	0
iothalamate meglumine	low	1	0
tropisetron	medium	24	12
leuprolide	low	1	0
phenylthiourea	low	1	0
capsaicin	medium	7	1
D-fructopyranose	low	2	0
succimer	low	1	0
capsazepine	low	1	0
tamoxifen	low	1	0
pica	low	1	0
lithium	low	4	0
raclopride	medium	2	1
dolasetron	medium	1	1
quinine	low	1	0
2-(2-benzofuranyl)-2-imidazoline	low	1	0
ascorbigen	medium	1	1
lenabasum	low	1	0
dinoprostone	medium	9	2
dinoprost	low	1	0
calcitriol	low	1	0
vitamin k semiquinone radical	low	1	0
beta carotene	medium	3	1
leukotriene b4	medium	4	1
daphnetin	low	1	0
vitamin d 2	medium	2	2
cholecalciferol	medium	3	1
lutein	low	2	0
esculetin	low	1	0
humulene	medium	17	2
fisetin	low	1	0
sdz psc 833	low	1	0
coenzyme q10	medium	20	7
anandamide	low	2	0
8-epi-prostaglandin f2alpha	low	1	0
glyceryl 2-arachidonate	low	1	0
isotretinoin	low	1	0
n-arachidonylglycine	low	1	0
n-oleoylethanolamine	low	2	0
phenylephrine hydrochloride	low	1	0
granisetron	medium	2	2
hydrocodone	low	1	0
levetiracetam	low	2	0
nabilone	medium	6	2
naloxone	medium	6	2
oxycodone	medium	3	1
topiramate	low	2	0
morphine	medium	8	3
dexmedetomidine	low	1	0
lysophosphatidic acid	low	2	0
lysophosphatidylcholines	low	1	0
neurokinin a	low	1	0
fluvoxamine	medium	1	1
su 11248	low	1	0
lead	medium	1	1
aluminum	low	1	0
dextrorphan	low	1	0
enalapril	low	1	0
cysteine	medium	4	1
phosphorus	medium	6	1
strontium radioisotopes	low	1	0
magnesium citrate	medium	1	1
selenium	medium	5	1
(3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid	low	1	0
dizocilpine maleate	low	1	0
gadolinium dtpa	low	1	0
shu 508	low	1	0
hypericum	low	3	0
phosphocreatine	medium	11	2
tapentadol	low	1	0
n-(2-methoxybenzyl)-n-(4-phenoxypyridin-3-yl)acetamide	low	1	0
mocetinostat	low	2	0
psd 502	medium	1	1
casopitant	low	1	0
ubiquinol	medium	1	1
g(m1) ganglioside	medium	2	1
n-((1-allyl-2-pyrrolidinyl)methyl)-5-(3-fluoropropyl)-2,3-dimethoxybenzamide	low	1	0
cystathionine	low	1	0
substance p	low	1	0
ribose	medium	2	1
lactulose	low	1	0
resolvin d2	low	1	0
lisdexamfetamine dimesylate	low	1	0
empagliflozin	low	1	0
calcimycin	low	1	0
pituitrin	low	1	0
podophyllin	low	1	0
enerbol	low	1	0
jaw	low	3	0
a 803467	low	1	0
calcitonin	medium	1	1
cosyntropin	low	2	0
cholecystokinin	low	1	0
dynorphins	low	2	0
nociceptin	medium	2	1
beta-endorphin	medium	4	2
neuropeptide y	low	6	0
c-peptide	low	1	0
endothelin-1	low	3	0
vendex	medium	7	1
ubiquinone	medium	20	7
9-(tetrahydro-2-furyl)-adenine	low	1	0
optimark	low	1	0
sodium glutamate	medium	2	1
sodium pertechnetate tc 99m	low	2	0
s-adenosylmethionine	medium	6	2
cr4056	low	1	0
suvorexant	medium	1	1
quetiapine fumarate	medium	9	5
cardiovascular agents	low	3	0
gw 1000	low	2	0
piperidines	low	3	0
resolvin d1	low	1	0
interleukin-8	medium	18	3
hydroxocobalamin	low	1	0
vasoactive intestinal peptide	low	1	0
chondroitin	low	2	0
ascorbic acid	medium	8	3
tetracycline	low	1	0
salicylates	medium	9	3
piroxicam	medium	3	1
mobiflex	medium	1	1
warfarin	low	1	0
transforming growth factor beta	low	1	0
vitamin b 12	low	7	0
cyclosporine	low	1	0
technetium tc 99m medronate	low	1	0
thromboplastin	low	1	0
muramidase	low	1	0
exudates	low	2	0
acyclovir	medium	3	1
cyclic gmp	low	1	0
deoxyguanosine	low	1	0
hypoxanthine	low	1	0
inosine	low	1	0
folic acid	low	3	0
neopterin	medium	2	1
clozapine	low	1	0
valacyclovir	medium	1	1
olanzapine	low	5	0
allopurinol	medium	2	1
tegaserod	medium	1	1
sildenafil citrate	low	1	0
8-hydroxy-2'-deoxyguanosine	low	1	0
eye	medium	3	1
ferric carboxymaltose	low	1	0
concanavalin a	low	2	0
technetium tc 99m bicisate	medium	4	1
leptin	medium	10	1

Protein Targets (2,658)

Protein	Potency Measurements	Inhibition Measurements	Activation Measurements	Drugs
Cytochrome P450 2C9	0	38	1	42
Chain B, pheromone binding protein	0	0	1	1
Chain A, pheromone binding protein	0	0	1	1
Chain A, JmjC domain-containing histone demethylation protein 3A	27	0	0	27
Chain A, RNA-directed RNA polymerase NS5	0	1	0	1
acid sphingomyelinase	5	0	0	5
thioredoxin reductase	80	0	0	80
USP1 protein, partial	54	0	0	54
TDP1 protein	121	0	0	121
vitamin D3 receptor isoform VDRA	41	0	0	41
importin subunit beta-1 isoform 1	15	0	0	15
flap endonuclease 1	29	0	0	29
serine/threonine-protein kinase PLK1	11	0	0	11
snurportin-1	15	0	0	15
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	26	0	0	26
GTP-binding nuclear protein Ran isoform 1	8	0	0	8
DNA polymerase eta isoform 1	14	0	0	14
DNA polymerase iota isoform a (long)	47	0	0	47
urokinase-type plasminogen activator precursor	13	0	0	13
plasminogen precursor	13	0	0	13
urokinase plasminogen activator surface receptor precursor	13	0	0	13
geminin	111	0	0	111
DNA polymerase kappa isoform 1	36	0	0	36
fibroblast growth factor 22 isoform 1 precursor	0	0	0	1
Mitogen-activated protein kinase 13	0	1	1	2
Beta-lactamase	0	1	0	1
Transthyretin	0	3	4	11
Fatty acid-binding protein, intestinal	0	5	1	6
Fatty acid-binding protein, adipocyte	0	3	1	4
Cyclin-A2	0	1	0	1
Cannabinoid receptor 1	0	9	3	12
Cyclin-dependent kinase 2	0	3	3	6
Choline O-acetyltransferase	0	2	0	2
Mitogen-activated protein kinase 12	0	1	1	2
Guanine nucleotide-binding protein G	10	0	0	10
Fatty acid-binding protein 5	0	2	1	3
Fatty acid-binding protein 5	0	0	2	2
Mitogen-activated protein kinase 11	0	1	1	2
Mitogen-activated protein kinase 14	0	5	1	6
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE	65	0	0	65
Chain A, HADH2 protein	46	0	0	46
Chain B, HADH2 protein	46	0	0	46
RAR-related orphan receptor gamma	93	0	0	93
GLI family zinc finger 3	103	0	0	103
AR protein	140	0	0	140
aldehyde dehydrogenase 1 family, member A1	81	0	0	81
thyroid stimulating hormone receptor	58	0	0	58
estrogen receptor 2 (ER beta)	61	0	0	61
nuclear receptor subfamily 1, group I, member 3	87	0	0	87
progesterone receptor	67	0	0	67
glucocorticoid receptor [Homo sapiens]	103	0	0	103
retinoic acid nuclear receptor alpha variant 1	101	0	0	101
estrogen-related nuclear receptor alpha	114	0	0	114
pregnane X nuclear receptor	94	0	0	94
estrogen nuclear receptor alpha	149	0	0	149
aryl hydrocarbon receptor	47	0	0	47
thyroid stimulating hormone receptor	40	0	0	40
activating transcription factor 6	44	0	0	44
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a	41	0	0	41
v-jun sarcoma virus 17 oncogene homolog (avian)	56	0	0	56
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1	33	0	0	33
thyroid hormone receptor beta isoform 2	93	0	0	93
nuclear factor erythroid 2-related factor 2 isoform 1	93	0	0	93
cytochrome P450 3A4 isoform 1	56	0	0	56
Gamma-aminobutyric acid receptor subunit pi	56	22	6	84
Voltage-dependent calcium channel gamma-2 subunit	47	0	0	47
Gamma-aminobutyric acid receptor subunit beta-1	56	22	6	84
Gamma-aminobutyric acid receptor subunit delta	56	22	6	84
Gamma-aminobutyric acid receptor subunit gamma-2	56	22	8	86
Glutamate receptor 2	50	3	3	56
Gamma-aminobutyric acid receptor subunit alpha-5	56	22	6	84
Gamma-aminobutyric acid receptor subunit alpha-3	56	22	6	84
Gamma-aminobutyric acid receptor subunit gamma-1	56	22	6	84
Gamma-aminobutyric acid receptor subunit alpha-2	56	22	6	84
Gamma-aminobutyric acid receptor subunit alpha-4	56	22	6	84
Gamma-aminobutyric acid receptor subunit gamma-3	56	22	6	84
Gamma-aminobutyric acid receptor subunit alpha-6	56	22	6	84
Gamma-aminobutyric acid receptor subunit alpha-1	56	25	8	89
Gamma-aminobutyric acid receptor subunit beta-3	56	22	6	84
Gamma-aminobutyric acid receptor subunit beta-2	56	22	8	86
Kelch-like ECH-associated protein 1	0	0	1	1
GABA theta subunit	56	22	6	84
Gamma-aminobutyric acid receptor subunit epsilon	56	22	6	84
Histone acetyltransferase KAT8	0	1	0	1
Chain A, ATP-DEPENDENT DNA HELICASE Q1	15	0	0	15
phosphopantetheinyl transferase	55	0	0	55
Microtubule-associated protein tau	55	0	0	55
glucocerebrosidase	17	0	0	17
Chain A, 2-oxoglutarate Oxygenase	44	0	0	44
Chain A, Amine oxidase [flavin-containing] B	0	0	1	1
cytochrome P450 2D6 isoform 1	38	0	0	38
Alpha-2A adrenergic receptor	0	52	8	63
Alpha-2B adrenergic receptor	0	57	5	65
Alpha-2C adrenergic receptor	0	45	6	54
Alpha-2B adrenergic receptor	0	27	8	35
Amine oxidase [flavin-containing] A	0	14	0	14
Alpha-2C adrenergic receptor	0	27	8	35
Alpha-2A adrenergic receptor	0	28	8	36
Amine oxidase [flavin-containing] B	0	16	2	18
Nischarin	0	6	0	6
Luciferase	33	0	0	33
retinoid X nuclear receptor alpha	76	0	0	76
peroxisome proliferator-activated receptor delta	56	0	0	56
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a	69	0	0	69
Histone H2A.x	31	0	0	31
DNA repair and recombination protein RadA	0	0	1	1
Cellular tumor antigen p53	80	0	0	80
Cytochrome P450 1A2	0	9	1	13
Cytochrome P450 2A6	0	7	2	9
Sulfotransferase 1A1	0	0	0	3
Cytochrome P450 2A5	0	2	0	2
Sulfotransferase 1E1	0	0	0	1
Sulfotransferase 1A1	0	0	0	1
Sulfotransferase 2A1	0	0	0	1
glp-1 receptor, partial	33	0	0	33
Smad3	27	0	0	27
apical membrane antigen 1, AMA1	10	0	0	10
cellular tumor antigen p53 isoform a	21	0	0	21
mitogen-activated protein kinase 1	32	0	0	32
nuclear receptor ROR-gamma isoform 1	33	0	0	33
lamin isoform A-delta10	109	0	0	109
Polyunsaturated fatty acid lipoxygenase ALOX15B	26	2	0	28
Carbonic anhydrase 12	0	11	1	19
Carbonic anhydrase 1	0	29	1	42
Carbonic anhydrase 2	0	31	4	48
Integrin beta-3	13	2	1	16
ATP-dependent translocase ABCB1	0	25	3	35
Integrin alpha-IIb	13	2	1	16
Calmodulin-1	0	4	1	5
Androgen receptor	0	8	3	11
Pyruvate kinase PKM	0	3	1	4
Polyunsaturated fatty acid lipoxygenase ALOX15	0	2	0	2
Polyunsaturated fatty acid lipoxygenase ALOX12	0	2	0	2
Histamine H2 receptor	44	5	2	58
Xanthine dehydrogenase/oxidase	0	10	0	11
Fatty acid synthase	0	2	0	2
Cytochrome P450 1B1	0	8	0	8
Carbonic anhydrase 9	0	15	2	25
Aurora kinase B	0	3	1	4
Dipeptidyl peptidase 3	0	2	0	2
HSP40, subfamily A [Plasmodium falciparum 3D7]	0	0	0	2
Polyunsaturated fatty acid 5-lipoxygenase	0	8	0	9
Genome polyprotein	0	0	1	1
chromobox protein homolog 1	85	0	0	85
transcriptional regulator ERG isoform 3	8	0	0	8
Polyphenol oxidase 2	0	7	0	9
Thiopurine S-methyltransferase	0	1	0	1
Succinate-semialdehyde dehydrogenase, mitochondrial	0	1	0	1
4-aminobutyrate aminotransferase, mitochondrial	0	1	0	2
Dihydropteroate synthase	0	0	1	1
5-hydroxytryptamine receptor 2C	0	30	4	35
5-hydroxytryptamine receptor 2A	0	34	6	40
5-hydroxytryptamine receptor 1A	0	53	6	60
5-hydroxytryptamine receptor 1B	0	39	2	41
5-hydroxytryptamine receptor 1D	0	14	3	17
5-hydroxytryptamine receptor 1F	0	13	2	15
5-hydroxytryptamine receptor 2B	0	27	5	32
5-hydroxytryptamine receptor 6	0	7	2	9
Sodium-dependent serotonin transporter	0	71	8	80
Sodium-dependent serotonin transporter	0	21	3	25
5-hydroxytryptamine receptor 7	0	14	2	16
5-hydroxytryptamine receptor 5A	0	7	2	9
5-hydroxytryptamine receptor 5B	0	7	2	9
5-hydroxytryptamine receptor 3A	0	12	3	15
5-hydroxytryptamine receptor 4	0	7	2	9
5-hydroxytryptamine receptor 3B	0	12	3	15
Alpha-1B adrenergic receptor	0	49	10	59
Beta-1 adrenergic receptor	0	9	2	14
Alpha-1D adrenergic receptor	0	38	10	49
Alpha-1A adrenergic receptor	0	56	12	68
Beta-2 adrenergic receptor	0	3	0	3
Chain A, Avidin	0	0	2	2
Chain A, Avidin	0	0	2	2
Chain B, Avidin	0	0	2	2
cytochrome P450 family 3 subfamily A polypeptide 4	87	0	0	87
EWS/FLI fusion protein	63	0	0	63
G	48	0	0	48
cytochrome P450 2D6	73	0	0	73
Potassium voltage-gated channel subfamily KQT member 3	0	1	1	3
Potassium voltage-gated channel subfamily KQT member 2	0	1	1	3
Interferon beta	66	0	0	66
HLA class I histocompatibility antigen, B alpha chain	48	0	0	48
Muscarinic acetylcholine receptor M2	0	43	4	50
Muscarinic acetylcholine receptor M4	0	36	2	40
5-hydroxytryptamine receptor 1A	0	25	16	41
Muscarinic acetylcholine receptor M5	0	39	1	42
Adenosine receptor A3	0	15	3	19
Muscarinic acetylcholine receptor M1	0	40	7	51
D(2) dopamine receptor	0	51	5	62
Muscarinic acetylcholine receptor M3	0	38	3	43
Cannabinoid receptor 1	0	11	4	18
D(1A) dopamine receptor	0	32	2	36
D(4) dopamine receptor	0	25	2	30
D(1B) dopamine receptor	0	8	0	10
Histamine H2 receptor	0	29	4	33
C-X-C chemokine receptor type 2	0	1	0	1
Endothelin-1 receptor	0	4	1	5
Adenosine receptor A1	0	1	0	1
5-hydroxytryptamine receptor 1B	0	8	2	10
5-hydroxytryptamine receptor 2A	0	57	6	68
5-hydroxytryptamine receptor 2C	0	59	4	64
Adenosine receptor A2a	0	7	6	15
Translocator protein	0	6	1	8
Adenosine receptor A1	0	9	3	15
Cholecystokinin receptor type A	0	2	1	3
C-C chemokine receptor type 1	0	1	0	1
5-hydroxytryptamine receptor 7	0	21	1	22
Cannabinoid receptor 2	0	11	3	17
Histamine H1 receptor	0	40	7	50
Alpha-1B adrenergic receptor	0	12	4	19
Mu-type opioid receptor	0	33	13	50
D(3) dopamine receptor	0	44	4	54
Delta-type opioid receptor	0	26	9	39
Kappa-type opioid receptor	0	27	9	41
Nociceptin receptor	0	5	2	8
P2Y purinoceptor 2	0	1	1	2
5-hydroxytryptamine receptor 3A	0	16	2	20
5-hydroxytryptamine receptor 5A	0	6	0	6
5-hydroxytryptamine receptor 6	0	39	1	43
P2X purinoceptor 3	0	1	1	2
Voltage-dependent N-type calcium channel subunit alpha-1B	0	8	0	8
Potassium voltage-gated channel subfamily H member 2	0	61	0	62
Sodium channel protein type 5 subunit alpha	0	13	0	13
Sodium channel protein type 9 subunit alpha	0	10	0	10
Sodium channel protein type 10 subunit alpha	0	2	0	2
Sodium channel protein type 10 subunit alpha	0	1	0	1
Transient receptor potential cation channel subfamily V member 1	0	6	6	14
Inositol hexakisphosphate kinase 1	48	0	0	48
Sodium channel protein type 2 subunit alpha	0	7	0	7
Sigma non-opioid intracellular receptor 1	0	51	2	53
Sodium channel protein type 3 subunit alpha	0	8	0	8
P2X purinoceptor 2	0	1	2	3
Sodium channel protein type 10 subunit alpha	0	5	0	5
cytochrome P450 2C9, partial	48	0	0	48
ATAD5 protein, partial	49	0	0	49
GLS protein	62	0	0	62
peroxisome proliferator activated receptor gamma	68	0	0	68
peripheral myelin protein 22	62	0	0	62
ATP-binding cassette sub-family C member 3	0	91	0	91
Multidrug resistance-associated protein 4	0	92	0	97
Solute carrier family 22 member 6	0	10	0	12
UDP-glucuronosyltransferase 1A9	0	1	0	5
Bile salt export pump	0	22	0	22
Bile salt export pump	0	146	0	146
Cytochrome P450 2B1	0	0	0	1
Cytochrome P450 1A1	0	0	0	1
Myoglobin	0	1	0	1
Cytochrome P450 1A1	0	3	1	5
Prostaglandin G/H synthase 1	0	18	0	19
Carbonic anhydrase 3	0	8	1	14
Cytochrome P450 3A4	0	31	3	39
Cytochrome P450 2D6	0	37	1	41
Polyunsaturated fatty acid lipoxygenase ALOX15	0	8	0	8
UDP-glucuronosyltransferase 1-6	0	4	0	6
Arachidonate 5-lipoxygenase-activating protein	0	2	0	2
UDP-glucuronosyltransferase 1A1	0	5	0	7
Carbonic anhydrase 4	0	12	1	20
Prostaglandin G/H synthase 1	0	25	0	26
Carbonic anhydrase 6	0	12	1	20
Carbonic anhydrase 5A, mitochondrial	0	9	2	18
Prostaglandin G/H synthase 2	0	21	3	26
Carbonic anhydrase 7	0	9	1	17
Nuclear receptor ROR-gamma	22	0	0	22
Cytochrome P450 2J2	0	23	0	24
Canalicular multispecific organic anion transporter 1	0	89	0	89
Carbonic anhydrase 15	0	10	0	14
Carbonic anhydrase 13	0	6	0	13
Carbonic anhydrase 14	0	7	1	15
Carbonic anhydrase 5B, mitochondrial	0	9	1	17
toxin B	0	0	0	1
pregnane X receptor	16	0	0	16
Chain E, Purine nucleoside phosphorylase	0	1	0	1
Chain A, Ferritin light chain	33	0	0	33
Thymidine kinase	0	2	0	3
arylsulfatase A	50	0	0	50
euchromatic histone-lysine N-methyltransferase 2	133	0	0	133
Bloom syndrome protein isoform 1	44	0	0	44
hemoglobin subunit beta	3	0	0	3
atrial natriuretic peptide receptor 1 precursor	8	0	0	8
ubiquitin carboxyl-terminal hydrolase 2 isoform a	14	0	0	14
Solute carrier family 22 member 1	0	34	0	44
Purine nucleoside phosphorylase	0	2	0	3
Thymidine kinase, cytosolic	0	5	0	10
POU domain, class 2, transcription factor 2	0	0	0	1
Disintegrin and metalloproteinase domain-containing protein 17	10	0	0	10
Purine nucleoside phosphorylase	0	0	2	2
Solute carrier family 22 member 6	0	9	0	15
Thymidine kinase	0	1	0	1
Solute carrier family 22 member 8	0	8	0	15
Thymidine kinase	0	1	0	2
Chain A, MTA/SAH nucleosidase	0	1	0	1
Chain A, Ribosome-inactivating protein alpha-trichosanthin	0	0	1	1
Chain A, Ricin A chain	0	0	1	1
Chain A, Ribosome-inactivating protein 3	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
nuclear factor erythroid 2-related factor 2 isoform 2	30	0	0	30
heat shock protein beta-1	33	0	0	33
tumor susceptibility gene 101 protein	3	0	0	3
Cyclin-dependent kinase 1	0	2	1	3
Heat shock protein HSP 90-beta	0	2	1	4
TAR DNA-binding protein 43	28	0	0	28
Protein mono-ADP-ribosyltransferase PARP15	0	1	0	1
Leucine-rich repeat serine/threonine-protein kinase 2	0	3	1	4
ATPase family AAA domain-containing protein 5	30	0	0	30
Ataxin-2	55	0	0	55
Chain A, Membrane lipoprotein tmpC	0	0	2	2
Chain A, Membrane lipoprotein tmpC	0	0	2	2
Chain A, Membrane lipoprotein tmpC	0	0	2	2
Chain A, Structure of PAE2307 in complex with adenosine	0	0	1	1
Chain B, Structure of PAE2307 in complex with adenosine	0	0	1	1
Chain A, ADENOSINE RECEPTOR A2A	0	1	0	1
Chain A, ADENOSINE RECEPTOR A2A	0	1	0	1
Chain A, tRNA (guanine-N(1)-)-methyltransferase	0	0	1	1
Chain A, Uncharacterized protein MJ0883	0	0	1	1
signal transducer and activator of transcription 6, interleukin-4 induced	1	0	0	1
regulator of G-protein signaling 4	50	0	0	50
NPYLR7B	0	0	4	4
IDH1	39	0	0	39
glycogen synthase kinase-3 beta isoform 1	0	0	2	2
survival motor neuron protein isoform d	30	0	0	30
high affinity choline transporter 1 isoform a	0	1	0	1
Sodium/nucleoside cotransporter 1	0	2	0	2
Calcium dependent protein kinase	0	1	0	1
Mitogen-activated protein kinase kinase kinase 7	0	0	3	3
Sodium/nucleoside cotransporter 2	0	2	0	2
Rap guanine nucleotide exchange factor 3	13	0	0	13
Epidermal growth factor receptor	0	15	1	16
Phosphoglycerate kinase 1	0	1	0	1
Adenosine deaminase	0	0	0	1
Avidin	0	0	1	1
Adenosine deaminase	0	0	0	1
Glyceraldehyde-3-phosphate dehydrogenase	0	2	0	2
Receptor tyrosine-protein kinase erbB-2	0	4	1	5
Insulin receptor	0	1	1	3
Phosphoglycerate kinase 2	0	1	0	1
Heat shock protein HSP 90-alpha	0	2	3	6
Platelet-derived growth factor receptor beta	0	3	1	5
Heat shock 70 kDa protein 1A	0	2	1	3
Heat shock cognate 71 kDa protein	0	0	2	2
Fibroblast growth factor receptor 1	0	1	1	3
Inosine-5'-monophosphate dehydrogenase 2	0	1	1	2
Endoplasmin	0	1	1	3
Inosine-5'-monophosphate dehydrogenase 1	0	1	0	1
Fibroblast growth factor receptor 2	0	0	1	2
Fibroblast growth factor receptor 4	0	0	1	2
Fibroblast growth factor receptor 3	0	0	1	2
Streptavidin	0	0	1	1
Adenosylhomocysteinase	0	1	0	3
Adenosine receptor A1	0	11	1	16
Adenosine receptor A3	0	2	0	2
Adenosine receptor A2b	0	2	1	5
Adenosine receptor A2b	0	4	2	7
Adenylate kinase 2, mitochondrial	0	1	0	1
Adenosine receptor A2a	0	9	3	17
Adenylate kinase isoenzyme 1	0	1	0	1
Phosphatidylinositol 4-kinase alpha	0	5	0	6
Adenosine receptor A1	0	1	1	2
Adenosine kinase	0	0	1	2
Adenosine deaminase	0	1	0	2
Equilibrative nucleoside transporter 2	0	2	0	2
Phosphatidylinositol 4-kinase type 2-beta	0	5	0	6
Histone-lysine N-methyltransferase, H3 lysine-79 specific	0	1	0	1
Equilibrative nucleoside transporter 1	0	2	0	2
Phosphatidylinositol 4-kinase type 2-alpha	0	5	0	6
Solute carrier family 28 member 3	0	2	0	2
Adenosine kinase	0	1	0	2
Phosphatidylinositol 4-kinase beta	0	5	1	7
5-methylthioadenosine/S-adenosylhomocysteine deaminase	0	0	0	1
Adenosine transporter 1	0	0	0	1
Chain A, Heat Shock Protein 90	0	0	1	1
Chain A, GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE	0	0	1	1
Chain B, GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE	0	0	1	1
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN	0	1	0	1
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN	0	1	0	1
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN	0	1	0	1
Chain A, Myosin Ie Heavy Chain	0	0	1	1
Chain A, Preprotein translocase secA	0	0	1	1
Chain A, Ribonuclease pancreatic	0	1	0	1
Chain A, Ribonuclease pancreatic	0	1	0	1
Chain A, Ribonuclease pancreatic	0	1	0	1
Chain A, Ribonuclease pancreatic	0	1	0	1
Chain A, Ribonuclease pancreatic	0	1	0	1
Chain A, Phosphoribosylformylglycinamidine synthase	0	1	0	1
Chain A, nucleoside diphosphate kinase A	0	0	1	1
Chain B, nucleoside diphosphate kinase A	0	0	1	1
Chain D, DNA polymerase III subunit gamma	0	0	1	1
Chain D, DNA polymerase III subunit gamma	0	0	1	1
Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3	0	0	1	1
Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3	0	0	1	1
Chain A, Kinesin-like protein KIF11	0	1	0	1
HPr kinase/phosphorylase	0	0	1	1
ATP-dependent molecular chaperone HSP82	0	0	0	1
2-dehydropantoate 2-reductase	0	1	1	2
Endoplasmic reticulum chaperone BiP	0	1	1	2
Pyruvate kinase PKM	0	0	0	1
Pyruvate kinase PKLR	0	0	0	1
Heat shock cognate 71 kDa protein	0	0	1	1
5'-nucleotidase	0	2	0	2
Endoplasmin	0	1	1	2
P2X purinoceptor 1	0	0	2	2
P2Y purinoceptor 1	0	0	1	1
P2Y purinoceptor 1	0	0	1	1
P2X purinoceptor 1	0	1	1	2
P2X purinoceptor 4	0	1	2	3
P2X purinoceptor 5	0	0	1	1
P2X purinoceptor 6	0	0	1	1
Inositol monophosphatase 1	23	0	0	23
Heat shock protein 75 kDa, mitochondrial	0	1	0	1
P2Y purinoceptor 6	0	0	1	1
P2Y purinoceptor 11	0	0	1	1
P2Y purinoceptor 12	0	3	1	4
Sensor protein kinase WalK	0	1	0	1
thyroid hormone receptor beta isoform a	38	0	0	38
Sex hormone-binding globulin	0	0	6	6
Corticosteroid-binding globulin	0	6	0	6
Mineralocorticoid receptor	0	5	4	10
Androgen receptor	0	16	0	17
Mineralocorticoid receptor	0	1	0	1
Solute carrier organic anion transporter family member 1A1	0	3	0	6
interleukin 8	15	0	0	15
ras-related protein Rab-9A	20	0	0	20
Hypoxanthine-guanine phosphoribosyltransferase	0	0	0	2
Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase	0	2	0	2
Nuclear receptor ROR-gamma	0	2	0	2
Xanthine dehydrogenase/oxidase	0	5	1	8
Shiga toxin subunit A	0	1	0	1
Histamine H3 receptor	0	3	0	5
Botulinum neurotoxin type A	0	1	0	1
Neutrophil cytosol factor 1	0	1	0	1
Nitric oxide synthase, endothelial	0	1	0	1
Nitric oxide synthase, brain	0	2	0	3
Nitric oxide synthase, brain	0	2	0	4
Nitric oxide synthase, inducible	0	2	1	6
Kappa-type opioid receptor	0	14	3	20
Mu-type opioid receptor	0	20	5	26
Tyrosine-protein kinase	0	0	1	1
Bromodomain-containing protein 4	0	0	1	1
Gamma-aminobutyric acid receptor subunit alpha-1	0	14	8	22
Gamma-aminobutyric acid receptor subunit gamma-2	0	14	5	19
Cholecystokinin receptor type A	0	5	0	5
Gamma-aminobutyric acid receptor subunit alpha-5	0	13	8	21
Gamma-aminobutyric acid receptor subunit alpha-3	0	13	6	19
Gamma-aminobutyric acid receptor subunit alpha-2	0	13	5	18
Gamma-aminobutyric acid receptor subunit beta-2	0	12	4	16
Cholecystokinin receptor type A	0	3	0	3
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)	20	0	0	20
parathyroid hormone/parathyroid hormone-related peptide receptor precursor	19	0	0	19
Lysosomal acid glucosylceramidase	0	1	1	2
15-lipoxygenase, partial	30	0	0	30
vitamin D (1,25- dihydroxyvitamin D3) receptor	67	0	0	67
histone deacetylase 9 isoform 3	8	0	0	8
Nicotinate phosphoribosyltransferase	0	7	0	7
ORF73	0	0	3	3
NFKB1 protein, partial	23	0	0	23
D(1A) dopamine receptor	41	0	0	41
atrial natriuretic peptide receptor 2 precursor	14	0	0	14
serine/threonine-protein kinase mTOR isoform 1	25	0	0	25
muscarinic acetylcholine receptor M1	44	0	0	44
Voltage-dependent L-type calcium channel subunit alpha-1F	0	10	1	11
5-hydroxytryptamine receptor 4	0	47	1	48
Albumin	0	0	9	9
High affinity nerve growth factor receptor	0	1	3	4
Aldo-keto reductase family 1 member B1	0	39	0	39
Muscarinic acetylcholine receptor M1	0	16	2	21
Muscarinic acetylcholine receptor M3	0	15	2	20
Muscarinic acetylcholine receptor M4	0	15	2	20
Muscarinic acetylcholine receptor M5	0	16	2	21
Muscarinic acetylcholine receptor M2	0	16	2	22
Angiotensin-converting enzyme	0	28	0	29
UDP-glucuronosyltransferase 1A4	0	4	0	11
Sodium-dependent noradrenaline transporter	0	58	7	65
Alpha-1D adrenergic receptor	0	47	4	54
Histamine H1 receptor	0	10	1	11
Sodium channel protein type 1 subunit alpha	0	5	0	5
Sodium channel protein type 4 subunit alpha	0	8	0	11
UDP-glucuronosyltransferase 1A3	0	0	0	7
5-hydroxytryptamine receptor 2B	0	57	3	61
D(1A) dopamine receptor	18	0	0	18
5-hydroxytryptamine receptor 7	0	16	0	16
Sodium channel protein type 7 subunit alpha	0	3	0	3
Voltage-dependent L-type calcium channel subunit alpha-1D	0	10	1	11
Sodium-dependent dopamine transporter	0	41	5	47
Voltage-dependent L-type calcium channel subunit alpha-1S	0	10	1	11
Voltage-dependent L-type calcium channel subunit alpha-1C	0	15	1	16
Sigma non-opioid intracellular receptor 1	0	11	2	13
Nuclear receptor subfamily 3 group C member 3	0	25	0	25
Sodium channel protein type 11 subunit alpha	0	3	0	3
Sodium channel protein type 8 subunit alpha	0	3	0	3
Histamine H3 receptor	0	10	2	12
farnesoid X nuclear receptor	57	0	0	57
Chain A, Beta-lactamase	33	0	0	33
Beta-lactamase	0	0	0	1
Beta-lactamase	0	0	0	2
Beta-lactamase	0	0	0	2
Beta-lactamase	0	0	0	2
Beta-lactamase	0	0	0	2
Beta-lactamase SHV-1	0	0	0	2
Beta-lactamase SHV-1	0	0	0	2
Beta-lactamase	0	0	0	2
Solute carrier family 15 member 1	0	7	0	8
Solute carrier family 15 member 1	0	4	0	4
B2 metallo-beta-lactamase	0	0	0	2
Solute carrier family 15 member 2	0	2	0	2
Beta-lactamase	0	0	0	2
Beta-lactamase	0	0	0	2
Solute carrier family 15 member 2	0	4	0	4
Beta-lactamase	0	0	0	2
Beta-lactamase	0	0	0	2
Fatty-acid amide hydrolase 1	0	7	0	7
Fatty-acid amide hydrolase 1	0	1	0	2
Potassium channel subfamily K member 3	0	4	0	4
Fatty acid-binding protein, liver	0	5	0	5
Glutamate receptor 1	3	3	3	9
Glutamate receptor 3	3	3	3	9
Glutamate receptor 4	3	3	3	9
Cannabinoid receptor 1	0	3	1	4
Cannabinoid receptor 2	0	2	2	4
Fatty-acid amide hydrolase 1	0	7	0	8
Corticotropin-releasing factor receptor 2	0	4	0	4
Lanosterol 14-alpha demethylase	0	1	0	1
Potassium channel subfamily K member 2	0	1	0	1
Cannabinoid receptor 2	0	4	0	4
Transient receptor potential cation channel subfamily V member 2	0	7	3	10
Aromatase	0	6	0	6
Amine oxidase [flavin-containing] A	0	7	1	8
Spike glycoprotein	54	3	7	64
histone acetyltransferase KAT2A isoform 1	38	0	0	38
Atrial natriuretic peptide receptor 3	0	1	0	1
Type-1A angiotensin II receptor	0	2	1	3
Type-1 angiotensin II receptor	0	0	1	1
Type-1B angiotensin II receptor	0	2	0	2
Type-1 angiotensin II receptor	0	3	3	6
Type-2 angiotensin II receptor	0	6	0	6
Type-2 angiotensin II receptor	0	2	0	2
neuropeptide S receptor isoform A	18	0	0	18
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN	0	0	1	1
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN	0	0	1	1
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN	0	0	1	1
alpha-galactosidase	10	0	0	10
cytochrome P450 2C19 precursor	23	0	0	23
lethal factor (plasmid)	29	0	0	29
Nitric oxide synthase, endothelial	0	0	0	2
Nitric oxide synthase, inducible	0	1	0	2
Cationic amino acid transporter 3	0	2	0	2
ATP-dependent phosphofructokinase	57	0	0	57
Translocator protein	0	7	5	13
Vasopressin V2 receptor	0	3	2	6
Oxytocin receptor	0	3	3	6
Vasopressin V1a receptor	0	1	3	4
Vasopressin V1a receptor	0	4	3	7
Vasopressin V1b receptor	0	2	2	4
Vasopressin V2 receptor	0	0	1	1
Vasopressin V1b receptor	0	2	1	4
Translocator protein	0	1	0	2
Oxytocin receptor	0	2	1	3
Vasopressin V2 receptor	0	2	1	3
Chain A, Hyaluronidase, phage associated	0	1	0	1
acetylcholinesterase	45	0	0	45
thioredoxin glutathione reductase	19	0	0	19
lethal(3)malignant brain tumor-like protein 1 isoform I	7	0	0	7
Pancreatic alpha-amylase	0	2	0	2
Albumin	0	2	0	3
Urease	0	1	0	1
Prolyl 4-hydroxylase subunit alpha-1	0	0	0	1
Tyrosinase	0	4	0	4
Hyaluronate lyase	0	1	0	1
Prolyl hydroxylase EGLN2	0	0	1	2
Egl nine homolog 1	0	0	1	2
Prolyl hydroxylase EGLN3	0	0	1	2
Hypoxia-inducible factor 1-alpha inhibitor	0	0	0	1
Solute carrier family 23 member 1	0	1	0	1
Neutral amino acid transporter A	0	5	0	5
Neutral amino acid transporter B(0)	0	5	0	5
Carbonic anhydrase-like protein, putative	0	0	0	8
Amino acid transporter	0	5	0	5
Chain A, TYROSYL-DNA PHOSPHODIESTERASE	35	0	0	35
Metabotropic glutamate receptor 6	0	1	2	4
Excitatory amino acid transporter 4	0	2	0	2
Glutamate transporter homolog	0	0	1	1
N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase	0	1	0	1
5-hydroxytryptamine receptor 1D	0	7	1	11
Glutamate receptor ionotropic, NMDA 1	0	18	5	28
Excitatory amino acid transporter 1	0	3	0	4
Excitatory amino acid transporter 2	0	3	0	4
Excitatory amino acid transporter 3	0	3	0	4
Glutamate receptor ionotropic, NMDA 2A	0	17	5	27
Glutamate receptor ionotropic, NMDA 2B	0	18	5	28
Glutamate receptor ionotropic, NMDA 2C	0	18	5	28
Metabotropic glutamate receptor 1	0	1	2	4
Metabotropic glutamate receptor 2	0	1	2	4
Glutamate receptor ionotropic, NMDA 2D	0	17	5	27
Glutamate receptor ionotropic, NMDA 3B	0	17	5	27
Carbonic anhydrase 4	0	6	0	8
Glutamate receptor ionotropic, NMDA 3A	0	17	5	27
Chain A, Phospholipase A2 isoform 3	0	0	1	1
GTP-binding protein (rab7)	0	0	3	3
ras protein, partial	0	0	3	3
hypothetical protein, conserved	7	0	0	7
Rac1 protein	0	0	3	3
cell division cycle 42 (GTP binding protein, 25kDa), partial	0	0	3	3
Prostaglandin-H2 D-isomerase	0	2	0	2
Prostaglandin G/H synthase 1	0	9	0	10
Prostaglandin G/H synthase 2	0	7	0	8
Fatty acid-binding protein, liver	0	6	0	6
Myeloperoxidase	0	4	0	4
Seed linoleate 13S-lipoxygenase-1	0	5	0	5
Glutathione hydrolase 1 proenzyme	0	1	0	1
Substance-P receptor	0	5	0	5
Urotensin-2 receptor	0	2	0	2
4-aminobutyrate aminotransferase, mitochondrial	0	2	0	2
Ras-related protein Rab-2A	0	0	3	3
Prostaglandin G/H synthase 2	0	13	0	13
Rho-associated protein kinase 2	0	2	0	2
Solute carrier family 22 member 20	0	8	0	8
Solute carrier family 22 member 6	0	8	0	8
Sigma non-opioid intracellular receptor 1	0	12	3	15
Small conductance calcium-activated potassium channel protein 3	0	2	1	3
cystic fibrosis transmembrane conductance regulator	0	1	0	1
DNA polymerase beta	14	0	0	14
short transient receptor potential channel 6 isoform 1	0	0	2	2
Muscarinic acetylcholine receptor M1	0	1	1	3
Muscarinic acetylcholine receptor M4	0	3	0	3
Reverse transcriptase/RNaseH	0	1	2	7
Muscarinic acetylcholine receptor	0	2	1	4
67.9K protein	24	0	0	24
Gamma-aminobutyric acid type B receptor subunit 2	0	2	2	4
Gamma-aminobutyric acid type B receptor subunit 2	0	3	0	3
Gamma-aminobutyric acid type B receptor subunit 1	0	2	2	4
Gamma-aminobutyric acid type B receptor subunit 1	0	2	0	2
potassium voltage-gated channel subfamily H member 2 isoform d	45	0	0	45
core protein, partial	0	1	0	1
Solute carrier organic anion transporter family member 1B3	0	4	0	7
Solute carrier organic anion transporter family member 1B1	0	4	0	7
Chain A, D-MALTODEXTRIN BINDING PROTEIN	0	0	1	1
Chain A, Limit Dextrinase	0	0	1	1
Chain A, Solute-binding protein	0	0	1	1
Chain A, Solute-binding protein	0	0	1	1
Chain B, SusD	0	0	1	1
Chain A, SusD	0	0	1	1
Chain A, SusD	0	0	1	1
Chain A, Alpha-hemolysin	0	0	1	1
Chain B, Alpha-hemolysin	0	0	1	1
Chain C, Alpha-hemolysin	0	0	1	1
Chain D, Alpha-hemolysin	0	0	1	1
Chain E, Alpha-hemolysin	0	0	1	1
Chain F, Alpha-hemolysin	0	0	1	1
Chain G, Alpha-hemolysin	0	0	1	1
nuclear receptor subfamily 1, group I, member 2	10	0	0	10
galanin receptor type 3	0	1	0	1
Glucocorticoid receptor	0	16	3	24
Glycine receptor subunit alpha-1	0	16	0	16
Glycine receptor subunit beta	0	16	0	16
Glycine receptor subunit alpha-2	0	16	0	16
Glycine receptor subunit alpha-3	0	16	0	16
Angiotensin-converting enzyme	0	7	1	9
B2 bradykinin receptor	0	1	0	1
B2 bradykinin receptor	0	4	1	7
B1 bradykinin receptor	0	1	0	1
Olfactory receptor 51E2	0	1	3	4
Potassium channel subfamily K member 3	0	1	0	1
Potassium channel subfamily K member 2	0	5	4	9
Potassium channel subfamily K member 9	0	1	0	1
Acetylcholine receptor subunit alpha	0	4	1	5
Acetylcholine receptor subunit gamma	0	4	1	5
Integrin alpha-5	0	1	0	1
Acetylcholine receptor subunit beta	0	4	1	5
UDP-glucuronosyltransferase 2B7	0	4	0	10
Neuronal acetylcholine receptor subunit beta-2	0	7	1	9
Cytochrome P450 2B6	0	4	1	7
Sodium-dependent dopamine transporter	0	21	2	23
Neuronal acetylcholine receptor subunit beta-4	0	5	1	7
Neuronal acetylcholine receptor subunit alpha-3	0	6	1	7
Cytochrome P450 2C19	0	17	0	19
UDP-glucuronosyltransferase 2B10	0	3	0	3
Neuronal acetylcholine receptor subunit alpha-7	0	4	3	7
Neuronal acetylcholine receptor subunit alpha-4	0	7	1	9
Acetylcholine receptor subunit delta	0	4	1	5
hypoxia-inducible factor 1 alpha subunit	34	0	0	34
cytochrome P450 2C9 precursor	25	0	0	25
Solute carrier family 22 member 2	0	9	0	15
Beta-2 adrenergic receptor	0	8	1	11
D	0	22	0	22
D(3) dopamine receptor	0	20	1	21
D(2) dopamine receptor	0	4	0	4
D(1B) dopamine receptor	0	14	0	14
Beta-3 adrenergic receptor	0	6	1	7
D(4) dopamine receptor	0	15	0	15
D(2) dopamine receptor	0	37	4	42
Alpha-2A adrenergic receptor	0	2	0	2
D	0	2	0	2
5-hydroxytryptamine receptor 2A	0	1	0	1
Multidrug and toxin extrusion protein 2	0	5	0	5
D	0	5	0	5
Multidrug and toxin extrusion protein 1	0	15	0	15
Lysosomal alpha-glucosidase	0	2	0	2
Chain A, Nitrile Hydratase alpha subunit	0	1	0	1
Chain B, Nitrile Hydratase beta subunit	0	1	0	1
SMAD family member 2	33	0	0	33
SMAD family member 3	33	0	0	33
Lysine-specific demethylase 4E	0	1	0	1
Free fatty acid receptor 3	0	0	1	1
Histone deacetylase 3	0	8	0	8
Histone deacetylase 4	0	7	0	7
Histone deacetylase 1	0	8	0	8
Histone deacetylase 7	0	7	0	7
Histone deacetylase 2	0	8	0	8
Polyamine deacetylase HDAC10	0	5	0	5
Histone deacetylase 11	0	6	0	6
Histone deacetylase 8	0	7	0	7
Histone deacetylase 6	0	7	0	7
Histone deacetylase 9	0	6	0	6
Histone deacetylase 5	0	7	0	7
Methyl-accepting chemotaxis protein NahY	0	0	2	2
Chain A, Glycogen Phosphorylase	0	1	0	1
Chain A, Glycogen phosphorylase, liver form	0	0	2	2
Chain A, glycogen phosphorylase, liver form	0	0	2	2
Chain A, Glycogen phosphorylase, liver form	0	0	2	2
Chain A, Glycogen phosphorylase, liver form	0	0	2	2
Chain A, Chitinase	0	1	0	1
Glycogen phosphorylase, muscle form	0	3	0	3
Renin	0	2	1	3
Cholinesterase	0	12	0	12
Glycogen phosphorylase, liver form	0	1	0	1
Glycogen phosphorylase, muscle form	0	1	0	1
Replicase polyprotein 1ab	0	6	7	13
Replicase polyprotein 1ab	0	8	7	15
Acetylcholinesterase	0	23	3	27
cAMP-specific 3',5'-cyclic phosphodiesterase 4A	0	4	0	4
Vasopressin V2 receptor	0	0	0	1
Serine/threonine-protein kinase mTOR	0	3	1	4
Adenosine receptor A2a	0	1	0	1
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	0	2	1	3
DNA-dependent protein kinase catalytic subunit	0	2	0	2
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	0	1	0	1
Adenylate cyclase type 1	0	1	1	3
Chitotriosidase-1	0	3	1	4
Serine-protein kinase ATM	0	1	0	1
Serine/threonine-protein kinase ATR	0	1	1	2
Adenosine receptor A2b	0	1	0	2
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C	0	1	0	1
Palmitoleoyl-protein carboxylesterase NOTUM	0	2	2	4
Endochitinase B1	0	3	1	4
Phosphodiesterase	0	1	0	1
Broad substrate specificity ATP-binding cassette transporter ABCG2	0	4	1	6
Guanine deaminase	0	3	0	3
Chain A, Putative fructose-1,6-bisphosphate aldolase	20	0	0	20
Chain A, Cruzipain	13	0	0	13
endonuclease IV	23	0	0	23
ClpP	6	0	0	6
electroneutral potassium-chloride cotransporter KCC2	0	0	1	1
Fumarate hydratase	25	0	0	25
TSHR protein	2	0	0	2
nonstructural protein 1	16	0	0	16
polyprotein	25	0	0	25
Parkin	11	0	0	11
LacZ protein (plasmid)	0	0	1	1
XBP1	0	1	0	1
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)	14	0	0	14
serine-protein kinase ATM isoform a	4	0	0	4
lysosomal alpha-glucosidase preproprotein	10	0	0	10
hexokinase-4 isoform 1	5	0	0	5
NPC intracellular cholesterol transporter 1 precursor	12	0	0	12
peripheral myelin protein 22 isoform 1	25	0	0	25
type-1 angiotensin II receptor	0	1	0	1
glucokinase regulatory protein	5	0	0	5
huntingtin isoform 2	10	0	0	10
apelin receptor	0	1	0	1
heat shock protein HSP 90-alpha isoform 2	0	1	0	5
DNA damage-inducible transcript 3 protein	0	1	0	1
Vpr	8	0	0	8
streptokinase A precursor	0	0	3	3
Amyloid-beta precursor protein	1	8	0	9
Alpha-synuclein	11	2	0	13
heat shock protein 90, putative	0	0	0	4
Chain A, Vitamin D Nuclear Receptor	0	0	1	1
Vitamin D3 receptor	0	0	1	1
PPM1D protein	19	0	0	19
Vitamin D-binding protein	0	0	1	1
Vitamin D3 receptor	0	3	4	11
Vitamin D3 receptor	0	1	1	3
Retinoic acid receptor RXR-alpha	0	0	3	3
Vitamin D3 receptor	0	0	2	2
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial	0	0	1	1
Vitamin D3 receptor	0	1	1	2
Transporter	0	6	0	6
Vitamin D3 receptor A	0	0	2	2
Acetylcholinesterase	0	13	0	13
L-lactate dehydrogenase A chain	0	2	0	2
Cytochrome P450 2C11	0	2	0	2
Steroid 17-alpha-hydroxylase/17,20 lyase	0	1	0	1
Cytochrome P450 3A5	0	2	0	2
Cytochrome P450 3A7	0	2	0	2
Caspase-1	0	4	1	6
Peroxisome proliferator-activated receptor gamma	0	2	8	11
Cholinesterase	0	9	0	9
N-acylethanolamine-hydrolyzing acid amidase	0	1	0	1
Heat sensitive channel TRPV3	0	1	1	2
Sigma intracellular receptor 2	0	5	0	5
Transient receptor potential cation channel subfamily A member 1	0	1	2	3
Transient receptor potential cation channel subfamily M member 8	0	1	0	1
Transient receptor potential cation channel subfamily V member 4	0	2	3	5
G-protein coupled receptor 55	0	1	2	3
Diacylglycerol lipase-alpha	0	1	0	1
transient receptor potential cation channel subfamily V member 1	3	0	0	3
Transient receptor potential cation channel subfamily V member 1	0	5	2	7
Lysine-specific histone demethylase 1A	0	2	0	2
NADH-ubiquinone oxidoreductase chain 1	0	1	0	1
Potassium voltage-gated channel subfamily A member 1	0	1	1	2
Thrombopoietin	14	0	0	14
bromodomain adjacent to zinc finger domain 2B	25	0	0	25
polyunsaturated fatty acid lipoxygenase ALOX12	7	0	0	7
M-phase phosphoprotein 8	29	0	0	29
Transient receptor potential cation channel subfamily M member 8	0	1	0	1
Transient receptor potential cation channel subfamily M member 8	0	1	0	1
Chain A, angiotensin converting enzyme	0	1	0	1
Chain A, angiotensin converting enzyme	0	1	0	1
Metallo-beta-lactamase type 2	0	1	1	3
Prothrombin	0	1	2	3
Neprilysin	0	1	0	1
Neprilysin	0	1	0	1
Leukotriene A-4 hydrolase	0	3	1	4
EEF1AKMT4-ECE2 readthrough transcript protein	0	1	0	1
Leukotriene A-4 hydrolase	0	1	0	1
Thymidine phosphorylase	0	0	1	2
Endothelin-converting enzyme 1	0	1	0	1
Succinyl-diaminopimelate desuccinylase	0	5	0	5
Angiotensin-converting enzyme	0	6	0	6
Beta-lactamase TEM	0	1	0	1
Beta-lactamase	0	3	0	4
Beta-lactamase	0	3	0	3
Angiotensin-converting enzyme 2	0	5	7	12
Beta-lactamase class B VIM-2	0	1	1	3
Major prion protein	0	0	4	4
Sodium channel protein type 1 subunit alpha	0	6	0	6
Sodium channel protein type 2 subunit alpha	0	7	0	7
Sodium channel protein type 3 subunit alpha	0	6	0	6
Frizzled-8	0	0	1	1
P2X purinoceptor 4	0	2	0	2
Delta-type opioid receptor	0	18	4	23
Mu-type opioid receptor	0	19	5	27
Kappa-type opioid receptor	0	11	4	16
Solute carrier family 22 member 5	0	0	0	1
Solute carrier family 22 member 5	0	0	0	1
Solute carrier family 22 member 16	0	0	0	1
Solute carrier family 22 member 21	0	0	0	1
Solute carrier family 22 member 5	0	0	0	1
Substance-P receptor	0	7	1	8
Chain A, Neutrophil gelatinase-associated lipocalin	0	0	1	1
Nrf2	3	0	0	3
DNA dC->dU-editing enzyme APOBEC-3G isoform 1	4	1	0	5
Tyrosine-protein kinase Fyn	0	5	1	6
3-dehydroquinate synthase	0	1	0	2
Matrix metalloproteinase-9	0	1	0	1
Prolyl 4-hydroxylase subunit alpha-1	0	2	0	2
Potassium-transporting ATPase subunit beta	0	0	0	1
Potassium-transporting ATPase alpha chain 1	0	0	0	1
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	0	2	1	3
Autoinducer 2-binding periplasmic protein LuxP	0	2	0	2
E3 ubiquitin-protein ligase Mdm2	0	1	0	1
Glutaminyl-peptide cyclotransferase	0	2	0	2
Arginase-1	0	1	0	1
Carbonic anhydrase	0	2	0	2
Carbonic anhydrase 3	0	2	0	2
phosphoglycerate kinase	6	0	0	6
Beta-lactamase	0	0	0	1
Beta-lactamase	0	0	0	1
Beta-lactamase	0	1	0	1
Beta-lactamase	0	0	0	1
Metallo-beta-lactamase VIM-11	0	0	0	1
Metallo-beta-lactamase VIM-2	0	0	0	1
Beta-lactamase	0	0	0	1
Metallo-beta-lactamase VIM-19	0	0	0	1
Beta-lactamase	0	0	0	1
Beta-lactamase	0	0	0	1
Metallo-beta-lactamase	0	0	0	1
Beta-lactamase	0	1	0	1
Albumin	0	7	11	19
Beta-lactamase	0	0	0	1
Beta-lactamase	0	0	0	1
Beta-lactamase	0	0	0	1
Metallo-beta-lactamase VIM-13	0	1	0	2
Beta-lactamase	0	0	0	1
Beta-lactamase	0	0	0	1
Metallo-beta-lactamase VIM-2	0	0	0	1
Beta-lactamase	0	0	0	1
Beta-lactamase Toho-1	0	0	0	1
Solute carrier family 22 member 7	0	2	0	7
Metallo-beta-lactamase	0	0	0	1
Beta-lactamase	0	0	0	1
Metallo-b-lactamase	0	0	0	1
BlaVIM-1	0	0	0	1
Beta-lactamase	0	0	0	1
Beta-lactamase	0	0	0	1
Carbapenem-hydrolyzing beta-lactamase KPC	0	0	0	1
Solute carrier family 22 member 11	0	2	0	8
Solute carrier family 22 member 8	0	1	0	2
Beta-lactamase VIM-1	0	1	0	2
Solute carrier family 22 member 7	0	1	0	5
Chain A, Carbonic anhydrase II	0	1	0	1
Carbonic anhydrase	0	0	0	3
Carbonic anhydrase	0	3	0	3
caspase 7, apoptosis-related cysteine protease	22	0	0	22
Carbonic anhydrase	0	3	0	3
Carbonic anhydrase	0	4	0	4
Carbonic anhydrase	0	4	0	4
caspase-3	22	0	0	22
thyrotropin-releasing hormone receptor	8	0	0	8
Caspase-7	12	0	0	12
interferon gamma precursor	0	0	0	2
prostaglandin E2 receptor EP2 subtype	1	0	0	4
caspase-3	12	0	0	12
Prostaglandin E synthase	0	2	0	2
3-phosphoinositide-dependent protein kinase 1	0	1	1	2
cGMP-specific 3',5'-cyclic phosphodiesterase	0	4	0	4
Cytochrome c oxidase subunit 1	0	1	0	1
Cytochrome c oxidase subunit 2	0	1	0	1
Catechol O-methyltransferase	0	1	0	1
Cytochrome c oxidase subunit 2	0	5	0	5
Procathepsin L	0	5	7	12
Neuronal acetylcholine receptor subunit alpha-4	5	10	2	18
Quinolone resistance protein NorA	0	3	0	4
Neuronal acetylcholine receptor subunit beta-2	5	8	2	16
Beta-3 adrenergic receptor	0	12	3	15
Calpain-2 catalytic subunit	0	2	0	2
Prostaglandin G/H synthase 1	0	4	0	4
Cruzipain	0	3	0	3
Sodium/hydrogen exchanger 1	0	1	0	1
Indoleamine 2,3-dioxygenase 1	0	2	0	2
Delta-type opioid receptor	0	16	4	24
Bifunctional epoxide hydrolase 2	0	4	0	4
Prostaglandin G/H synthase 2	0	9	0	11
Carbonic anhydrase	0	7	0	11
Carbonic anhydrase	0	3	0	8
Carbonic anhydrase	0	2	0	2
Beta-carbonic anhydrase 1	0	3	0	3
Carbonic anhydrase 2	0	3	0	3
Prostaglandin G/H synthase 2	0	5	0	6
Carbonic anhydrase, alpha family	0	4	0	4
Carbonic anhydrase	0	3	0	8
Carbonic anhydrase	0	3	0	8
Carbonic anhydrase	0	3	0	8
Carbonic anhydrase	0	3	0	3
Sigma intracellular receptor 2	0	9	0	9
Delta carbonic anhydrase	0	3	0	3
Prostaglandin G/H synthase 1	0	9	0	11
Carbonic anhydrase	0	3	0	8
Prostaglandin G/H synthase 1	0	1	0	1
Carbonic anhydrase 13	0	3	1	6
Cyclooxygenase-2	0	2	0	2
Rap guanine nucleotide exchange factor 4	8	0	0	8
Caspase-2	0	0	1	1
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase	0	2	0	2
Spike glycoprotein	0	3	7	10
Replicase polyprotein 1ab	0	4	7	11
glucose-6-phosphate 1-dehydrogenase isoform b	0	2	0	2
Transmembrane protease serine 2	0	3	7	10
Dihydrofolate reductase	0	3	0	3
DNA ligase	0	1	0	1
Riboflavin-binding protein	0	1	2	3
Histidine-rich protein PFHRP-II	0	2	0	3
Replicase polyprotein 1a	0	3	7	10
Replicase polyprotein 1ab	0	3	7	10
Spike glycoprotein	0	1	0	1
Ribosyldihydronicotinamide dehydrogenase [quinone]	0	3	1	4
DNA ligase 1	0	1	0	1
Nuclear receptor subfamily 4 group A member 2	0	0	2	2
Beta-secretase 1	0	4	0	4
Calcium-dependent protein kinase 1	0	0	1	1
MO15-related protein kinase Pfmrk	0	1	0	1
DNA ligase A	0	1	0	1
Phosphoethanolamine N-methyltransferase	0	1	0	1
Cysteine proteinase falcipain 2a	0	1	0	1
Cysteine proteinase falcipain 2a	0	1	0	1
Proteasome subunit beta type-11	0	0	0	1
NADPH oxidase 1	0	2	0	2
Snq2p	0	0	0	4
Adenylate cyclase type 1	0	3	0	3
Proteasome subunit alpha type-7	0	0	0	1
Glutamate receptor ionotropic, NMDA 2D	0	8	0	8
Glutamate receptor ionotropic, NMDA 3B	0	8	0	8
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	0	2	0	2
Major prion protein	0	0	1	1
Cys-loop ligand-gated ion channel	0	1	0	1
Sphingomyelin phosphodiesterase	0	2	0	2
Proteasome subunit beta type-1	0	0	0	1
Substance-K receptor	0	10	0	11
Adenylate cyclase type 3	0	3	0	3
Proteasome subunit alpha type-1	0	0	0	1
Proteasome subunit alpha type-2	0	0	0	1
Proteasome subunit alpha type-3	0	0	0	1
Proteasome subunit alpha type-4	0	0	0	1
Adenylate cyclase type 2	0	3	1	4
Adenylate cyclase type 4	0	3	0	3
Proteasome subunit beta type-8	0	0	0	1
Proteasome subunit beta type-9	0	0	0	1
Proteasome subunit alpha type-5	0	0	0	1
Proteasome subunit beta type-4	0	0	0	1
Proteasome subunit beta type-6	0	0	0	1
Proteasome subunit beta type-5	0	0	0	1
Trypanothione reductase	0	4	0	4
Histamine H1 receptor	0	6	3	10
Melanocortin receptor 4	0	4	0	4
Melanocortin receptor 5	0	8	0	8
Pleiotropic ABC efflux transporter of multiple drugs	0	4	0	8
Adenylate cyclase type 8	0	3	0	3
Proteasome subunit beta type-10	0	0	0	1
Melanocortin receptor 3	0	4	0	4
Proteasome subunit beta type-3	0	0	0	1
Proteasome subunit beta type-2	0	0	0	1
Gastrin/cholecystokinin type B receptor	0	2	0	2
Proteasome subunit alpha type-6	0	0	1	2
Calmodulin	0	2	3	5
Aldehyde oxidase 1	0	1	0	1
Adenylate cyclase type 6	0	3	0	3
Adenylate cyclase type 5	0	3	0	3
Glutamate receptor ionotropic, NMDA 1	0	12	0	12
Aldehyde oxidase	0	2	0	2
Glutamate receptor ionotropic, NMDA 2A	0	12	0	12
Glutamate receptor ionotropic, NMDA 2B	0	11	0	11
Glutamate receptor ionotropic, NMDA 2C	0	8	0	8
Adenylyl cyclase 7	0	3	0	3
Proteasome subunit alpha-type 8	0	0	0	1
Glutamate receptor ionotropic, NMDA 3A	0	8	0	8
Proteasome subunit beta type-7	0	0	0	1
PINK1	2	0	0	2
Acetylcholinesterase	0	1	0	1
Carboxylic ester hydrolase	0	1	0	1
muscleblind-like protein 1 isoform 1	16	0	0	16
60 kDa chaperonin	0	3	0	3
60 kDa heat shock protein, mitochondrial	0	3	0	3
Glycine receptor subunit alpha-1	0	0	3	3
10 kDa heat shock protein, mitochondrial	0	3	0	3
Thiosulfate sulfurtransferase	0	3	0	3
60 kDa chaperonin	0	3	0	3
10 kDa chaperonin	0	3	0	3
Ubiquitin carboxyl-terminal hydrolase 2	0	1	0	1
Phospholipase A2	0	1	1	2
G-protein coupled bile acid receptor 1	0	1	0	1
G-protein coupled bile acid receptor 1	0	1	4	5
Bile acid receptor	0	1	1	2
Chain A, Acetylcholinesterase	0	0	2	2
Chain A, Acetylcholinesterase	0	0	2	2
Chain A, Acetylcholinesterase	0	0	2	2
Chain A, Acetylcholinesterase	0	0	2	2
Chain A, Acetylcholinesterase	0	0	2	2
Chain A, Acetylcholinesterase	0	0	2	2
Chain A, Acetylcholinesterase	0	0	2	2
Chain A, Putative Glycine Betaine-binding Abc Transporter Protein	0	0	1	1
Chain A, PUTATIVE GLYCINE BETAINE-BINDING ABC TRANSPORTER PROTEIN	0	0	1	1
Chain A, Glycine betaine/carnitine/choline-binding protein	0	0	1	1
Chain A, Glycine betaine/carnitine/choline-binding protein	0	0	1	1
Chain A, Glycine betaine/carnitine/choline-binding protein	0	0	1	1
Chain A, Glycine betaine/carnitine/choline-binding protein	0	0	1	1
Chain A, Choline-binding protein	0	0	1	1
Solute carrier family 22 member 1	0	2	0	3
Solute carrier family 22 member 2	0	2	0	2
Neuronal acetylcholine receptor subunit alpha-3	0	5	2	8
Neuronal acetylcholine receptor subunit alpha-2	0	3	2	6
Neuronal acetylcholine receptor subunit beta-3	0	3	2	6
Neuronal acetylcholine receptor subunit beta-4	0	5	2	8
Neuronal acetylcholine receptor subunit alpha-5	0	3	2	6
Sodium- and chloride-dependent creatine transporter 1	0	1	0	1
Choline O-acetyltransferase	0	1	0	2
Neuronal acetylcholine receptor subunit alpha-6	0	4	2	7
Neuronal acetylcholine receptor subunit alpha-9	0	3	2	6
Neuronal acetylcholine receptor subunit alpha-7	0	8	3	12
Solute carrier family 22 member 1	0	11	0	17
High affinity choline transporter 1	0	1	0	1
Neuronal acetylcholine receptor subunit alpha-10	0	3	2	6
Solute carrier family 22 member 2	0	9	0	12
DNA gyrase subunit B	0	1	0	1
DNA gyrase subunit A	0	1	0	1
DNA gyrase subunit B	0	1	0	2
DNA gyrase subunit A	0	2	0	4
DNA gyrase subunit B	0	2	0	4
DNA topoisomerase 4 subunit A	0	1	0	1
DNA topoisomerase 4 subunit B	0	1	0	2
DNA topoisomerase 4 subunit A	0	1	0	2
DNA topoisomerase 2-alpha	0	1	1	6
DNA gyrase subunit A	0	1	0	2
Multidrug resistance protein MdtK	0	0	1	1
DNA gyrase subunit B	0	1	0	1
DNA gyrase subunit A	0	1	0	1
Enoyl-[acyl-carrier-protein] reductase [NADH]	0	2	0	3
DNA topoisomerase 4 subunit A	0	1	0	1
DNA topoisomerase 4 subunit B	0	1	0	1
Integrase	0	3	0	3
Sodium-dependent noradrenaline transporter	0	5	0	5
Tryptophan 5-hydroxylase 1	0	3	0	3
Aldo-keto reductase family 1 member B1	0	4	0	4
Aromatase	0	1	0	1
Sodium-dependent serotonin transporter	0	5	0	5
Sodium-dependent dopamine transporter	0	6	0	6
Transporter	0	22	1	24
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, N5-carboxyaminoimidazole ribonucleotide mutase	0	0	1	1
Chain B, N5-carboxyaminoimidazole ribonucleotide mutase	0	0	1	1
Chain A, N5-carboxyaminoimidazole ribonucleotide mutase	0	0	1	1
Chain B, N5-carboxyaminoimidazole ribonucleotide mutase	0	0	1	1
hepatocyte nuclear factor 4-alpha isoform 2	0	1	0	1
perilipin-5	0	1	0	1
perilipin-1	0	1	0	1
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a	0	1	0	1
Beta-lactamase	0	1	0	1
Proto-oncogene tyrosine-protein kinase Src	0	2	1	3
3-dehydroquinate dehydratase	0	0	1	1
ATP-citrate synthase	0	1	0	2
Ribonuclease T	0	0	0	1
Cell death-related nuclease 4	0	0	0	1
3-dehydroquinate dehydratase	0	0	1	1
Prolyl 4-hydroxylase	0	3	0	3
Alpha-ketoglutarate-dependent dioxygenase FTO	0	4	0	4
Gamma-aminobutyric acid receptor subunit pi	0	10	0	10
Gamma-aminobutyric acid receptor subunit delta	0	10	0	10
Gamma-aminobutyric acid receptor subunit alpha-1	0	5	0	6
Gamma-aminobutyric acid receptor subunit beta-1	0	5	0	6
Gamma-aminobutyric acid receptor subunit alpha-2	0	5	0	6
Gamma-aminobutyric acid receptor subunit alpha-3	0	5	0	6
Gamma-aminobutyric acid receptor subunit beta-1	0	11	2	13
Gamma-aminobutyric acid receptor subunit alpha-4	0	5	0	6
Gamma-aminobutyric acid receptor subunit gamma-2	0	5	0	6
Gamma-aminobutyric acid receptor subunit beta-3	0	13	4	17
Translocator protein	0	2	0	2
Gastrin/cholecystokinin type B receptor	0	3	0	3
Gamma-aminobutyric acid receptor subunit alpha-4	0	11	2	13
Gamma-aminobutyric acid receptor subunit epsilon	0	10	0	10
Gamma-aminobutyric acid receptor subunit alpha-6	0	12	2	14
Gamma-aminobutyric acid receptor subunit gamma-1	0	10	0	10
Gamma-aminobutyric acid receptor subunit gamma-3	0	10	0	10
Gamma-aminobutyric acid receptor subunit theta	0	10	0	10
Beta-1 adrenergic receptor	0	2	3	7
Alpha-1B adrenergic receptor	0	0	2	2
Membrane primary amine oxidase	0	1	0	1
5-hydroxytryptamine receptor 3A	0	1	2	3
Solute carrier family 22 member 3	0	7	0	8
Alpha-1A adrenergic receptor	0	3	2	5
Alpha-2B adrenergic receptor	0	1	0	2
Alpha-1A adrenergic receptor	0	17	5	25
Alpha-2C adrenergic receptor	0	1	0	2
Alpha-2A adrenergic receptor	0	1	0	2
Nischarin	0	3	0	3
5-hydroxytryptamine receptor 3E	0	9	2	13
5-hydroxytryptamine receptor 3B	0	9	2	13
Endothelin receptor type B	0	4	0	4
5-hydroxytryptamine receptor 3A	0	5	0	5
Endothelin receptor type B	0	4	0	4
5-hydroxytryptamine receptor 2C	0	4	0	4
5-hydroxytryptamine receptor 2A	0	2	0	2
3-hydroxy-3-methylglutaryl-coenzyme A reductase	0	3	0	3
D(2) dopamine receptor	0	1	0	1
D(3) dopamine receptor	0	1	0	1
D(2) dopamine receptor	0	4	0	4
5-hydroxytryptamine receptor 2B	0	2	0	2
5-hydroxytryptamine receptor 4	0	3	1	4
5-hydroxytryptamine receptor 1A	0	2	0	2
5-hydroxytryptamine receptor 3D	0	9	2	13
5-hydroxytryptamine receptor 3C	0	9	2	13
Histamine H4 receptor	0	3	4	7
Chain A, CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION	0	0	1	1
Chain B, CHIMERA OF IG GAMMA-1 CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION	0	0	1	1
Chain H, Fab M82G2, Heavy chain	0	0	1	1
Chain L, Fab M82G2, Light chain	0	0	1	1
Chain H, Fab M82g2, Heavy Chain	0	0	1	1
Chain L, Fab M82g2, Light Chain	0	0	1	1
Fatty acid-binding protein, heart	0	1	0	1
Muscarinic acetylcholine receptor M2	0	1	0	1
Liver carboxylesterase 1	0	3	0	5
Lysosomal Pro-X carboxypeptidase	0	1	0	1
cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	3	0	3
cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	4	0	4
Leukotriene B4 receptor 1	0	3	0	3
Leukotriene B4 receptor 2	0	2	0	2
Histone acetyltransferase p300	0	1	0	1
Histone acetyltransferase KAT2B	0	1	0	1
Histone acetyltransferase KAT5	0	1	0	1
N-alpha-acetyltransferase 50	0	0	1	1
PAX8	0	0	0	1
nuclear receptor subfamily 0 group B member 1	0	2	0	2
steroidogenic factor 1	0	2	0	2
caspase-1 isoform alpha precursor	7	0	0	7
Tubulin alpha-1A chain	0	2	1	3
Tubulin beta chain	0	2	1	3
Plasma kallikrein	0	0	0	5
Tubulin beta-4A chain	0	2	2	5
ATP-dependent translocase ABCB1	0	3	0	3
Tubulin beta chain	0	2	2	5
Tubulin alpha-3C chain	0	2	2	5
Serine/threonine-protein kinase pim-1	0	2	1	4
ATP-dependent translocase ABCB1	0	3	0	3
Tubulin alpha-1B chain	0	2	2	5
Tubulin alpha-4A chain	0	2	2	5
Tubulin beta-4B chain	0	2	2	5
Vesicular acetylcholine transporter	0	1	0	1
Tubulin beta-3 chain	0	2	2	5
Tubulin beta-2A chain	0	2	2	5
Tubulin polymerization-promoting protein	0	0	1	1
Tubulin beta-8 chain	0	2	2	5
Tubulin beta-2B chain	0	2	0	2
Tubulin alpha-3E chain	0	2	2	5
Tubulin alpha-1A chain	0	2	2	5
Similar to alpha-tubulin isoform 1	0	1	0	1
Similar to alpha-tubulin isoform 1	0	1	0	1
CREB-binding protein	2	0	0	2
Tubulin alpha-1C chain	0	2	2	5
Tubulin beta-6 chain	0	2	2	5
Tubulin beta-2B chain	0	2	2	5
Tubulin beta-1 chain	0	2	2	5
histone-lysine N-methyltransferase 2A isoform 2 precursor	11	0	0	11
relaxin receptor 1 isoform 1	3	0	0	3
relaxin receptor 2 isoform 1	1	0	0	1
Nuclear receptor subfamily 1 group I member 2	0	0	5	5
Solute carrier family 2, facilitated glucose transporter member 1	0	0	1	1
Adenylate cyclase type 8	0	0	1	1
Relaxin receptor 1	0	0	1	1
Nuclear receptor subfamily 1 group I member 2	0	0	2	2
GALC protein	12	0	0	12
Solute carrier family 22 member 3	0	1	0	1
C-8 sterol isomerase	0	3	0	3
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase	0	4	1	5
dopamine D1 receptor	8	0	0	8
Sodium- and chloride-dependent creatine transporter 1	0	1	0	1
Proton-coupled amino acid transporter 1	0	8	0	9
Phosphodiesterase	0	1	0	1
Multidrug resistance-associated protein 5	0	0	0	1
cGMP-inhibited 3',5'-cyclic phosphodiesterase B	0	1	0	1
cGMP-inhibited 3',5'-cyclic phosphodiesterase A	0	2	0	2
chaperonin GroEL	1	0	0	1
Glycogen phosphorylase, brain form	0	1	1	2
Glycogen phosphorylase, muscle form	0	1	0	1
Histone-lysine N-methyltransferase SETD7	0	2	0	2
Glutathione S-transferase P	0	1	0	1
Alpha-tocopherol transfer protein	0	0	1	1
pyruvate kinase	2	0	0	2
Induced myeloid leukemia cell differentiation protein Mcl-1	0	4	0	4
Cytochrome P450 2D1	0	4	0	4
Cytochrome P450 2D26	0	5	0	5
Cytochrome P450 2D3	0	5	0	5
Cytochrome P450 2D4	0	5	0	5
Beta-glucuronidase	0	1	0	1
Beta-glucuronidase	0	1	0	1
Glucose-6-phosphate 1-dehydrogenase	0	5	0	5
Glucose-6-phosphate 1-dehydrogenase	0	1	0	1
NPC1-like intracellular cholesterol transporter 1	0	0	1	1
Solute carrier organic anion transporter family member 1A4	0	3	0	6
Solute carrier organic anion transporter family member 1A5	0	0	0	4
Steryl-sulfatase	0	1	0	2
Multidrug resistance-associated protein 1	0	2	0	4
Solute carrier organic anion transporter family member 1A2	0	0	0	3
Solute carrier organic anion transporter family member 1A3	0	3	0	8
ATP-binding cassette sub-family C member 11	0	0	0	2
Solute carrier organic anion transporter family member 1A1	0	0	0	1
Solute carrier organic anion transporter family member 1B2	0	0	0	2
Deoxycytidine kinase	0	0	1	2
AAA family ATPase	0	0	0	1
Sterol O-acyltransferase 1	0	2	0	2
Phenylethanolamine N-methyltransferase	0	1	0	1
Amine oxidase [flavin-containing] B	0	7	0	7
Amine oxidase [flavin-containing] B	0	3	0	3
Trace amine-associated receptor 1	0	0	1	1
Trace amine-associated receptor 1	0	0	1	1
Trace amine-associated receptor 1	0	0	1	1
Trace amine-associated receptor 1	0	0	1	1
Taste receptor type 2 member 46	0	0	2	2
Gamma-aminobutyric acid	0	2	1	3
Alpha-1-acid glycoprotein 1	0	0	0	1
Gamma-aminobutyric acid receptor subunit alpha-6	0	2	1	3
Gamma-aminobutyric acid receptor subunit gamma-2	0	2	1	3
Gamma-aminobutyric acid receptor subunit delta	0	2	1	3
Gamma-aminobutyric acid receptor subunit alpha-2	0	2	1	3
Gamma-aminobutyric acid receptor subunit alpha-3	0	2	1	3
Gamma-aminobutyric acid receptor subunit gamma-3	0	2	1	3
Gamma-aminobutyric acid receptor subunit beta-1	0	2	1	3
Gamma-aminobutyric acid receptor subunit alpha-1	0	2	1	3
Gamma-aminobutyric acid receptor subunit beta-3	0	2	1	3
Gamma-aminobutyric acid receptor subunit alpha-5	0	2	1	3
Gamma-aminobutyric acid receptor subunit pi	0	2	1	3
Sphingosine-1-phosphate lyase 1	0	2	0	2
Gamma-aminobutyric acid receptor subunit alpha-4	0	2	1	3
Gamma-aminobutyric acid receptor subunit theta	0	2	1	3
Gamma-aminobutyric acid receptor subunit gamma-1	0	2	1	3
Aldo-keto reductase family 1 member B10	0	4	0	4
Transient receptor potential cation channel subfamily A member 1	0	0	3	4
Dihydrofolate reductase	0	9	0	10
Interleukin-8	0	3	0	3
Calcium/calmodulin-dependent protein kinase type II subunit alpha	0	1	0	1
Aldo-keto reductase family 1 member B1	0	9	0	9
Sodium- and chloride-dependent GABA transporter 1	0	4	0	4
C-X-C chemokine receptor type 1	0	1	0	1
Sodium- and chloride-dependent GABA transporter 2	0	4	0	4
Sodium- and chloride-dependent GABA transporter 3	0	4	0	4
Sodium- and chloride-dependent betaine transporter	0	4	0	4
UDP-glucuronosyltransferase 1A7	0	1	0	1
UDP-glucuronosyltransferase 1A10	0	1	0	1
runt-related transcription factor 1 isoform AML1b	1	0	0	1
core-binding factor subunit beta isoform 2	1	0	0	1
Caspase-7	7	0	0	7
Thromboxane A2 receptor	0	1	1	2
Prostaglandin E2 receptor EP1 subtype	0	3	2	5
Prostaglandin E2 receptor EP4 subtype	0	3	1	4
Prostaglandin F2-alpha receptor	0	2	0	2
Prostaglandin F2-alpha receptor	0	2	2	4
Prostaglandin E2 receptor EP3 subtype	0	3	2	5
Prostaglandin E2 receptor EP2 subtype	0	3	1	4
Prostaglandin F2-alpha receptor	0	0	1	1
Prostacyclin receptor	0	3	1	4
Solute carrier organic anion transporter family member 2A1	0	1	0	3
Prostaglandin D2 receptor	0	1	0	1
Solute carrier organic anion transporter family member 2A1	0	2	0	4
Solute carrier organic anion transporter family member 2A1	0	1	0	1
Solute carrier organic anion transporter family member 2B1	0	1	0	1
Prostaglandin E2 receptor EP3 subtype	0	2	0	2
Prostaglandin E2 receptor EP4 subtype	0	2	0	2
Prostaglandin E2 receptor EP1 subtype	0	2	0	2
Prostaglandin E2 receptor EP4 subtype	0	1	1	2
Prostaglandin E2 receptor EP2 subtype	0	2	0	2
Prostaglandin E2 receptor EP2 subtype	0	1	1	2
Solute carrier family 22 member 7	0	0	0	1
mu-type opioid receptor isoform MOR-1	0	0	2	2
D(3) dopamine receptor isoform e	1	0	0	1
5-hydroxytryptamine receptor 2A	0	0	2	2
Acetylcholinesterase	0	3	0	3
Amine oxidase [flavin-containing] A	0	3	0	3
Acetylcholinesterase	0	5	0	5
Acetylcholinesterase	0	4	0	4
Acetylcholinesterase	0	2	0	2
Glycogen synthase kinase-3 beta	0	3	1	4
Cholinesterase	0	2	0	2
Acetylcholine receptor subunit epsilon	0	1	1	2
Acyl-CoA:cholesterol acyltransferase	0	1	0	1
Carboxylic ester hydrolase	0	1	0	2
Carboxylic ester hydrolase	0	5	0	5
Alpha-1A adrenergic receptor	0	2	1	3
Interstitial collagenase	0	1	0	1
Beta-2 adrenergic receptor	0	14	4	19
N-arachidonyl glycine receptor	0	1	2	3
Lysophosphatidylserine lipase ABHD12	0	1	0	1
Monoglyceride lipase	0	1	0	1
Monoacylglycerol lipase ABHD6	0	1	0	1
Mas-related G-protein coupled receptor member X2	0	0	5	5
Eyes absent homolog 2	0	1	0	1
Sodium/glucose cotransporter 1	0	0	1	1
Sodium/glucose cotransporter 2	0	1	1	2
Opioid receptor, delta 1b	0	2	0	2
Opioid receptor homologue	0	2	0	2
Proenkephalin-B	0	0	1	1
Kappa-type opioid receptor	0	7	4	13
Mu-type opioid receptor	0	8	4	16
Mu-type opioid receptor	0	2	0	2
Genome polyprotein	0	2	1	3
chaperonin-containing TCP-1 beta subunit homolog	4	0	0	4
eyes absent homolog 2 isoform a	4	0	0	4
Flavin reductase (NADPH)	0	0	2	2
large T antigen	0	2	0	2
MPI protein	0	1	0	1
ERAP1 protein	0	0	0	1
ERAP2 protein	0	0	0	1
M17 leucyl aminopeptidase	0	1	0	1
M18 aspartyl aminopeptidase	0	1	0	1
M1-family alanyl aminopeptidase	0	1	0	1
leucyl-cystinyl aminopeptidase [Mus musculus]	0	0	0	1
Macrophage migration inhibitory factor	0	4	0	4
Sorbitol dehydrogenase	0	1	0	1
Voltage-dependent T-type calcium channel subunit alpha-1I	0	1	0	1
Estrogen receptor	0	13	2	16
Chain B, Cell division protein kinase 6	0	1	0	1
G2/mitotic-specific cyclin-B2	0	1	0	1
Alpha-amylase 1A	0	1	0	1
G2/mitotic-specific cyclin-B1	0	1	0	1
G2/mitotic-specific cyclin-B	0	1	0	1
Glycogen synthase kinase-3 beta	0	1	0	1
Casein kinase II subunit alpha'	0	2	1	3
Testosterone 17-beta-dehydrogenase 3	0	1	0	1
Tyrosine-protein kinase SYK	0	1	2	3
1-deoxy-D-xylulose 5-phosphate reductoisomerase	0	1	0	1
Glycogen synthase kinase-3 alpha	0	2	1	3
Mitogen-activated protein kinase 10	0	1	1	2
Casein kinase II subunit beta	0	2	0	2
Casein kinase II subunit alpha	0	2	1	3
Cyclin-dependent kinase 6	0	1	1	2
Cyclin-dependent-like kinase 5	0	1	1	2
Cyclin homolog	0	1	0	1
Lactoylglutathione lyase	0	4	0	4
Cyclin-dependent kinase 5 activator 1	0	1	0	1
Casein kinase II subunit alpha 3	0	1	0	1
G2/mitotic-specific cyclin-B3	0	1	0	1
Enoyl-acyl-carrier protein reductase	0	3	0	3
3-oxoacyl-acyl-carrier protein reductase	0	1	0	1
Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein)	0	1	0	1
Cyclin-dependent kinase 1	0	1	0	1
Chain A, PROTEIN (TRANSTHYRETIN)	0	0	1	1
Chain B, PROTEIN (TRANSTHYRETIN)	0	0	1	1
Transient receptor potential cation channel subfamily M member 2	0	1	0	1
Aldo-keto reductase family 1 member C4	0	3	0	3
Aldo-keto reductase family 1 member C3	0	6	0	6
Transcription factor SOX-18	0	1	0	1
Aldo-keto reductase family 1 member C2	0	3	0	3
Aldo-keto reductase family 1 member C1	0	3	0	3
Peroxisome proliferator-activated receptor alpha	2	1	3	6
Transcriptional enhancer factor TEF-3	0	2	1	3
Potassium channel subfamily K member 18	0	1	1	2
Acid-sensing ion channel 5	0	0	1	1
Cytochrome P450 2C8	0	7	1	8
Dipeptidyl peptidase 4	0	1	0	1
Potassium voltage-gated channel subfamily C member 1	0	1	0	1
Gastrin/cholecystokinin type B receptor	0	1	0	1
Beta-2 adrenergic receptor	0	4	3	8
Serine hydroxymethyltransferase, mitochondrial	0	1	0	1
Potassium voltage-gated channel subfamily KQT member 4	0	0	0	1
Single-stranded DNA cytosine deaminase	2	0	0	2
Potassium voltage-gated channel subfamily KQT member 5	0	0	0	1
Cytochrome P450 1A2	0	2	0	2
Chain A, Dihydrofolate reductase	0	0	1	1
Thymidylate synthase	0	4	0	4
Thymidylate synthase	0	3	0	4
Dihydrofolate reductase	0	4	3	7
Folylpolyglutamate synthase, mitochondrial	0	1	0	4
Folylpolyglutamate synthase, mitochondrial	0	1	0	4
Multidrug resistance associated protein	0	1	0	3
Voltage-dependent calcium channel subunit alpha-2/delta-1	0	2	0	2
Chain A, ACETYLCHOLINESTERASE	0	1	0	1
Chain A, Acetylcholinesterase	0	1	0	1
Vascular endothelial growth factor receptor 1	0	3	1	4
Vascular endothelial growth factor receptor 3	0	3	1	4
Vascular endothelial growth factor receptor 2	0	4	1	5
Prolyl endopeptidase	0	1	0	1
Gamma-aminobutyric acid receptor subunit rho-3	0	0	1	1
Hsf1 protein	0	0	3	4
Gamma-aminobutyric acid receptor subunit rho-1	0	0	2	2
Gamma-aminobutyric acid receptor subunit rho-2	0	0	1	1
Sodium- and chloride-dependent GABA transporter 1	0	1	0	1
Sodium- and chloride-dependent taurine transporter	0	1	0	1
Sodium- and chloride-dependent GABA transporter 1	0	2	0	2
Sodium- and chloride-dependent GABA transporter 2	0	3	0	3
Sodium- and chloride-dependent GABA transporter 3	0	3	0	3
Sodium- and chloride-dependent betaine transporter	0	1	0	1
Sodium- and chloride-dependent GABA transporter 3	0	1	0	1
4-aminobutyrate aminotransferase, mitochondrial	0	0	0	1
Sterol O-acyltransferase 1	0	0	1	1
Platelet glycoprotein VI	0	0	1	1
Sodium- and chloride-dependent GABA transporter 2	0	1	0	1
Asialoglycoprotein receptor 1	0	1	1	2
Chain A, GLUTAMATE RECEPTOR SUBUNIT 2	0	1	0	1
Chain A, Glutamate Receptor Subunit 2	0	1	0	1
Chain B, Glutamate Receptor Subunit 2	0	1	0	1
Chain A, Slr1257 protein	0	0	1	1
Chain A, Glucosamine--fructose-6-phosphate aminotransferase [isomerizing]	0	1	0	1
beta-2 adrenergic receptor	3	0	0	3
Metabotropic glutamate receptor 8	0	2	0	2
Glutathione reductase, mitochondrial	0	5	0	6
Bifunctional aspartokinase/homoserine dehydrogenase 1	0	1	0	1
Glutamate receptor ionotropic, kainate 1	0	3	1	4
Metabotropic glutamate receptor 1	0	2	1	3
Metabotropic glutamate receptor 2	0	0	1	1
Metabotropic glutamate receptor 3	0	0	1	1
Metabotropic glutamate receptor 4	0	1	1	2
Metabotropic glutamate receptor 5	0	1	2	3
Metabotropic glutamate receptor 6	0	0	1	1
Metabotropic glutamate receptor 7	0	0	1	1
Glutamate receptor ionotropic, kainate 1	0	1	1	2
Metabotropic glutamate receptor 5	0	1	1	3
Glutamate receptor ionotropic, kainate 2	0	3	1	4
Glutamate receptor 1	0	2	1	3
Glutamate receptor 2	0	2	1	3
Glutamate receptor 3	0	1	1	2
Glutamate receptor ionotropic, kainate 3	0	3	0	3
Metabotropic glutamate receptor 8	0	0	1	1
Glutamate receptor 4	0	2	1	3
Excitatory amino acid transporter 3	0	0	0	1
Glutamate racemase	0	0	0	1
Metabotropic glutamate receptor 8	0	1	1	2
Glutamate receptor ionotropic, kainate 4	0	3	0	3
Glutamate carboxypeptidase 2	0	1	0	2
Glutamate receptor ionotropic, kainate 2	0	1	1	2
Glutamate receptor ionotropic, kainate 3	0	1	0	1
Metabotropic glutamate receptor 7	0	1	1	3
Metabotropic glutamate receptor 3	0	1	1	3
Metabotropic glutamate receptor 4	0	1	1	3
Glutamate receptor ionotropic, kainate 5	0	1	0	1
Glutamate receptor ionotropic, kainate 5	0	3	0	3
Glutamate racemase	0	0	0	1
Chain A, Glutamine Binding Protein	0	0	1	1
Asc-type amino acid transporter 1	0	2	0	2
Chain B, EUKARYOTIC TRANSLATION INITIATION FACTOR 4E	0	0	1	1
Sodium- and chloride-dependent glycine transporter 1	0	1	0	1
Large neutral amino acids transporter small subunit 1	0	8	0	9
Serine racemase	0	1	0	1
Sodium- and chloride-dependent glycine transporter 2	0	2	0	2
Chain A, CARBONIC ANHYDRASE II	0	0	1	1
Chain A, Protein (female-specific Histamine Binding Protein 2)	0	0	1	1
aryl hydrocarbon receptor nuclear translocator	0	0	0	1
transforming acidic coiled-coil-containing protein 3	0	0	0	1
Histamine H3 receptor	0	1	0	1
Histamine N-methyltransferase	0	1	0	1
Equilibrative nucleoside transporter 4	0	0	0	1
Histamine H4 receptor	0	1	2	3
Histamine H4 receptor	0	1	2	3
Histamine H4 receptor	0	1	0	1
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	0	2	0	3
Protein cereblon	0	2	0	2
Cyclic GMP-AMP synthase	0	1	0	1
Toll-like receptor 9	0	1	0	1
Toll-like receptor 7	0	1	0	1
Uracil nucleotide/cysteinyl leukotriene receptor	0	3	0	3
Chain A, Purine-nucleoside Phosphorylase	0	1	0	1
Chain C, Xanthine dehydrogenase/oxidase	0	0	1	1
Purine nucleoside phosphorylase	0	0	1	2
Acid-sensing ion channel 3	0	1	0	1
Polyunsaturated fatty acid 5-lipoxygenase	0	5	0	9
Caspase-3	0	4	0	4
Caspase-4	0	4	0	4
Caspase-5	0	4	0	4
Caspase-9	0	4	0	4
Acid-sensing ion channel 1	0	1	0	1
Dehydrogenase/reductase SDR family member 9	0	1	0	1
Voltage-dependent L-type calcium channel subunit alpha-1C	0	3	0	3
Envelope glycoprotein	0	0	3	3
isocitrate dehydrogenase 1, partial	2	0	0	2
Tyrosine-protein phosphatase non-receptor type 7	0	1	0	1
Dual specificity protein phosphatase 3	0	2	0	2
Chain A, membrane-associated prostaglandin E synthase-2	0	1	0	1
3',5'-cyclic-AMP phosphodiesterase	0	1	0	1
Solute carrier organic anion transporter family member 2B1	0	2	0	2
Phospholipase A2, major isoenzyme	0	1	0	1
Thromboxane-A synthase	0	2	0	2
Serum paraoxonase/arylesterase 1	0	3	0	3
C-X-C chemokine receptor type 3	0	2	0	2
Prostaglandin D2 receptor	0	2	0	2
Dehydrogenase/reductase SDR family member 9	0	1	0	1
Cytosolic phospholipase A2 gamma	0	1	0	1
Prostaglandin D2 receptor 2	0	1	1	2
Chain A, ADENOSINE DEAMINASE	0	1	0	1
Chain A, ADENOSINE DEAMINASE	0	1	0	1
Chain B, Pulmonary surfactant-associated protein D	0	1	0	1
Chain A, Pulmonary surfactant-associated protein D	0	1	0	1
Sodium/myo-inositol cotransporter 2	0	1	0	1
Beta-1 adrenergic receptor	0	11	3	14
Beta-2 adrenergic receptor	0	0	1	1
Beta-adrenergic receptor kinase 1	0	1	3	4
Beta-3 adrenergic receptor	0	0	1	1
Beta-1 adrenergic receptor	0	2	1	3
Taste receptor type 2 member 38	0	0	2	3
Taste receptor type 2 member 39	0	0	1	1
Taste receptor type 2 member 40	0	0	1	1
Taste receptor type 2 member 41	0	0	1	1
Taste receptor type 2 member 43	0	0	1	1
Taste receptor type 2 member 31	0	0	1	1
Taste receptor type 2 member 45	0	0	1	1
Taste receptor type 2 member 30	0	0	1	1
Taste receptor type 2 member 19	0	0	1	1
Taste receptor type 2 member 20	0	0	1	1
Taste receptor type 2 member 50	0	0	1	1
Taste receptor type 2 member 60	0	0	1	1
Beta-2 adrenergic receptor	0	1	1	2
Taste receptor type 2 member 42	0	0	1	1
Taste receptor type 2 member 16	0	0	1	1
Taste receptor type 2 member 14	0	0	1	1
Taste receptor type 2 member 13	0	0	1	1
Taste receptor type 2 member 10	0	0	1	1
Taste receptor type 2 member 9	0	0	1	1
Taste receptor type 2 member 8	0	0	1	1
Taste receptor type 2 member 7	0	0	1	1
Taste receptor type 2 member 5	0	0	1	1
Taste receptor type 2 member 4	0	0	1	1
Taste receptor type 2 member 3	0	0	1	1
Taste receptor type 2 member 1	0	0	1	1
2,3-bisphosphoglycerate-independent phosphoglycerate mutase	1	0	0	1
Ornithine decarboxylase	0	0	0	1
Retinoic acid receptor alpha	0	1	0	1
Retinoic acid receptor gamma	0	1	0	1
Retinoic acid receptor beta	0	1	0	1
Cellular retinoic acid-binding protein 2	0	0	1	1
Mitogen-activated protein kinase 1	0	1	2	3
Retinoic acid receptor RXR-alpha	0	1	0	1
Retinoic acid receptor RXR-beta	0	1	0	1
Retinoic acid receptor RXR-gamma	0	1	0	1
Cellular retinoic acid-binding protein 1	0	1	0	1
Cellular retinoic acid-binding protein 1	0	0	1	1
Voltage-dependent L-type calcium channel subunit alpha-1C	0	1	0	1
Voltage-dependent L-type calcium channel subunit alpha-1D	0	2	0	2
Chymotrypsinogen A	0	1	0	1
Synaptic vesicular amine transporter	0	4	1	5
Vesicular acetylcholine transporter	0	1	0	1
Potassium voltage-gated channel subfamily E member 1	0	4	0	4
Potassium voltage-gated channel subfamily KQT member 1	0	4	0	4
Chain A, AMINOPEPTIDASE	0	2	0	2
Chain A, AMINOPEPTIDASE	0	2	0	2
Chain A, Leucine Aminopeptidase	0	1	0	1
Alkaline phosphatase, tissue-nonspecific isozyme	0	3	0	3
Intestinal-type alkaline phosphatase	0	3	0	3
Phospholipase A-2-activating protein	0	3	0	3
Gonadotropin-releasing hormone receptor	0	1	0	1
Gonadotropin-releasing hormone receptor	0	2	0	2
Synaptic vesicle glycoprotein 2A	0	2	0	2
WRN	1	0	0	1
integrase, partial	0	2	0	2
lens epithelium-derived growth factor p75	0	2	0	2
Tyrosine-protein kinase Lck	0	3	1	4
SLC16A10 protein	0	0	0	3
Monocarboxylate transporter 10	0	0	0	3
Potassium voltage-gated channel subfamily A member 5	0	1	0	1
Potassium voltage-gated channel subfamily D member 2	0	1	0	1
Menin	0	1	0	1
Cocaine esterase	0	3	0	3
Angiopoietin-1 receptor	0	1	2	3
retinoic acid receptor alpha isoform 1	0	1	0	1
retinoic acid receptor RXR-alpha isoform a	0	1	0	1
Catechol O-methyltransferase	0	1	0	1
5-hydroxytryptamine receptor 1E	0	3	0	3
Sodium-dependent dopamine transporter	0	1	0	1
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast	0	1	0	1
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast	0	1	0	1
Lysophosphatidic acid receptor 6	0	0	1	1
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2	0	2	0	2
Lysophosphatidic acid receptor 4	0	0	1	1
Lysophosphatidic acid receptor 1	0	0	2	2
Lysophosphatidic acid receptor 4	0	0	1	1
Lysophosphatidic acid receptor 5	0	0	1	1
Lysophosphatidic acid receptor 2	0	0	1	1
Lysophosphatidic acid receptor 3	0	0	1	1
histone-lysine N-methyltransferase NSD2 isoform 1	0	0	0	1
MBT domain-containing protein 1	0	1	0	1
Lethal(3)malignant brain tumor-like protein 4	0	1	0	1
Lethal(3)malignant brain tumor-like protein 3	0	1	0	1
Lethal(3)malignant brain tumor-like protein 1	0	1	0	1
Nociceptin receptor	0	1	1	2
Melatonin receptor type 1A	0	4	2	6
Melatonin receptor type 1C	0	0	1	1
Melatonin receptor type 1A	0	2	2	4
Melatonin receptor type 1B	0	4	2	6
Melatonin receptor type 1C	0	2	2	4
Melatonin receptor type 1B	0	2	2	4
Nuclear factor erythroid 2-related factor 2	0	0	1	2
Dipeptidyl peptidase 4	0	1	0	1
Aldehyde oxidase 1	0	1	0	1
Chain A, Methionyl-tRNA synthetase	0	0	1	1
Chain A, Methionyl-tRNA synthetase	0	0	1	1
Chain A, Aminopeptidase	0	1	0	1
Chain A, Methionine aminopeptidase	0	1	0	1
S-ribosylhomocysteine lyase	0	1	0	1
Adenylate cyclase type 5	0	0	0	1
S-adenosylmethionine synthase isoform type-1	0	0	0	1
S-adenosylmethionine synthase isoform type-2	0	0	0	1
Chain B, DIHYDROFOLATE REDUCTASE	0	0	1	1
Chain B, DIHYDROFOLATE REDUCTASE	0	0	1	1
Chain B, DIHYDROFOLATE REDUCTASE	0	0	1	1
Thymidylate synthase	0	1	0	1
Thymidylate synthase	0	1	0	1
nuclear receptor coactivator 1 isoform 1 [Homo sapiens]	0	1	0	1
transactivating tegument protein VP16 [Human herpesvirus 1]	0	1	0	1
nuclear receptor coactivator 3 isoform a	0	1	0	1
Toll-like receptor 4	0	1	0	1
ATP-binding cassette sub-family C member 3	0	1	0	2
Dihydrofolate reductase	0	2	0	3
Dihydrofolate reductase	0	1	0	1
Dihydrofolate reductase	0	1	0	1
Dihydrofolate reductase	0	2	0	3
Thymidylate synthase	0	1	0	1
Tyrosine-protein kinase ABL1	0	1	3	4
Bifunctional dihydrofolate reductase-thymidylate synthase	0	1	0	1
High mobility group protein B1	0	0	2	2
Dihydrofolate reductase	0	1	0	1
Thymidylate synthase	0	1	0	1
Bifunctional dihydrofolate reductase-thymidylate synthase	0	1	0	1
Folate receptor beta	0	1	0	1
Cytochrome P450 11B1, mitochondrial	0	2	0	2
Folate receptor alpha	0	1	0	1
Dihydrofolate reductase	0	2	0	2
Histidine decarboxylase	0	1	3	4
Trifunctional purine biosynthetic protein adenosine-3	0	1	0	1
Bifunctional purine biosynthesis protein ATIC	0	2	0	2
Reduced folate transporter	0	2	0	2
6-phosphogluconate dehydrogenase, decarboxylating	0	1	0	1
Dihydrofolate reductase	0	1	0	1
Pteridine reductase 1	0	1	0	1
Bifunctional dihydrofolate reductase-thymidylate synthase	0	1	0	1
Bifunctional dihydrofolate reductase-thymidylate synthase	0	1	0	1
Canalicular multispecific organic anion transporter 1	0	1	0	2
Trifunctional purine biosynthetic protein adenosine-3	0	1	0	1
Dihydrofolate reductase	0	1	0	1
Dihydrofolate reductase	0	1	0	1
Proton-coupled folate transporter	0	1	0	1
Protein-arginine deiminase type-4	0	3	0	3
Chain E, Fibrin beta chain	0	1	0	1
T cell receptor, partial	1	0	0	1
luteinizing hormone receptor	1	0	0	1
Caspase 6, apoptosis-related cysteine peptidase	0	0	0	1
Apoptotic peptidase activating factor 1	0	1	0	1
luciferase	1	0	0	1
neutrophil cytosol factor 1	0	1	0	1
caspase-9 isoform alpha precursor	0	1	0	1
pyruvate kinase PKM isoform a	2	0	0	2
caspase-3 isoform a preproprotein	0	1	0	1
protein AF-9 isoform a	0	0	0	1
replicative DNA helicase	0	0	0	1
recombinase A	0	0	1	1
POsterior Segregation	0	0	2	2
DNA repair protein RAD52 homolog isoform a	0	0	0	1
Glutathione reductase	0	1	0	1
Glycoprotein hormones alpha chain	1	0	0	1
Dihydrolipoyl dehydrogenase, mitochondrial	0	1	0	2
Microtubule-associated protein tau	0	1	1	2
Thioredoxin reductase 1, cytoplasmic	0	1	0	2
Dihydrolipoyl dehydrogenase	0	1	0	2
Zinc finger protein mex-5	0	0	2	2
Steroid 17-alpha-hydroxylase/17,20 lyase	0	1	0	1
Cytochrome P450 11B1, mitochondrial	0	1	0	1
Cytochrome P450 11B1, mitochondrial	0	1	0	1
Cytochrome P450 11B2, mitochondrial	0	1	0	1
5-hydroxytryptamine receptor 3B	0	4	0	4
G-protein coupled receptor	0	1	0	1
POU domain, class 2, transcription factor 1	0	0	0	1
Nuclear receptor corepressor 1	0	1	0	1
Integrin beta-1	0	1	0	1
Integrin alpha-4	0	1	0	1
Nuclear receptor corepressor 2	0	1	0	1
Acyl-CoA desaturase 1	0	1	0	1
Proteinase-activated receptor 1	0	2	2	4
Nociceptin receptor	0	1	0	1
Mu-type opioid receptor	0	1	0	1
FATTY-ACID-CoA LIGASE FADD28 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE)	0	0	0	1
Peroxisome proliferator-activated receptor delta	0	0	1	2
Acid ceramidase	0	2	0	2
Glucose-dependent insulinotropic receptor	0	0	1	1
Glucose-dependent insulinotropic receptor	0	0	1	1
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	0	0	0	1
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	0	0	0	1
UDP-glucuronosyltransferase 1A8	0	0	0	3
Hormone-sensitive lipase	0	1	0	1
Neuromedin-K receptor	0	0	2	2
Substance-K receptor	0	1	2	3
Neuromedin-K receptor	0	2	2	4
Substance-K receptor	0	2	0	2
Substance-K receptor	0	2	0	2
Substance-K receptor	0	2	0	2
Neuropeptide Y receptor type 1	0	2	0	2
Neuropeptide Y receptor type 2	0	2	0	2
Cholesteryl ester transfer protein	0	1	0	1
D-amino-acid oxidase	0	1	0	1
Hydroxycarboxylic acid receptor 3	0	0	1	1
Nicotinamidase	0	1	0	1
Hydroxycarboxylic acid receptor 2	0	0	1	1
Hydroxycarboxylic acid receptor 2	0	2	1	3
D-aspartate oxidase	0	1	0	1
Hydroxycarboxylic acid receptor 2	0	1	1	2
Neuronal acetylcholine receptor subunit alpha-4	0	2	1	3
Acetylcholine receptor subunit alpha	0	2	1	3
Acetylcholine receptor subunit beta	0	2	1	3
Acetylcholine receptor subunit gamma	0	2	1	3
Acetylcholine receptor subunit delta	0	2	1	3
Neuronal acetylcholine receptor subunit alpha-4	0	1	0	1
Acetylcholine receptor subunit beta-like 2	0	2	0	2
Neuronal acetylcholine receptor subunit alpha-5	0	0	1	1
Neuronal acetylcholine receptor subunit alpha-7	0	4	0	4
Acetylcholine-binding protein	0	1	1	2
Neuronal acetylcholine receptor subunit beta-3	0	1	1	2
Neuronal acetylcholine receptor subunit alpha-2	0	1	0	1
Neuronal acetylcholine receptor subunit alpha-6	0	1	1	2
Cytochrome P450 2A13	0	3	2	5
Neuronal acetylcholine receptor subunit alpha-5	0	2	0	2
Liver carboxylesterase B-1	0	1	0	1
Transient receptor potential cation channel subfamily A member 1	0	0	1	1
Neuronal acetylcholine receptor subunit beta-3	0	2	0	2
Neuronal acetylcholine receptor subunit beta-4	0	2	0	2
Neuronal acetylcholine receptor subunit alpha-3	0	2	0	2
Soluble acetylcholine receptor	0	1	0	1
Neuronal acetylcholine receptor subunit alpha-2	0	2	0	2
Neuronal acetylcholine receptor subunit beta-2	0	2	1	3
Neuronal acetylcholine receptor subunit alpha-6	0	2	0	2
Integrin beta	0	0	1	1
Glycoprotein IIb	0	0	1	1
Sodium/iodide cotransporter	0	1	0	1
Nociceptin receptor	0	1	3	4
Estrogen receptor	0	1	2	4
Progesterone receptor	0	7	3	11
Estrogen receptor beta	0	1	2	4
Sodium- and chloride-dependent betaine transporter	0	1	0	1
FAD-linked sulfhydryl oxidase ALR	0	0	0	1
Phosphotyrosine protein phosphatase	0	1	0	1
Hemagglutinin [Cleaved into: Hemagglutinin HA1 chain; Hemagglutinin HA2 chain]	0	0	1	1
Pancreatic alpha-amylase	0	1	0	3
DNA polymerase beta	0	2	0	2
DNA polymerase beta	0	1	0	1
Receptor-type tyrosine-protein phosphatase C	0	1	0	1
Receptor-type tyrosine-protein phosphatase F	0	1	0	1
DNA topoisomerase 1	0	3	0	4
Tissue factor	0	4	0	4
Tyrosine-protein phosphatase non-receptor type 2	0	1	0	1
Tyrosine-protein phosphatase non-receptor type 1	0	6	0	8
Receptor-type tyrosine-protein phosphatase alpha	0	1	0	1
Receptor-type tyrosine-protein phosphatase epsilon	0	1	0	1
Low molecular weight phosphotyrosine protein phosphatase	0	2	0	2
Tyrosine-protein phosphatase non-receptor type 6	0	1	0	1
M-phase inducer phosphatase 2	0	1	0	1
Signal transducer and activator of transcription 3	0	1	0	1
Transcription factor p65	0	1	0	1
Tyrosine-protein phosphatase non-receptor type 11	0	1	0	1
Env polyprotein	0	0	1	1
NAD-dependent protein deacylase sirtuin-5, mitochondrial	0	2	0	2
Transmembrane prolyl 4-hydroxylase	0	0	1	1
Protease	0	1	0	1
Chain A, Adipocyte Lipid-binding Protein	0	0	1	1
Chain A, SERUM ALBUMIN	0	0	1	1
Chain A, SERUM ALBUMIN	0	0	1	1
Chain A, MUSCLE FATTY ACID BINDING PROTEIN	0	0	1	1
Chain A, MUSCLE FATTY ACID BINDING PROTEIN	0	0	1	1
Chain A, MUSCLE FATTY ACID BINDING PROTEIN	0	0	1	1
Chain A, BCL-2-RELATED PROTEIN A1	0	0	1	1
putative potassium channel subunit	0	0	1	1
bcl-2-like protein 11 isoform 1	0	0	1	1
Sterol O-acyltransferase 1	0	1	0	1
Trypsin	0	2	0	2
Fatty acid-binding protein, liver	0	0	1	1
Coagulation factor VII	0	2	0	2
Protein kinase C alpha type	0	2	2	5
Sterol O-acyltransferase 1	0	1	0	1
Voltage-dependent L-type calcium channel subunit alpha-1C	0	2	0	2
Interleukin-6 receptor subunit alpha	0	1	0	1
Thyrotropin-releasing hormone receptor	0	1	0	1
Voltage-dependent L-type calcium channel subunit alpha-1S	0	1	0	1
Glycine receptor subunit alpha-4	0	1	0	1
Histamine H3 receptor	0	1	0	1
Leukotriene B4 receptor 1	0	1	0	1
Microphthalmia-associated transcription factor	0	0	0	1
caspase recruitment domain family, member 15	0	1	0	1
receptor-interacting serine/threonine-protein kinase 2 isoform 1	0	1	0	1
Beta lactamase (plasmid)	0	1	0	1
Oxytocin receptor	0	0	1	1
Type II pantothenate kinase	0	0	0	1
Type III pantothenate kinase	0	0	0	1
Pyrroline-5-carboxylate reductase 1, mitochondrial	0	1	0	1
Renin	0	1	0	1
Beta-adrenergic receptor kinase 1	0	2	0	2
Potassium voltage-gated channel subfamily A member 3	0	1	0	1
Rhodopsin kinase GRK1	0	1	0	1
G protein-coupled receptor kinase 5	0	2	0	2
G protein-coupled receptor kinase 5	0	1	0	1
Rhodopsin kinase GRK1	0	1	1	2
Beta-adrenergic receptor kinase 1	0	0	0	1
Cystathionine gamma-lyase	0	2	0	2
vasopressin V1b receptor	1	0	0	1
cGMP-dependent 3',5'-cyclic phosphodiesterase	0	1	0	1
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A	0	1	0	1
Tumor necrosis factor	0	1	0	1
Indoleamine 2,3-dioxygenase 1	0	2	0	3
Membrane primary amine oxidase	0	1	0	1
estrogen receptor beta isoform 1	0	2	0	2
Alpha-1B adrenergic receptor	0	1	0	1
Alkaline phosphatase, tissue-nonspecific isozyme	0	1	0	1
Intestinal-type alkaline phosphatase	0	1	0	1
E3 ubiquitin-protein ligase XIAP	0	1	0	1
Large neutral amino acids transporter small subunit 1	0	1	0	1
Estrogen receptor 1	0	1	0	1
fMet-Leu-Phe receptor	0	1	0	1
Chain A, PROTEIN (CATECHOL OXIDASE)	0	1	0	1
Tyrosinase	0	1	0	1
Muscarinic acetylcholine receptor DM1	0	2	0	2
CDGSH iron-sulfur domain-containing protein 1	0	1	0	1
tyrosine-protein kinase Yes	3	0	0	3
Free fatty acid receptor 1	0	0	1	1
Peroxisome proliferator-activated receptor gamma	0	1	0	1
Carnitine O-palmitoyltransferase 2, mitochondrial	0	1	0	1
Peroxisome proliferator-activated receptor alpha	0	1	0	1
Carnitine O-palmitoyltransferase 2, mitochondrial	0	1	0	1
Peroxisome proliferator-activated receptor gamma	0	1	1	2
Carnitine O-palmitoyltransferase 1, liver isoform	0	1	0	1
Enoyl-[acyl-carrier-protein] reductase [NADH]	0	2	0	2
CDGSH iron-sulfur domain-containing protein 2	0	1	0	1
CDGSH iron-sulfur domain-containing protein 1	0	2	0	2
Muscarinic acetylcholine receptor M5	0	1	0	1
Muscarinic acetylcholine receptor M3	0	1	0	1
Muscarinic acetylcholine receptor M2	0	1	0	1
Cytochrome P450 2E1	0	1	0	1
Cytochrome P450 4B1	0	1	0	1
Cytochrome P450 2A7	0	1	0	1
Cytochrome P450 2F1	0	1	0	1
Transcriptional enhancer factor TEF-1	0	1	1	2
Cytochrome P450 2C18	0	1	0	1
Cytochrome P450 4F2	0	1	0	1
Cytochrome P450 4F8	0	1	0	1
Cytochrome P450 4A11	0	1	0	1
Cytochrome P450 4F3	0	1	0	1
Transcriptional enhancer factor TEF-4	0	1	0	1
Cytochrome P450 4A22	0	1	0	1
Vitamin D 25-hydroxylase	0	1	0	1
Cytochrome P450 2U1	0	1	0	1
Cytochrome P450 2W1	0	1	0	1
Cytochrome P450 2S1	0	1	0	1
Transcriptional enhancer factor TEF-5	0	1	0	1
Cytochrome P450 3A43	0	1	0	1
Nuclear receptor subfamily 1 group I member 3	0	1	0	1
luciferase	0	0	0	1
Glucocorticoid receptor	0	1	1	2
Glucocorticoid receptor	0	0	1	1
Glutamine synthetase	0	0	1	1
Estrogen receptor beta	0	6	2	8
Voltage-dependent calcium channel subunit alpha-2/delta-1	0	2	0	3
Voltage-dependent calcium channel subunit alpha-2/delta-2	0	2	0	2
Glutamate 5-kinase	0	0	0	1
Chain A, Ferritin light chain	0	0	1	1
Chain A, Ferritin light chain	0	0	1	1
Chain A, Ferritin light chain	0	0	1	1
Chain A, Ferritin light chain	0	0	1	1
Chain A, Ferritin light chain	0	0	1	1
Chain A, Ferritin light chain	0	0	1	1
Chain A, Ferritin light chain	0	0	1	1
Neuromedin-K receptor	0	0	1	1
Sodium/bile acid cotransporter	0	1	0	1
Nuclear receptor subfamily 2 group E member 1	0	0	2	2
Receptor-type tyrosine-protein phosphatase beta	0	0	0	1
Trans-sialidase	0	1	0	1
Trans-sialidase	0	1	0	1
Pyridoxal kinase	0	0	1	2
Chain A, dATP pyrophosphohydrolase	0	1	0	1
Chain A, Adenylate cyclase type 5	0	1	0	1
Chain B, Adenylate cyclase type 2	0	1	0	1
Monocarboxylate transporter 4	0	0	0	1
Monocarboxylate transporter 2	0	0	0	1
Monocarboxylate transporter 1	0	0	0	1
C-terminal-binding protein 2	0	1	0	1
Monocarboxylate transporter 2	0	1	0	1
Prolyl 4-hydroxylase, beta polypeptide	0	0	0	1
nuclear factor NF-kappa-B p105 subunit isoform 1	3	0	0	3
HLA class I histocompatibility antigen, A alpha chain	0	0	2	2
Gastric inhibitory polypeptide receptor	0	1	0	1
DNA dC->dU-editing enzyme APOBEC-3F isoform a	1	0	0	1
Chromaffin granule amine transporter	0	1	0	1
Synaptic vesicular amine transporter	0	1	0	1
Synaptic vesicular amine transporter	0	1	0	1
Chain A, PLASMA RETINOL-BINDING PROTEIN PRECURSOR	0	0	1	1
Retinol-binding protein 4	0	0	1	1
Beta-lactoglobulin	0	0	1	1
Chain A, 6,7-Dimethyl-8-ribityllumazine Synthase	0	0	1	1
Chain B, 6,7-Dimethyl-8-ribityllumazine Synthase	0	0	1	1
Chain A, Breast cancer type 1 susceptibility protein	1	0	0	1
Chain H, Immunoglobulin Igg1 Heavy chain	0	0	1	1
Chain L, Immunoglobulin Igg1 Lambda Light Chain	0	0	1	1
Chain A, DODECIN	0	0	1	1
Chain A, DODECIN	0	0	1	1
Chain C, DODECIN	0	0	1	1
Chain E, DODECIN	0	0	1	1
tumor necrosis factor	1	0	0	1
DNA polymerase III, partial	2	0	0	2
ubiquitin-conjugating enzyme E2 N	0	2	0	2
pyruvate kinase PKM isoform b	1	0	0	1
Ornithine decarboxylase	1	0	0	1
Diacylglycerol kinase alpha	0	1	0	1
inositol monophosphatase 1	1	0	0	1
Prostaglandin G/H synthase 2	0	1	0	1
Cytochrome c oxidase subunit 1	0	1	0	1
Transporter	0	1	0	1
Sodium-dependent serotonin transporter	0	1	0	1
Sphingosine kinase 2	0	2	0	2
Sphingosine kinase 1	0	1	0	1
Met repressor	0	0	2	2
Protein arginine N-methyltransferase 5	0	0	1	1
Histone H3K27 methylase	0	0	0	1
Phenylethanolamine N-methyltransferase	0	0	1	2
S-adenosylmethionine decarboxylase proenzyme	0	1	0	2
Protein-L-isoaspartate(D-aspartate) O-methyltransferase	0	1	0	1
Catechol O-methyltransferase	0	0	0	1
Protein arginine N-methyltransferase 1	0	1	0	1
Methylosome protein 50	0	0	1	1
Chain A, Lysr-type Regulatory Protein	0	0	1	1
Chain A, Lysr-type Regulatory Protein	0	0	1	1
Chain A, Lysr-type Regulatory Protein	0	0	1	1
Chain A, 146aa long hypothetical transcriptional regulator	0	0	1	1
Chain A, Anthranilate phosphoribosyltransferase	0	1	0	1
Chain A, Anthranilate phosphoribosyltransferase	0	1	0	1
Chain A, Anthranilate phosphoribosyltransferase	0	1	0	1
Chain B, Anthranilate phosphoribosyltransferase	0	1	0	1
Chain C, Anthranilate phosphoribosyltransferase	0	1	0	1
Chain A, Anthranilate phosphoribosyltransferase	0	1	0	1
Anthranilate phosphoribosyltransferase	0	1	0	1
Estrogen receptor beta	0	1	0	2
Inhibitor of nuclear factor kappa-B kinase subunit beta	0	0	1	2
5'-AMP-activated protein kinase subunit beta-2	0	0	0	1
Polymerase acidic protein	0	0	1	1
Stromelysin-1	0	2	1	3
Tyrosine-protein phosphatase YopH	0	1	0	1
Estrogen receptor	0	1	0	2
5'-AMP-activated protein kinase subunit gamma-1	0	0	1	2
5'-AMP-activated protein kinase catalytic subunit alpha-2	0	1	1	3
5'-AMP-activated protein kinase catalytic subunit alpha-1	0	1	1	3
Ubiquitin-like domain-containing CTD phosphatase 1	0	1	0	1
5'-AMP-activated protein kinase subunit gamma-3	0	0	0	1
5'-AMP-activated protein kinase subunit gamma-2	0	0	1	2
5'-AMP-activated protein kinase subunit beta-1	0	0	0	1
Transcriptional activator protein LuxR	0	2	0	2
3-oxo-5-alpha-steroid 4-dehydrogenase 2	0	1	0	1
Potassium voltage-gated channel subfamily D member 3	0	2	0	2
Free fatty acid receptor 3	0	0	1	1
Chain A, Mineralocorticoid receptor	0	1	0	1
Chain A, Mineralocorticoid receptor	0	1	0	1
Leukotriene C4 synthase	0	0	1	1
Bone morphogenetic protein receptor type-1B	0	0	1	1
Membrane-associated progesterone receptor component 1	0	0	1	1
Cell division cycle 7-related protein kinase	0	0	1	1
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	0	1	1	2
Serine/threonine-protein kinase PLK4	0	1	1	2
Serine/threonine-protein kinase 25	0	0	1	1
ATP-dependent RNA helicase DDX3X	0	0	1	1
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	0	0	1	1
Citron Rho-interacting kinase	0	0	1	1
Serine/threonine-protein kinase RIO3	0	0	1	1
Dual specificity mitogen-activated protein kinase kinase 7	0	0	1	1
Serine/threonine-protein kinase Chk1	0	1	1	2
Peripheral plasma membrane protein CASK	0	0	1	1
Aurora kinase A	0	1	1	2
Cyclin-G-associated kinase	0	0	1	1
Serine/threonine-protein kinase DCLK1	0	0	1	1
Inhibitor of nuclear factor kappa-B kinase subunit alpha	0	0	1	1
Muscle, skeletal receptor tyrosine-protein kinase	0	0	1	1
Ephrin type-B receptor 6	0	0	1	1
Peroxisomal acyl-coenzyme A oxidase 3	0	0	1	1
Mitogen-activated protein kinase kinase kinase 13	0	0	1	1
Death-associated protein kinase 3	0	0	1	1
Receptor-interacting serine/threonine-protein kinase 2	0	0	1	1
Mitotic checkpoint serine/threonine-protein kinase BUB1	0	0	1	1
NUAK family SNF1-like kinase 1	0	1	1	2
Dynamin-like 120 kDa protein, mitochondrial	0	0	1	1
Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	0	0	1	1
Tyrosine-protein kinase JAK2	0	0	1	1
Eukaryotic translation initiation factor 5B	0	0	1	1
Rho-associated protein kinase 2	0	0	1	1
Serine/threonine-protein kinase ULK1	0	0	1	1
Serine/threonine-protein kinase/endoribonuclease IRE1	0	0	1	1
Ribosomal protein S6 kinase alpha-5	0	0	1	1
U5 small nuclear ribonucleoprotein 200 kDa helicase	0	0	1	1
Ribosomal protein S6 kinase alpha-4	0	0	1	1
Serine/threonine-protein kinase 16	0	0	1	1
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	0	0	1	1
Serine/threonine-protein kinase PAK 3	0	0	1	1
Cyclin-dependent kinase-like 5	0	0	1	1
Serine/threonine-protein kinase 17B	0	0	1	1
Serine/threonine-protein kinase 10	0	0	1	1
Serine/threonine-protein kinase D3	0	1	2	3
Cyclin-dependent kinase 14	0	0	1	1
Structural maintenance of chromosomes protein 2	0	0	1	1
Mitogen-activated protein kinase kinase kinase 6	0	0	1	1
Serine/threonine-protein kinase OSR1	0	0	1	1
Mitogen-activated protein kinase kinase kinase kinase 4	0	0	1	1
Serine/threonine-protein kinase LATS1	0	0	1	1
Serine/threonine-protein kinase PAK 4	0	2	1	3
Serine/threonine-protein kinase Chk2	0	1	1	2
Proto-oncogene tyrosine-protein kinase Src	0	1	0	1
RAF proto-oncogene serine/threonine-protein kinase	0	1	1	2
Guanine nucleotide-binding protein G(i) subunit alpha-2	0	0	1	1
ADP/ATP translocase 2	0	0	1	1
Mast/stem cell growth factor receptor Kit	0	1	0	1
Platelet-derived growth factor receptor beta	0	1	0	1
Protein kinase C beta type	0	3	2	5
Glycogen phosphorylase, liver form	0	0	1	1
Tyrosine-protein kinase Fes/Fps	0	0	1	1
Macrophage colony-stimulating factor 1 receptor	0	1	1	2
Adenine phosphoribosyltransferase	0	0	1	1
Tyrosine-protein kinase Yes	0	0	1	1
Tyrosine-protein kinase Lyn	0	0	1	1
Proto-oncogene tyrosine-protein kinase receptor Ret	0	1	1	2
Insulin-like growth factor 1 receptor	0	0	1	1
Signal recognition particle receptor subunit alpha	0	0	1	1
Cytochrome c1, heme protein, mitochondrial	0	0	1	1
Hepatocyte growth factor receptor	0	1	1	2
Tyrosine-protein kinase HCK	0	1	1	2
Proto-oncogene tyrosine-protein kinase ROS	0	0	1	1
Tyrosine-protein kinase Fgr	0	0	1	1
Wee1-like protein kinase 2	0	0	1	1
Uncharacterized serine/threonine-protein kinase SBK3	0	0	1	1
Serine/threonine-protein kinase A-Raf	0	0	1	1
Mast/stem cell growth factor receptor Kit	0	3	1	4
Breakpoint cluster region protein	0	0	2	2
Myosin light chain kinase, smooth muscle	0	0	1	1
Cyclin-dependent kinase 4	0	0	1	1
ADP/ATP translocase 3	0	0	1	1
cAMP-dependent protein kinase type II-alpha regulatory subunit	0	0	1	1
Insulin receptor-related protein	0	0	1	1
Serine/threonine-protein kinase B-raf	0	0	1	1
Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	0	0	1	1
Platelet-derived growth factor receptor alpha	0	2	1	3
Tyrosine-protein kinase Fer	0	0	1	1
cAMP-dependent protein kinase catalytic subunit alpha	0	0	1	1
General transcription and DNA repair factor IIH helicase subunit XPD	0	0	1	1
Interferon-induced, double-stranded RNA-activated protein kinase	0	0	1	1
Ras-related protein Rab-6A	0	0	1	1
Serine/threonine-protein kinase MAK	0	0	1	1
Cyclin-dependent kinase 11B	0	0	1	1
Ephrin type-A receptor 1	0	0	1	1
Receptor tyrosine-protein kinase erbB-3	0	0	1	1
Multifunctional protein ADE2	0	0	1	1
cAMP-dependent protein kinase catalytic subunit gamma	0	0	1	1
cAMP-dependent protein kinase catalytic subunit beta	0	0	1	1
Ferrochelatase, mitochondrial	0	0	1	1
Ribosomal protein S6 kinase beta-1	0	0	1	1
Tyrosine-protein kinase JAK1	0	0	1	1
Protein kinase C eta type	0	1	2	3
Probable ATP-dependent RNA helicase DDX6	0	0	1	1
Platelet-derived growth factor receptor alpha	0	1	0	1
Activin receptor type-2A	0	0	1	1
Mitogen-activated protein kinase 3	0	0	1	1
MAP/microtubule affinity-regulating kinase 3	0	0	1	1
Ephrin type-A receptor 2	0	0	1	1
Ephrin type-A receptor 3	0	0	1	1
Ephrin type-A receptor 8	0	0	1	1
Ephrin type-B receptor 2	0	0	1	1
Leukocyte tyrosine kinase receptor	0	0	1	1
Non-receptor tyrosine-protein kinase TYK2	0	0	1	1
UMP-CMP kinase	0	0	1	1
Phosphatidylethanolamine-binding protein 1	0	0	1	1
Wee1-like protein kinase	0	0	1	1
Heme oxygenase 2	0	0	1	1
Tyrosine-protein kinase receptor UFO	0	1	1	2
Mitogen-activated protein kinase 4	0	0	1	1
S-adenosylmethionine synthase isoform type-2	0	0	1	1
DnaJ homolog subfamily A member 1	0	0	1	1
RAC-alpha serine/threonine-protein kinase	0	1	1	2
RAC-beta serine/threonine-protein kinase	0	0	1	1
G protein-coupled receptor kinase 4	0	0	1	1
Dual specificity protein kinase TTK	0	0	1	1
DNA replication licensing factor MCM4	0	0	1	1
Myosin-10	0	0	1	1
Tyrosine-protein kinase receptor Tie-1	0	0	1	1
Dual specificity mitogen-activated protein kinase kinase 2	0	0	1	1
Receptor-type tyrosine-protein kinase FLT3	0	1	1	3
Bone morphogenetic protein receptor type-1A	0	0	1	1
Activin receptor type-1B	0	0	1	1
TGF-beta receptor type-1	0	0	1	1
Serine/threonine-protein kinase receptor R3	0	0	1	1
TGF-beta receptor type-2	0	0	1	1
Electron transfer flavoprotein subunit beta	0	0	1	1
Tyrosine-protein kinase CSK	0	0	1	1
Glycine--tRNA ligase	0	0	1	1
Protein kinase C iota type	0	1	2	3
Exosome RNA helicase MTR4	0	0	1	1
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	0	1	1	2
Megakaryocyte-associated tyrosine-protein kinase	0	0	1	1
Tyrosine-protein kinase Tec	0	0	1	1
Tyrosine-protein kinase TXK	0	0	1	1
Tyrosine-protein kinase ABL2	0	0	1	1
Tyrosine-protein kinase FRK	0	0	1	1
G protein-coupled receptor kinase 6	0	0	1	1
Tyrosine-protein kinase ZAP-70	0	0	1	1
26S proteasome regulatory subunit 6B	0	0	1	1
Mitogen-activated protein kinase 8	0	0	1	1
Mitogen-activated protein kinase 9	0	0	1	1
Dual specificity mitogen-activated protein kinase kinase 4	0	0	1	1
Dual specificity mitogen-activated protein kinase kinase 3	0	0	1	1
Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	0	0	1	1
Casein kinase I isoform alpha	0	1	1	2
Casein kinase I isoform delta	0	0	1	1
MAP kinase-activated protein kinase 2	0	0	1	1
Cyclin-dependent kinase 8	0	0	1	1
Elongation factor Tu, mitochondrial	0	0	1	1
Choline-phosphate cytidylyltransferase A	0	0	1	1
Cysteine--tRNA ligase, cytoplasmic	0	0	1	1
Casein kinase I isoform epsilon	0	0	1	1
Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	0	0	1	1
Dual specificity protein kinase CLK1	0	0	1	1
Dual specificity protein kinase CLK2	0	0	1	1
Dual specificity protein kinase CLK3	0	0	1	1
Cyclin-dependent kinase 7	0	0	1	1
Cyclin-dependent kinase 9	0	0	1	1
Ras-related protein Rab-27A	0	0	1	1
Tyrosine-protein kinase Blk	0	0	1	1
Interleukin-1 receptor-associated kinase 1	0	0	1	1
Ribosomal protein S6 kinase alpha-3	0	1	1	2
Cytoplasmic tyrosine-protein kinase BMX	0	0	1	1
cAMP-dependent protein kinase catalytic subunit PRKX	0	0	1	1
Serine/threonine-protein kinase Nek2	0	1	1	2
Serine/threonine-protein kinase Nek3	0	0	1	1
Serine/threonine-protein kinase Nek4	0	0	1	1
Tyrosine-protein kinase JAK3	0	0	1	1
Dual specificity mitogen-activated protein kinase kinase 6	0	0	1	1
Serine/threonine-protein kinase PLK1	0	2	1	3
Death-associated protein kinase 1	0	0	1	1
LIM domain kinase 1	0	0	1	1
LIM domain kinase 2	0	0	1	1
Tyrosine--tRNA ligase, cytoplasmic	0	0	1	1
Ephrin type-B receptor 3	0	0	1	1
Ephrin type-A receptor 5	0	0	1	1
Ephrin type-B receptor 4	0	1	1	2
Ephrin type-B receptor 1	0	0	1	1
Ephrin type-A receptor 4	0	0	1	1
Adenylate kinase 2, mitochondrial	0	0	1	1
Hormonally up-regulated neu tumor-associated kinase	0	0	1	1
Serine/threonine-protein kinase SIK1	0	0	1	1
Receptor-interacting serine/threonine-protein kinase 4	0	0	1	1
Ras-related protein Rab-10	0	0	1	1
Cell division control protein 2 homolog	0	0	1	1
Actin-related protein 3	0	0	1	1
Actin-related protein 2	0	0	1	1
Calcium-dependent protein kinase 1	0	0	1	1
GTP-binding nuclear protein Ran	0	0	1	1
Tubulin alpha-1A chain	0	0	1	1
Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	0	0	1	1
SRSF protein kinase 2	0	0	1	1
Casein kinase I isoform gamma-2	0	0	1	1
Mitogen-activated protein kinase kinase kinase 9	0	0	1	1
Protein delta homolog 1	0	1	1	2
Serine/threonine-protein kinase PknB	0	0	1	1
Cyclin-dependent kinase 3	0	0	1	1
Cyclin-dependent kinase-like 1	0	0	1	1
Cyclin-dependent kinase 16	0	0	1	1
Cyclin-dependent kinase 17	0	0	1	1
ATP-dependent 6-phosphofructokinase, platelet type	0	0	1	1
Protein kinase C epsilon type	0	3	2	5
Dual specificity mitogen-activated protein kinase kinase 1	0	0	1	1
Mitogen-activated protein kinase kinase kinase 10	0	0	1	1
DNA topoisomerase 2-beta	0	0	1	1
Protein kinase C theta type	0	1	2	3
Activin receptor type-1	0	0	1	1
Macrophage-stimulating protein receptor	0	0	1	1
Focal adhesion kinase 1	0	1	1	2
Protein kinase C zeta type	0	1	2	3
Protein kinase C delta type	0	2	2	4
Tyrosine-protein kinase BTK	0	0	1	1
Tyrosine-protein kinase receptor TYRO3	0	0	1	1
Cyclin-dependent kinase 18	0	0	1	1
Activated CDC42 kinase 1	0	0	1	1
Epithelial discoidin domain-containing receptor 1	0	0	1	1
Tyrosine-protein kinase ITK/TSK	0	0	1	1
Myotonin-protein kinase	0	0	1	1
Mitogen-activated protein kinase kinase kinase kinase 2	0	0	1	1
Mitogen-activated protein kinase kinase kinase 12	0	0	1	1
Tyrosine-protein kinase Mer	0	0	1	1
Serine/threonine-protein kinase 4	0	0	1	1
Serine/threonine-protein kinase PAK 1	0	0	1	1
Dual specificity mitogen-activated protein kinase kinase 5	0	0	1	1
Mitogen-activated protein kinase 7	0	0	1	1
Serine/threonine-protein kinase PAK 2	0	0	1	1
Serine/threonine-protein kinase 3	0	0	1	1
Mitogen-activated protein kinase kinase kinase 1	0	0	1	1
cGMP-dependent protein kinase 2	0	0	1	1
Integrin-linked protein kinase	0	0	1	1
Rho-associated protein kinase 1	0	0	1	1
Non-receptor tyrosine-protein kinase TNK1	0	0	1	1
Serine/threonine-protein kinase PRP4 homolog	0	0	1	1
Receptor-interacting serine/threonine-protein kinase 1	0	0	1	1
Calcium/calmodulin-dependent protein kinase type II subunit beta	0	0	1	1
Calcium/calmodulin-dependent protein kinase type II subunit gamma	0	0	1	1
Calcium/calmodulin-dependent protein kinase type II subunit delta	0	0	1	1
Dual specificity tyrosine-phosphorylation-regulated kinase 1A	0	0	1	1
Activin receptor type-2B	0	0	1	1
Bone morphogenetic protein receptor type-2	0	0	1	1
Protein-tyrosine kinase 6	0	0	1	1
cGMP-dependent protein kinase 1	0	0	1	1
Cyclin-dependent kinase 13	0	0	1	1
Calcium/calmodulin-dependent protein kinase type 1	0	0	1	1
Inhibitor of nuclear factor kappa-B kinase subunit epsilon	0	0	1	1
Protein-tyrosine kinase 2-beta	0	0	1	1
Maternal embryonic leucine zipper kinase	0	0	1	1
Structural maintenance of chromosomes protein 1A	0	0	1	1
Chromodomain-helicase-DNA-binding protein 4	0	0	1	1
Peroxisomal acyl-coenzyme A oxidase 1	0	0	1	1
Cyclin-dependent kinase 10	0	0	1	1
Serine/threonine-protein kinase D1	0	1	2	3
Serine/threonine-protein kinase 38	0	0	1	1
Receptor tyrosine-protein kinase erbB-4	0	0	1	1
Ribosomal protein S6 kinase alpha-2	0	0	1	1
Ephrin type-A receptor 7	0	0	1	1
Delta(24)-sterol reductase	0	0	1	1
Ribosomal protein S6 kinase alpha-1	0	1	1	2
Dual specificity testis-specific protein kinase 1	0	0	1	1
Myosin light chain kinase, smooth muscle	0	0	1	1
Serine/threonine-protein kinase STK11	0	0	1	1
NT-3 growth factor receptor	0	0	1	1
Serine/threonine-protein kinase N1	0	0	1	1
Serine/threonine-protein kinase N2	0	0	1	1
Calcium/calmodulin-dependent protein kinase type IV	0	0	1	1
Mitogen-activated protein kinase kinase kinase 11	0	0	1	1
BDNF/NT-3 growth factors receptor	0	0	1	1
Mitogen-activated protein kinase 6	0	0	1	1
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	0	0	1	1
Discoidin domain-containing receptor 2	0	0	1	1
AP2-associated protein kinase 1	0	1	1	2
Myosin light chain kinase 3	0	0	1	1
Uncharacterized aarF domain-containing protein kinase 5	0	0	1	1
Serine/threonine-protein kinase ULK3	0	0	1	1
Serine/threonine-protein kinase SBK1	0	0	1	1
Mitogen-activated protein kinase kinase kinase 19	0	0	1	1
Putative heat shock protein HSP 90-beta 2	0	0	1	1
Serine/threonine-protein kinase TNNI3K	0	0	1	1
Rab-like protein 3	0	0	1	1
Serine/threonine-protein kinase MRCK alpha	0	0	1	1
Serine/threonine-protein kinase MRCK gamma	0	0	1	1
Serine/threonine-protein kinase Nek5	0	0	1	1
Serine/threonine-protein kinase N3	0	0	1	1
Serine/threonine-protein kinase ULK3	0	0	1	1
Dual serine/threonine and tyrosine protein kinase	0	0	1	1
Mitogen-activated protein kinase kinase kinase 15	0	0	1	1
Uncharacterized protein FLJ45252	0	0	1	1
Acyl-CoA dehydrogenase family member 11	0	0	1	1
Serine/threonine-protein kinase/endoribonuclease IRE2	0	0	1	1
Serine/threonine-protein kinase MARK2	0	0	1	1
ATP-dependent RNA helicase DHX30	0	0	1	1
Serine/threonine-protein kinase TAO1	0	0	1	1
STE20-related kinase adapter protein alpha	0	0	1	1
Myosin-14	0	0	1	1
AarF domain-containing protein kinase 1	0	0	1	1
Serine/threonine-protein kinase tousled-like 2	0	0	1	1
Serine/threonine-protein kinase 32C	0	0	1	1
Serine/threonine-protein kinase pim-3	0	0	1	1
ATP-dependent RNA helicase DDX42	0	0	1	1
Serine/threonine-protein kinase VRK2	0	0	1	1
Myosin light chain kinase family member 4	0	0	1	1
Homeodomain-interacting protein kinase 1	0	0	1	1
Calcium/calmodulin-dependent protein kinase type 1D	0	0	1	1
Mitogen-activated protein kinase kinase kinase kinase 3	0	0	1	1
Cyclin-dependent kinase-like 3	0	0	1	1
MAP kinase-activated protein kinase 5	0	0	1	1
Serine/threonine-protein kinase BRSK2	0	0	1	1
NAD-dependent protein deacetylase sirtuin-2	0	1	0	1
Serine/threonine-protein kinase NIM1	0	0	1	1
Serine/threonine-protein kinase ULK2	0	0	1	1
Misshapen-like kinase 1	0	0	1	1
Serine/threonine-protein kinase DCLK2	0	0	1	1
Calcium/calmodulin-dependent protein kinase kinase 1	0	0	1	1
Casein kinase I isoform alpha-like	0	0	1	1
Homeodomain-interacting protein kinase 4	0	0	1	1
Myosin-IIIa	0	0	1	1
Ankyrin repeat and protein kinase domain-containing protein 1	0	0	1	1
Serine/threonine-protein kinase Nek11	0	0	1	1
Atypical kinase COQ8A, mitochondrial	0	0	1	1
Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	0	0	1	1
Mitogen-activated protein kinase 15	0	0	1	1
Serine/threonine-protein kinase Nek9	0	0	1	1
Serine/threonine-protein kinase BRSK1	0	0	1	1
Serine/threonine-protein kinase 35	0	0	1	1
Serine/threonine-protein kinase Nek7	0	0	1	1
Rhodopsin kinase GRK7	0	0	1	1
Serine/threonine-protein kinase 32A	0	0	1	1
Myosin-IIIb	0	0	1	1
ATP-dependent RNA helicase DDX1	0	0	1	1
Dual specificity tyrosine-phosphorylation-regulated kinase 2	0	0	1	1
Cyclin-dependent kinase-like 2	0	0	1	1
Mitogen-activated protein kinase kinase kinase kinase 1	0	0	1	1
Serine/threonine-protein kinase Sgk3	0	0	1	1
Atypical kinase COQ8B, mitochondrial	0	0	1	1
MAP/microtubule affinity-regulating kinase 4	0	0	1	1
Calcium/calmodulin-dependent protein kinase type 1G	0	0	1	1
Serine/threonine-protein kinase Nek1	0	0	1	1
Cyclin-dependent kinase 15	0	0	1	1
PAS domain-containing serine/threonine-protein kinase	0	0	1	1
Calcium/calmodulin-dependent protein kinase kinase 2	0	0	1	1
EKC/KEOPS complex subunit TP53RK	0	0	1	1
SRSF protein kinase 1	0	0	1	1
Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	0	0	1	1
Mitogen-activated protein kinase kinase kinase 5	0	0	1	1
Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	0	0	1	1
Mitogen-activated protein kinase kinase kinase 3	0	0	1	1
Eukaryotic translation initiation factor 2-alpha kinase 1	0	0	1	1
Serine/threonine-protein kinase RIO1	0	0	1	1
MAP kinase-interacting serine/threonine-protein kinase 1	0	0	1	1
Serine/threonine-protein kinase RIO2	0	0	1	1
Cyclin-dependent kinase 19	0	0	1	1
Transient receptor potential cation channel subfamily M member 6	0	0	1	1
Testis-specific serine/threonine-protein kinase 1	0	0	1	1
Serine/threonine-protein kinase 33	0	0	1	1
Nucleolar GTP-binding protein 1	0	0	1	1
Serine/threonine-protein kinase D2	0	0	1	1
Serine/threonine-protein kinase DCLK3	0	0	1	1
NUAK family SNF1-like kinase 2	0	0	1	1
RNA cytidine acetyltransferase	0	0	1	1
Serine/threonine-protein kinase SIK2	0	0	1	1
Myosin light chain kinase 2, skeletal/cardiac muscle	0	0	1	1
STE20-like serine/threonine-protein kinase	0	0	1	1
Poly [ADP-ribose] polymerase tankyrase-2	0	0	1	1
Serine/threonine-protein kinase TAO3	0	0	1	1
Homeodomain-interacting protein kinase 2	0	0	1	1
Tyrosine-protein kinase Srms	0	0	1	1
Homeodomain-interacting protein kinase 3	0	0	1	1
Serine/threonine-protein kinase PLK3	0	1	1	2
dCTP pyrophosphatase 1	0	0	1	1
Bromodomain-containing protein 9	0	0	1	1
Dual specificity protein kinase CLK4	0	0	1	1
MAP kinase-interacting serine/threonine-protein kinase 2	0	0	1	1
Serine/threonine-protein kinase Nek6	0	0	1	1
Casein kinase I isoform gamma-1	0	0	1	1
Serine/threonine-protein kinase 3	0	0	1	1
Bromodomain-containing protein 7	0	0	1	1
Serine/threonine-protein kinase PAK 6	0	1	1	2
SNF-related serine/threonine-protein kinase	0	0	1	1
Serine/threonine-protein kinase LATS2	0	0	1	1
Serine/threonine-protein kinase 36	0	0	1	1
Phenylalanine--tRNA ligase beta subunit	0	0	1	1
Isoleucine--tRNA ligase, mitochondrial	0	0	1	1
BMP-2-inducible protein kinase	0	0	1	1
Obg-like ATPase 1	0	0	1	1
Midasin	0	0	1	1
Interleukin-1 receptor-associated kinase 4	0	0	1	1
Serine/threonine-protein kinase 32B	0	0	1	1
Mitogen-activated protein kinase kinase kinase 20	0	0	1	1
Cyclin-dependent kinase 12	0	0	1	1
Serine/threonine-protein kinase PLK2	0	1	1	2
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	0	0	1	1
Serine/threonine-protein kinase MARK1	0	0	1	1
Serine/threonine-protein kinase pim-2	0	0	1	1
Serine/threonine-protein kinase PAK 5	0	1	1	2
Serine/threonine-protein kinase 26	0	0	1	1
eIF-2-alpha kinase GCN2	0	0	1	1
Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial	0	0	1	1
Serine/threonine-protein kinase NLK	0	0	1	1
Serine/threonine-protein kinase 17A	0	0	1	1
STE20/SPS1-related proline-alanine-rich protein kinase	0	0	1	1
Ephrin type-A receptor 6	0	0	1	1
Serine/threonine-protein kinase TBK1	0	1	1	2
Septin-9	0	0	1	1
Death-associated protein kinase 2	0	0	1	1
Ribosomal protein S6 kinase alpha-6	0	0	1	1
TRAF2 and NCK-interacting protein kinase	0	0	1	1
Serine/threonine-protein kinase tousled-like 1	0	0	1	1
Serine/threonine-protein kinase TAO2	0	0	1	1
Long-chain-fatty-acid--CoA ligase 5	0	0	1	1
ALK tyrosine kinase receptor	0	1	1	2
SRSF protein kinase 3	0	0	1	1
Serine/threonine-protein kinase ICK	0	0	1	1
Cyclin-dependent kinase 11A	0	0	1	1
Aurora kinase C	0	0	1	1
Calcium/calmodulin-dependent protein kinase type II subunit alpha	0	0	1	1
RAC-gamma serine/threonine-protein kinase	0	0	1	1
Serine/threonine-protein kinase 38-like	0	0	1	1
Microtubule-associated serine/threonine-protein kinase 1	0	0	1	1
Serine/threonine-protein kinase SIK3	0	0	1	1
Mitogen-activated protein kinase kinase kinase 2	0	0	1	1
Thyroid hormone receptor-associated protein 3	0	0	1	1
Dual specificity tyrosine-phosphorylation-regulated kinase 1B	0	0	1	1
Mitogen-activated protein kinase kinase kinase kinase 5	0	0	1	1
Receptor-interacting serine/threonine-protein kinase 3	0	0	1	1
Serine/threonine-protein kinase MRCK beta	0	0	1	1
Interleukin-1 receptor-associated kinase 3	0	0	1	1
Serine/threonine-protein kinase 24	0	0	1	1
Casein kinase I isoform gamma-3	0	0	1	1
Mitogen-activated protein kinase kinase kinase 4	0	0	1	1
Substance-P receptor	0	2	0	2
Growth hormone secretagogue receptor type 1	0	0	1	1
Chain A, MALTOPORIN	0	0	1	1
Chain B, MALTOPORIN	0	0	1	1
Carbonic anhydrase	0	2	0	2
D(2) dopamine receptor	0	1	0	1
Carboxypeptidase M	0	1	0	1
5-hydroxytryptamine receptor 1F	0	2	1	3
5-hydroxytryptamine receptor 1B	0	1	0	1
5-hydroxytryptamine receptor 1D	0	1	0	1
5-hydroxytryptamine receptor 1B	0	1	0	1
Orexin receptor type 1	0	2	0	2
Orexin receptor type 2	0	2	0	2
Orexin receptor type 1	0	1	0	1
Orexin receptor type 2	0	1	0	1
Chain A, CES1 protein	0	1	0	1
Protein kinase C gamma type	0	2	1	3
Protein kinase C alpha type	0	1	0	1
Protein kinase C delta type	0	1	0	1
Protein kinase C epsilon type	0	1	0	1
Protein kinase C zeta type	0	1	0	1
Steroid hormone receptor ERR1	0	1	0	1
Estrogen-related receptor gamma	0	1	0	1
Protein kinase C gamma type	0	1	0	1
Protein kinase C beta type	0	1	0	1
Phospholipase D1	0	1	0	1
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	0	1	0	1
Platelet-activating factor acetylhydrolase	0	1	0	1
Phospholipase D1	0	1	0	1
Protein kinase C eta type	0	1	0	1
Emopamil-binding protein-like	0	1	0	1
7-dehydrocholesterol reductase	0	1	1	2
Protein kinase C theta type	0	1	0	1
90-kda heat shock protein beta HSP90 beta, partial	0	1	0	1
tyrosine-protein phosphatase non-receptor type 7 isoform 2	0	1	0	1
Dihydroxyacetone phosphate acyltransferase	0	0	0	1
30S ribosomal protein S6	0	2	0	2
30S ribosomal protein S7	0	2	0	2
50S ribosomal protein L15	0	2	0	2
Tetracycline resistance protein, class B	0	0	0	1
72 kDa type IV collagenase	0	1	0	1
50S ribosomal protein L10	0	2	0	2
50S ribosomal protein L11	0	2	0	2
50S ribosomal protein L7/L12	0	2	0	2
50S ribosomal protein L19	0	2	0	2
50S ribosomal protein L1	0	2	0	2
50S ribosomal protein L20	0	2	0	2
50S ribosomal protein L27	0	2	0	2
50S ribosomal protein L28	0	2	0	2
50S ribosomal protein L29	0	2	0	2
50S ribosomal protein L31	0	2	0	2
50S ribosomal protein L31 type B	0	2	0	2
50S ribosomal protein L32	0	2	0	2
50S ribosomal protein L33	0	2	0	2
50S ribosomal protein L34	0	2	0	2
50S ribosomal protein L35	0	2	0	2
50S ribosomal protein L36	0	2	0	2
30S ribosomal protein S10	0	2	0	2
30S ribosomal protein S11	0	2	0	2
30S ribosomal protein S12	0	2	0	2
30S ribosomal protein S13	0	2	0	2
30S ribosomal protein S16	0	2	0	2
30S ribosomal protein S18	0	2	0	2
30S ribosomal protein S19	0	2	0	2
30S ribosomal protein S20	0	2	0	2
30S ribosomal protein S2	0	2	0	2
30S ribosomal protein S3	0	2	0	2
30S ribosomal protein S4	0	2	0	2
30S ribosomal protein S5	0	2	0	2
30S ribosomal protein S8	0	2	0	2
30S ribosomal protein S9	0	2	0	2
50S ribosomal protein L13	0	2	0	2
50S ribosomal protein L14	0	2	0	2
50S ribosomal protein L16	0	2	0	2
50S ribosomal protein L23	0	2	0	2
30S ribosomal protein S15	0	2	0	2
Multidrug transporter MdfA	0	1	0	1
50S ribosomal protein L17	0	2	0	2
50S ribosomal protein L21	0	2	0	2
50S ribosomal protein L30	0	2	0	2
50S ribosomal protein L6	0	2	0	2
30S ribosomal protein S14	0	2	0	2
30S ribosomal protein S17	0	2	0	2
30S ribosomal protein S1	0	2	0	2
50S ribosomal protein L18	0	2	0	2
Neutrophil collagenase	0	1	0	1
Collagenase 3	0	1	0	1
50S ribosomal protein L2	0	2	0	2
50S ribosomal protein L3	0	2	0	2
50S ribosomal protein L24	0	2	0	2
50S ribosomal protein L4	0	2	0	2
50S ribosomal protein L22	0	2	0	2
50S ribosomal protein L5	0	2	0	2
30S ribosomal protein S21	0	2	0	2
50S ribosomal protein L25	0	2	0	2
50S ribosomal protein L36 2	0	2	0	2
P2Y purinoceptor 12	0	1	0	1
Luciferin 4-monooxygenase	0	0	1	1
Ras guanyl-releasing protein 3	0	0	1	1
Chain A, ykoF	0	0	1	1
Chain B, ykoF	0	0	1	1
Chain A, ThiT	0	0	1	1
Thiamine transporter ThiT	0	0	1	1
Transketolase	0	0	1	1
Thiamine-binding periplasmic protein	0	0	1	1
1-deoxy-D-xylulose-5-phosphate synthase	0	0	1	1
1-deoxy-D-xylulose-5-phosphate synthase	0	0	1	1
Ubiquitin-like modifier activating enzyme 2	0	1	0	1
SUMO1 activating enzyme subunit 1	0	1	0	1
hexokinase	0	1	0	1
SUMO-conjugating enzyme UBC9	0	1	0	1
eukaryotic translation initiation factor 4 gamma 1 isoform 4	0	1	0	1
eukaryotic translation initiation factor 4E isoform 1	0	1	0	1
Vif	0	1	0	1
Tat	0	1	0	1
bifunctional UDP-N-acetylglucosamine pyrophosphorylase/glucosamine-1-phosphate N-acetyltransferase	0	1	0	1
Thymidine kinase	0	1	0	2
Thymidine phosphorylase	0	0	0	1
Thymidylate kinase	0	1	0	1
Thymidine kinase, cytosolic	0	0	0	3
Thymidine kinase	0	0	0	1
Thymidylate kinase	0	2	0	2
Thymidine kinase	0	2	0	4
Thymidine kinase	0	1	0	3
Chain X, Thyroid hormone receptor beta-1	0	0	2	2
Chain X, Thyroid hormone receptor beta-1	0	0	2	2
Thyroid hormone receptor alpha	0	2	3	5
Thyroid hormone receptor beta	0	2	3	5
Proliferating cell nuclear antigen	0	2	0	2
Malate dehydrogenase, mitochondrial	0	1	0	1
Solute carrier organic anion transporter family member 4C1	0	1	0	2
Monocarboxylate transporter 8	0	0	0	1
Solute carrier organic anion transporter family member 1C1	0	0	0	1
BRCA1	1	0	0	1
Ubiquitin carboxyl-terminal hydrolase isozyme L5	0	1	0	1
Chain A, Carbonic anhydrase 1	0	1	0	1
Prolyl endopeptidase	0	1	0	1
Carbonic anhydrase-related protein 11	0	0	0	1
Carbonic anhydrase 5A, mitochondrial	0	1	0	1
Carbonic anhydrase 2	0	1	0	1
procathepsin L isoform 1 preproprotein	0	1	0	1
Chain A, enoyl-acyl carrier reductase	0	1	0	1
Chain C, enoyl-acyl carrier reductase	0	1	0	1
Chain A, enoyl-acyl carrier reductase	0	1	0	1
Chain C, enoyl-acyl carrier reductase	0	1	0	1
Chain A, enoyl-acyl carrier reductase	0	1	0	1
Chain C, enoyl-acyl carrier reductase	0	1	0	1
Chain A, Repressor	0	0	1	1
3-oxoacyl-[acyl-carrier-protein] synthase 3	0	1	0	1
twin arginine protein translocation system - TatA protein	0	0	0	2
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI	0	1	0	1
Carbonyl reductase [NADPH] 1	0	2	0	2
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI	0	1	0	1
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI	0	1	0	1
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI	0	2	0	2
Enoyl-acyl carrier reductase	0	1	0	1
Enoyl-ACP reductase II	0	1	0	1
Thyroid hormone receptor beta	0	1	0	1
Solute carrier organic anion transporter family member 4C1	0	0	0	1
Solute carrier organic anion transporter family member 4A1	0	0	0	1
Solute carrier organic anion transporter family member 1C1	0	1	0	1
5-hydroxytryptamine receptor 4	0	0	0	1
Chain A, Trp Rna-binding Attenuation Protein	0	0	1	1
Chain K, Trp Rna-binding Attenuation Protein	0	0	1	1
Chain B, tryptophanyl-tRNA synthetase	0	0	1	1
Chain C, Tryptophanyl-tRNA synthetase II	0	0	1	1
Tryptophan 2,3-dioxygenase	0	1	0	2
Tryprostatin B synthase	0	0	0	1
2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase	0	0	1	1
Urease subunit alpha	0	1	0	1
Urease subunit beta	0	1	0	1
Solute carrier family 2, facilitated glucose transporter member 9	0	1	1	2
Valacyclovir hydrolase	0	0	0	1
Chain A, Arginase 1	0	1	0	1
Aldo-keto reductase family 1 member A1	0	1	0	1
Aldo-keto reductase family 1 member A1	0	1	0	1
Aldo-keto reductase family 1 member A1	0	1	0	1
Aldo-keto reductase family 1 member B7	0	1	0	1
Proprotein convertase subtilisin/kexin type 7	0	1	0	1
Vitamin K epoxide reductase complex subunit 1-like protein 1	0	1	0	1
Vitamin K epoxide reductase complex subunit 1	0	1	0	1
Protease	0	2	1	3
Vitamin K epoxide reductase complex subunit 1-like protein 1	0	1	0	1
Vitamin K epoxide reductase complex subunit 1	0	2	0	2
Ricin	0	1	0	1
Alpha-2A adrenergic receptor	0	1	0	1
M-phase inducer phosphatase 1	0	1	0	1
Lysosomal alpha-glucosidase	0	1	0	1
Ectonucleoside triphosphate diphosphohydrolase 1	0	0	0	1
Aspartate aminotransferase, cytoplasmic	0	1	0	1
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

chemdatabank.com